A Multi-Scale Cell-Based Model to Simulate and Elucidate the Mechanisms Controlling Tumor-Induced Angiogenesis. by Bauer, Amy L.
A Multi-Scale Cell-Based Model to Simulate and




A dissertation submitted in partial fulfillment
of the requirements for the degree of
Doctor of Philosophy
(Mathematics)
in The University of Michigan
2007
Doctoral Committee:
Associate Professor Trachette L. Jackson, Co-Chair
Yi Jiang, Co-Chair, Los Alamos National Laboratory
Professor Daniel M. Burns Jr.
Associate Professor Denise E. Kirschner
Professor Charles D. Little, The University of Kansas Medical Center

c© Amy L. Bauer 2007All Rights Reserved
Only those who will risk going too far can possibly find out how far one can go.
T.S. Eliot
Without the unconditional support and encouragement from my family and dear friends, this
research would not have been completed. I dedicate this dissertation to them.
ii
ACKNOWLEDGEMENTS
I gratefully acknowledge my advisers, Trace Jackson and Yi Jiang, for their su-
perior scientific guidance and mentoring. Individually and collectively, you are an
inspiring example of exceptional scientific ability and of what is possible to achieve as
women in science. Thank you both for showing me the ropes and for your patience.
I am grateful to my committee members: Professors Denise Kirschner, Dan Burns,
and Charlie Little for their insightful and valuable comments. I would like to express
my appreciation to the members of the Mathematical Analysis and Modeling Group
at Los Alamos National Laboratory for providing the infrastructure (computing re-
sources and programming training) critical to the computational component of this
research. Heartfelt thanks to all who offered words of encouragement, expressed your
belief in me, and offered personal and professional advice along the way, especially:
SCH, DEK, NLJ, CPS, CAL, JH, RED, JAS, TdF, LBG, TSV, NEB, MOM, DAD.
iii
TABLE OF CONTENTS
DEDICATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ii
ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iii
LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xiii
CHAPTER
I. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
II. Biological Background to Angiogenesis . . . . . . . . . . . . . . . . . . . . . . 7
2.1 Tumor–Induced Angiogenesis . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2.2 The Dynamic Role of the Extracellular Matrix in Angiogenesis . . . . . . . . 14
2.2.1 ECM mediated changes in cell phenotype . . . . . . . . . . . . . . 15
2.2.2 Mechanical properties of the ECM . . . . . . . . . . . . . . . . . . 17
2.3 Intracellular Signal Transduction Pathways in Angiogenesis . . . . . . . . . . 19
2.3.1 The VEGF receptors . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.3.2 Integrin receptors . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.3.3 Vascular endothelial (VE)–cadherins . . . . . . . . . . . . . . . . . 23
2.3.4 Receptor cross-talk . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.4 Historical Milestones in the Angiogenesis Field . . . . . . . . . . . . . . . . . 25
III. Modeling Angiogenesis Mathematically . . . . . . . . . . . . . . . . . . . . . . 28
3.1 Modeling Biological Systems Mathematically . . . . . . . . . . . . . . . . . . 28
3.2 The Role of Agent Based Models in Multi-Scale Systems . . . . . . . . . . . 30
3.3 Existing Mathematical Models of Angiogenesis . . . . . . . . . . . . . . . . . 32
3.4 Cell-Based Modeling Approach to Simulate Angiogenesis . . . . . . . . . . . 36
IV. First Cell-Based Model of Tumor-Induced Angiogenesis . . . . . . . . . . . 38
4.1 Model Architecture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
4.2 Model Domain and Geometry . . . . . . . . . . . . . . . . . . . . . . . . . . 39
4.3 Extracellular Dynamics (VEGF) . . . . . . . . . . . . . . . . . . . . . . . . . 41
4.4 Modeling the Stroma and Extracellular Matrix . . . . . . . . . . . . . . . . . 44
4.5 Cellular Potts Model for Cellular Dynamics . . . . . . . . . . . . . . . . . . . 45
4.6 Hybridization: Interfacing the Discrete & Continuous Models . . . . . . . . 50
4.7 Parameters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
4.8 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
4.9 Dimensional Analysis of VEGF Dynamics . . . . . . . . . . . . . . . . . . . . 54
iv
4.10 ANGIO – Simulation Software Developed in Python . . . . . . . . . . . . . . 55
4.10.1 Fourier transform solutions to the PDE . . . . . . . . . . . . . . . 56
4.10.2 Visualization techniques . . . . . . . . . . . . . . . . . . . . . . . . 57
V. Cell-Based Model Exhibits Emergent Phenomena: Branching and Anas-
tomosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
5.1 Using Simulation as an Investigative Tool . . . . . . . . . . . . . . . . . . . . 59
5.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
5.2.1 Realistic capillary sprout morphology captured . . . . . . . . . . . 62
5.2.2 Local VEGF gradient influences capillary sprout morphology . . . 64
5.2.3 Average rates of sprout extension are affected by proliferating re-
gion and cooperation of cellular functions . . . . . . . . . . . . . . 68
5.2.4 Stroma composition & ECM structure:
Mechanisms for capillary sprout branching and anastomosis . . . . 71
5.2.5 Sensitivity analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
5.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
VI. Topography of Extracellular Matrix Mediates Vascular Morphogenesis . . 83
6.1 Extended Cellular Model of Angiogenesis . . . . . . . . . . . . . . . . . . . . 85
6.1.1 Parameter calibration . . . . . . . . . . . . . . . . . . . . . . . . . 89
6.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
6.2.1 Model validation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
6.2.2 Model predicts ranges of matrix fiber density that may inhibit an-
giogenesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
6.2.3 Network connectedness and matrix fiber alignment influence sprout
extension speeds . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
6.2.4 Cell shape and orientation are linked to matrix fiber alignment . . 106
6.2.5 Changes in average extension rates due to tip cell matrix degrada-
tion varies as a function of ECM density . . . . . . . . . . . . . . . 109
6.2.6 Sensitivity analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
6.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
6.3.1 Clinical implications: ECM targeted angiogenic therapies . . . . . 117
VII. Intracellular Signal Transduction and Its Role in Controlling Cellular
Behavior During Angiogenesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
7.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
7.2 Review of Boolean Network Models . . . . . . . . . . . . . . . . . . . . . . . 122
7.3 VEGF-Integrin-Cadherin Receptor Cross-Talk: A Boolean Network Model . 125
7.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
7.4.1 Cellular phenotype linked to external cues . . . . . . . . . . . . . . 129
7.4.2 Investigating the relationship between Rac1 and Rho . . . . . . . . 132
7.4.3 Dynamical stability analysis . . . . . . . . . . . . . . . . . . . . . . 133
7.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
VIII. Multi-Scale Model of Angiogenesis . . . . . . . . . . . . . . . . . . . . . . . . . 144
8.1 Incorporating Intracellular Signaling . . . . . . . . . . . . . . . . . . . . . . . 144
8.1.1 Parameter calibration . . . . . . . . . . . . . . . . . . . . . . . . . 149
8.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
8.2.1 Cell phenotype distribution in time predicted by multi-scale cell-
based model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
v
8.2.2 Model reveals link between matrix density, cell phenotype, and
sprout branching . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
8.2.3 “Brush border” effect captured by multi-scale cell-based model . . 161
8.2.4 Sensitivity analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
8.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166
IX. Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
9.1 Impact of Dissertation Research . . . . . . . . . . . . . . . . . . . . . . . . . 171
9.2 Future Outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
9.2.1 Modeling matrix fiber reorganization . . . . . . . . . . . . . . . . . 174
9.2.2 Influence of various VEGF isoforms . . . . . . . . . . . . . . . . . . 177




2.1 Depiction adapted from Zetter et al. [175] showing the three distinct phases of
tumor growth. Angiogenesis is the bridge between avascular and vascular tumor
growth, a potentially fatal stage of cancer. . . . . . . . . . . . . . . . . . . . . . . . 8
2.2 An illustration of early events in angiogenesis taken from Bauer et al. [12]: VEGF
mediated endothelial cell activation and degradation of the basement membrane,
subsequent migration and invasion into the tissue led by tip cells extending filopo-
dia, cell division, and endothelial cell interaction with extracellular matrix fibers.
This illustration emphasizes that the processes involved in angiogenesis are con-
trolled at the level of individual cells. In this context, cellular dynamics are a
discrete process and a cell-based model is a better description of cellular dynamics
than continuous models, which deal solely with cell densities. . . . . . . . . . . . . 9
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4.1 The geometry of the initial domain. An endothelial cell bud (red) grows into the
tissue from a parent blood vessel adjacent to the left boundary; an avascular tumor
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matrix fibers (yellow), tissue specific cells (dark blue) and interstitial fluid (light
blue). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
4.2 Left: Magnification of Type I collagen fibers. Right: Model representation of
heterogeneity and random distribution of ECM fibers of constant width. . . . . . . 46
4.3 A schematic that shows the interface between the discrete and the continuous mod-
els. The continuous model for VEGF and the discrete model of cellular dynamics
are used as initial conditions for each other at every time step to produce a coupled
system of extra- and intercellular dynamics. . . . . . . . . . . . . . . . . . . . . . . 50
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chemotactic forces and adhesion to the matrix. Parameters used are as given in
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5.6 Numerical simulations ruling out the possibility that branching is induced solely
by the tessellated structure of the stroma. For an identical parameter set, (a)
depicts a branch emerging from the main capillary as a result of anisotropies in
the stroma, (b) demonstrates that the structure of the matrix fibers alone can
induce branching, and (c) shows branch formation induced by resident tissue cells.
No branching occurs in a homogeneous extracellular environment due to a loss of
adhesive guidance cues (d). Parameters are given in Table 4.1. Results suggest two
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Cancer kills one in four Americans. It is the leading cause of death in the United
States [73]. Cancer invasion and metastasis depend on tumor-induced angiogenesis,
which is the formation of new blood vessels from existing vasculature in response to
chemical signals from a tumor. Angiogenesis marks the pivotal transition from benign
solid tumor growth to vascular growth, a more progressive and potentially fatal stage
of cancer beyond which cancer becomes extremely difficult to treat and survival
rates decrease [156]. Angiogenesis is a complex process, involving multiple time
scales and intricate interplay between biochemical and biomechanical mechanisms,
including cell-cell and cell-matrix interactions, cell surface receptor binding, and
intracellular signal transduction. The sequential morphogenetic processes required
for angiogenesis to occur are well known and a thorough review of these processes is
given in Chapter II; however, what is still not completely understood is how cellular
and molecular mechanisms are coordinated to control these processes.
The processes that occur during angiogenesis span multiple time and length scales.
These time and spatial scales can range from 10−2 seconds and 10−9 meters during
gene transcription and protein production at the molecular level to 106 seconds and
10−1 meters at the tissue and whole organ level. However, experimental investigations
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and data generated from these investigations focus on specific mechanisms relegated
to isolated time or length scales and must be translated between biological scales.
For processes relevant to angiogenesis, this information exists at the whole organ
and tissue level: where tumor cells develop into cancer and blood vessels grow to
form vascular networks, the cellular level: where the study of the biomechanics of
cell motility, growth, division, and apoptosis are central themes, and the molecular
level: where investigations have led to detailed regulatory and signaling networks. A
major challenge facing the modeling and the experimental research communities is to
integrate this information in a way that improves our understanding of the principal
underpinnings driving angiogenic processes and that will advance efforts aimed at the
development of new therapies for treating cancer and other angiogenesis-dependent
diseases.
A cell-based multi-scale approach to modeling angiogenesis, which is applicable
to other biological systems as well, responds well to this challenge. Mammalian cells
are only capable of a limited collection of behaviors. They can grow, divide, mi-
grate, and synthesize biochemical products. However, even with all the impressive
research focused on elucidating cellular regulation, scientists are still far from having
the complete picture of a single cell and understanding how, from this rather limited
repertoire of behaviors, cells cooperate to form very complex biological structures.
Moreover, most of the phenomena that we eventually care about occur at the tissue
and whole organism scale, for example as in cancer, and host-pathogen interactions
leading to disease. A phenomenological description of cell behavior can provide a
great deal of insight into these tissue level dynamics, much more than detailed but
isolated segments of regulation networks and signaling pathways can ever hope to
achieve. In addition, the ability to integrate a cell-based phenomenological model
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with some detailed understanding at the regulation level becomes a powerful investi-
gatory tool. Looking forward, coupling a tumor growth model [75] with a cell-based
model of angiogenesis [12, 125] and the immune system response against the tumor
will be a major step towards the development of an integrated systems approach
to modeling tumor growth and cancer invasion and towards the ultimate goal of
predicting the effects of novel cancer and anti-angiogenic therapies.
The research conducted for this dissertation concentrates on the development of
a multi-scale model of angiogenesis that integrates tissue, cellular, and molecular
level dynamics. This multi-scale model captures key biochemical and biomechanical
interactions that occur between endothelial cells and the extracellular matrix. Using
this model, we investigate the mechanisms responsible for promoting and inhibiting
angiogenesis.
This dissertation is organized in the following manner. Chapter II provides a
background to the biological processes involved in angiogenesis. This chapter high-
lights angiogenesis as the key event that enables a benign solid tumor to progress
to cancer and metastasis. There is a discussion of the importance of the extracel-
luar matrix and critical signaling receptors and pathways as critical regulators of the
morphologic events during angiogenesis. The chapter concludes with some historical
milestones in the angiogenesis field.
Chapter III presents an overview of different mathematical modeling techniques
used to describe biological systems and the need for multiple scale methods to cap-
ture and integrate the dynamics that frequently occur over widely varying time and
length scales. This chapter includes a survey of existing mathematical models of
angiogenesis and identifies their strengths and limitations. The choice of a cell-based
model to investigate angiogenesis is based on the premise that the interactions that
4
govern angiogenic events are spatially and temporally localized and cell specific, that
is, these interactions are regulated at the level of the individual cells.
The existing body of mathematical and physics research in angiogenesis is void
of a model capable of capturing individual cellular behaviors and the fine details
of newly formed vascular sprouts and in Chapter IV we present the first cell-based
model of angiogenesis. Our approach is a hybrid model integrating continuous and
discrete mathematical models. Specifically, cellular dynamics are described using a
lattice Monte Carlo model, and a continuous partial differential equation incorpo-
rates extracellular chemical dynamics. Using this model, in Chapter V we explore
the mechanisms driving different sprout morphologies and test several hypothesis
proposed to provide insight on conflicting experimental data. The model is capable
of simulating sprout branching and anastomosis, larger scale structures that emerge
only as a result of the featured cellular and molecular level dynamics. This result
is an important contribution to modeling angiogenesis as no other model has repro-
duced sprout branching without a priori prescribing phenomenological rules for these
events. The results presented in Chapters IV and V have already been published in
Biophysical Journal [12].
Then in Chapter VI, additional mechanisms for cellular motility and sprout ex-
tension are incorporated into the model. This extended model accurately reproduces
and is validated against empirical measurements of sprout extension speed. Thus,
the model can be used to study how extracellular matrix topography influences cell
shape, intercellular and cell-matrix interactions, and multicellular sprout extension
speed. We find distinct ranges of extracellular matrix density that specifically pro-
mote or interrupt sprout growth, and identify a density range optimal for sprout
branching. The extended model and the results described in this chapter are in
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revision for publication in Biophysical Journal [13].
As the first step towards a multi-scale model of angiogenesis, Chapter VII devel-
ops a Boolean network model for critical signal transduction pathways involved in
regulating key cellular behaviors. This model is then used to understand how a cell
interprets the biochemical signals initiated by key external stimuli involved in angio-
genesis and the influence of these external signals on cellular function. The major
contribution from this study is that it is the first to propose a network model that
highlights the cross-talk between growth factor, integrin, and cadherin receptors.
Finally, in Chapter VIII, we integrate the intracellular signaling model from Chap-
ter VII into the extended cellular model from Chapter VI and present a multiple scale
model of angiogenesis. This integrated systems approach allows the removal of the
phenomenological rules that determine cell phenotype. Instead, each cell is equipped
with the internal decision making machinery to survey its local landscape and re-
spond to external cues. The integrated model is used to examine how the external
environment guides critical cellular decisions, including whether the cell is going to
proliferate, migrate, or initiate apoptosis, and how these decisions influence sprout
morphology. In previous models of angiogenesis, apoptosis has largely been neglected
and cell quiescence has not been considered at all. Our multi-scale model captures
both cell quiescence and apoptosis, and consequently, it can be used to investigate
a whole new area of angiogenesis treatment strategies. The model produces some
exciting results: the appearance of multiple branches, different proliferation regions,
and the brush border effect. Our studies reveal a link between matrix density, cell
phenotype, and sprout morphology. This multi-scale model is another step toward
a whole systems approach to understanding how the mechanisms controlling angio-
genesis are regulated and feedback on each other between hierarchical levels: from
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tissue to individual cell to molecular signaling and back again.
The summary chapter IX discusses the impact of this research in a broader context
and proposes future applications and extensions of the multi-scale model.
CHAPTER II
Biological Background to Angiogenesis
2.1 Tumor–Induced Angiogenesis
Tumor growth can be characterized as having three distinct stages: (1) avascular
growth, (2) angiogenesis, and (3) vascular growth (Figure 2.1). Initially, tumor
growth is avascular. The solid tumor mass develops as the cancer cells proliferate in
the absence of a blood supply. In this phase, the tumor obtains nutrients, including
oxygen and glucose, and exports its metabolic waste by diffusion transport processes
alone. Since a tumor’s mechanism for growth is a diffusion limited process, avascular
tumors cannot grow indefinitely. The diffusion limit for oxygen is approximately
100 microns (µm). Thus, as the tumor increases in size, cells near the center of the
tumor are beyond this diffusion limit and become oxygen starved. These cells become
hypoxic and stop growing, a state known as quiescence. As the tumor continues to
expand, the quiescent cells eventually become so oxygen deprived that they die,
forming a necrotic core. Typically avascular tumors can only grow to approximately
1−2 millimeters in diameter [107].
To ensure its sustained growth, a tumor must acquire a supply of nutrients and
the ability to export metabolic waste. It does this by stimulating new blood vessel
growth from nearby existing vasculature. This new vessel formation is called angio-
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Figure 2.1: Depiction adapted from Zetter et al. [175] showing the three distinct phases of tumor
growth. Angiogenesis is the bridge between avascular and vascular tumor growth, a
potentially fatal stage of cancer.
genesis. Circulating endothelial precursors, shed from the vessel wall or mobilized
from bone marrow can also contribute to tumor angiogenesis [10]. Another way
tumor vascularization can occur is when tumor cells grow around an existing vessel
forming a perivascular cuff [21]. Oxygen deprived tumor cells release a wide variety of
polypeptide angiogenic factors that initiate new vessel growth [93]. These angiogenic
factors diffuse through the surrounding tissue, setting up a chemical gradient between
the tumor and any existing vasculature. Among these, members of the vascular en-
dothelial growth factor (VEGF) and angiopoietin family have a prominent role [19].
Angiopoietins are involved in maintaining cell-cell contacts, inhibiting apoptosis, and
promoting vessel maturation [126]. However, VEGF is the most well-characterized
angiogenic factor critical for angiogenesis. When VEGF reaches the blood vessel, it
triggers a cascade of events. Figure 2.2 illustrates the major VEGF mediated events
that occur during early angiogenesis. Endothelial cells, which form the interior lin-









Figure 2.2: An illustration of early events in angiogenesis taken from Bauer et al. [12]: VEGF
mediated endothelial cell activation and degradation of the basement membrane, sub-
sequent migration and invasion into the tissue led by tip cells extending filopodia, cell
division, and endothelial cell interaction with extracellular matrix fibers. This illustra-
tion emphasizes that the processes involved in angiogenesis are controlled at the level
of individual cells. In this context, cellular dynamics are a discrete process and a cell-
based model is a better description of cellular dynamics than continuous models, which
deal solely with cell densities.
cells are activated via two high affinity VEGF receptors, VEGFR1 and VEGFR2.
At the onset of angiogenesis, endothelial cell activation results in increased vascular
permeability [129] and the production of proteases that locally degrade the basement
membrane of the blood vessel [113, 69]. This breakdown of the basement membrane
enables the endothelial cells to migrate into the extracellular matrix of the extravas-
cular tissue, also referred to as the stroma. In order to reach the tumor, endothelial
cells must navigate the complex structure of the extracellular matrix (ECM). The
role of the ECM in sprout guidance is described in detail in Section 2.2. VEGF
activated endothelial cells also upregulate additional cell surface receptors called in-
tegrins, which regulate cellular adhesion to matrix molecules [146]. To facilitate
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their migration, endothelial cells have the ability to condition the ECM by produc-
ing a number of different proteolytic enzymes which degrade specific ECM proteins
[113, 69]. Two such proteases are plasminogen activators and matrix metallopro-
teinases. Plasminogen activators are crucial for the degradation of fibronectin and
laminin, whereas matrix metalloproteinases degrade collagen and elastin [113, 124].
As endothelial cells interact with the ECM, they can also cause the release of an-
giogenic factors that were bound to the ECM [107, 63, 91]. These newly liberated
angiogenic factors are then available for endothelial cells to use to further coordinate
their movement through the stroma [63, 91]. Considerable attention has been given
to the role of growth factors, such as vascular endothelial growth factor (VEGF), in
endothelial cell migration, survival, and proliferation.
There is substantial empirical evidence indicating that VEGF induces endothe-
lial cell migration [150, 50, 172, 18]. One means of endothelial cell migration is by
chemotaxis, which is directed motility toward positive chemical gradients. Using a
Boyden chamber assay, Cao et al. showed that VEGF elicits a strong chemotactic
response in human umbilical vein endothelial cells [18]. In an in vitro study of two
populations of porcine aortic cells, one cell line expressing only VEGFR1 and the
other only VEGFR2, Waltenberger et al. demonstrated that VEGFR2 was solely
responsible for VEGF mediated chemotaxis [167]. Endothelial cell migration also
occurs along positive gradients of cellular adhesion sites that are naturally present
in the ECM [154], a process called haptotaxis. Endothelial cell degradation and pro-
duction of collagen and fibronectin can create new or amplify existing local adhesive
gradients, which also affects endothelial cell haptotaxis [56].
VEGF can regulate very different cellular responses resulting in phenotypically
distinct populations of endothelial cells. Experiments of murine retinal angiogenesis
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Figure 2.3: High magnification confocal images showing phenotypically distinct tip cells during
angiogenesis [50]. The endothelial cells at the tips of the vascular sprouts extend long
filopodia. Scale bar = 20 µm.
show that the sprout tip consists of a single endothelial cell, which responds to VEGF
solely by chemotaxis (no proliferation), and that VEGF induced proliferation occurs
only in the cells comprising the sprout stalk [50]. Figure 2.3a is a confocal micrograph
of VEGF induced angiogenesis demonstrating the distinctive morphology of vascular
sprout tip cells. Figure 2.3b is a close-up of one of these tip cells. Evident in both
images, the endothelial cells at the tips of the vascular sprouts extend long filopodia.
The scale bars represent 20 µm. The mitogenicity of VEGF on endothelial cells is
also well substantiated [128, 40, 150, 18]. From the experiments of Waltenberger et
al. [167] described above, it is shown that VEGFR2 is the only receptor implicated
in VEGF stimulated endothelial cell mitosis. During angiogenesis, endothelial cell
proliferation provides the additional cells necessary for the sprout to grow and extend
further into the stroma towards the tumor (see Figure 2.2) [54, 124, 151]. Branches
develop when the sprout bifurcates and loops form when neighboring sprouts fuse
together. This fusing of two vessels is a process called anastomosis. As the new
sprout approaches the tumor, there is an increased incidence of sprout branching
that is referred to as the brush border effect [116].
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Newly formed capillary sprouts are initially immature [171]. Immature sprouts
lack a basement membrane and are not yet capable of supporting blood flow [124].
For sprouts to mature, many other processes must first occur, including lumen and
vacuole formation, the recruitment of specialized cells, and the construction of a
basement membrane. Endothelial cells must abandon their invasive phenotype and
reassociate with the ECM via cell surface integrins [107]. In vitro experiments of hu-
man endothelial cells in three dimensional collagen matrices show that vacuole and
lumen formation depend on collagen-binding integrin α2β1 [32]. These studies reveal
that intracellular vacuoles enlarge and coalesce to create a luminal compartment.
Endothelial cells further associate and develop lumens at sites of cell-cell contact,
thereby generating tubular structures. Endothelial cells also recruit specialized cells
called pericytes and smooth muscle cells. These cells contribute to vessel stability
and maturation by inhibiting endothelial cell proliferation and promoting new base-
ment membrane synthesis [59]. The result is a fully mature vessel capable of blood
transport and thus nutrient delivery to the tumor.
Although these fundamental processes that occur during angiogenesis are well
established, there is still considerable ambiguity and debate among researchers as
to how biochemical and biomechanical mechanisms are coordinated to control vas-
cular development. Recent efforts in experimental research have intensely focused
on advancing understanding of these mechanisms in hopes of discovering novel anti-
angiogenesis therapies. However, as new experimental assays capable of examining
the cellular and molecular level dynamics during angiogenesis are developed, discor-
dant data have been published. The following sections review some of the experi-
mental observations that have given rise to dogma, and present conflicting empirical
data that have generated confusion.
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Figure 2.4: Plot of tumor volume for distinct phases of tumor growth in the rabbit cornea [52].
Rapid tumor expansion that occurs after vascularization is evident.
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The vascular growth phase of tumor development occurs after the blood vessels
reach the tumor (Figure 2.1). The newly acquired vasculature provides a direct
source of oxygen and nutrients to the tumor and increases the tumor’s capacity to
export waste products, thereby allowing the tumor to sustain rapid continued growth
unattainable by avascular tumors [52]. In Figure 2.4, tumor volume in mm3 is mea-
sured over time and the prevascular and vascular phases of tumor growth are labeled
[52]. This plot punctuates the rapid growth that ensues after tumor vasculariza-
tion. Tumor vascularization has been closely linked to metastasis [41], which is the
transmission of cancer cells distal to the original tumor. Often secondary tumors
develop. Vascular growth and metastasis mark a progressive and potentially fatal
stage of cancer. Angiogenesis, therefore, is the critical transition between the benign
avascular stage of tumor growth and cancer. Because of its important role in cancer,
understanding the processes involved in angiogenesis is an area of intense focus for
experimental biologists and mathematical modelers, and provides the motivation for
this dissertation.
2.2 The Dynamic Role of the Extracellular Matrix in Angiogenesis
The location of the tumor dictates the environment in which endothelial cells
must survive and migrate. Depending on the tissue, the density of the matrix and
the various other cells that make up the stroma can vary a great deal. It is widely
accepted that cellular interactions with the ECM and the location of the tumor have
a significant impact on new capillary sprout formation and morphology. Therefore
understanding how the ECM modulates angiogenic processes has commanded consid-
erable attention in experimental research. There is, however, speculation concerning
the precise mechanisms involved and important questions are, as yet, unanswered.
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What role does the ECM play in endothelial cell function? How are growth differ-
entials between neighboring endothelial cells established? How is sprout branching
initiated? And, can the composition of the stroma be manipulated to inhibit angio-
genesis? A more in depth investigation of the role of the composition and structure
of the stroma on capillary formation is needed and cell-based modeling provides a
forum for such studies.
The extracellular matrix is a dynamic macromolecular structure that influences
the interactions among cells and the organization of tissues. It is a major component
of the extravascular tissue region, or stroma, and plays a central role not only in new
blood vessel growth [34], but also in other morphogenic processes, including embryo-
genesis [29], tissue repair and wound healing [112], and cancer invasion [135]. The
ECM is made up of fibrous proteins, collagen and elastin, specialized proteins, such
as fibronectin and laminin, and chains of complex sugars [4]. It provides molecules
for cellular adhesion to the matrix as well as mechanical support for cell migration
and morphogenesis. A large body of research is concentrated on understanding how
cell-ECM interactions impact and regulate morphogenic processes. Results from such
investigations illuminate the active role of the ECM in transmitting biochemical sig-
nals and mechanical forces that can mediate cell survival, phenotype, shape, and
orientation. This area continues to be a target of intense investigation.
2.2.1 ECM mediated changes in cell phenotype
Cells are equipped with and can upregulate transmembrane receptors that enable
them to receive signals from and interact with their environment. Signaling proteins,
including focal adhesion kinase, α-actinin, and vinculin, associate with the intracellu-
lar integrin domain to form a focal complex that binds to the cell’s cytoskeleton [118].
Once assembled, a focal adhesion anchors the cell to the ECM, which is used by the
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cell for movement. These focal adhesions are assembled and disassembled dynam-
ically to facilitate cell migration. The presence of highly clustered focal adhesions
are a hallmark of a migratory cell phenotype. Migratory guidance via focal adhesion
binding sites in the ECM is a phenomenon referred to as contact guidance and plays
a key role in guiding new vessel growth [160]. Contact guidance results in biased cel-
lular motion in the direction of matrix fiber alignment. This differs from haptotaxis,
which is another mechanism for directed cell motility whereby cells move in response
to gradients of adhesion. The haptotactic response is to adhesive glycoproteins, such
as fibronectin, found in the extracelluar matrix.
Experiments have linked the mechanical forces induced by cell attachment to the
ECM via integrins to changes in a cell’s internal molecular machinery [26]. Such
tension-dependent alterations affect signal transduction pathways, cellular biochem-
istry, and changes in the cytoskeleton [26]. Experiments using human microvascular
endothelial cells on substrates patterned with adhesive islands were performed to
explore how the ECM influences cell shape and cellular function [25, 64]. In these
experiments, cell shape was regulated by controlling the size and number of adhe-
sive islands. Cells on adhesive islands that allow sufficient cell spreading successfully
enter and progress through their growth cycle. As the size of the adhesive islands is
reduced, cell spreading is limited and the cells enter a program of apoptosis. Even in
the presence of saturating concentrations of growth factor, loss of anchorage to the
ECM results in cell cycle cessation and apoptosis. These studies reveal the impor-
tant relationship between cell shape and function and the role of the ECM as a key
mediator.
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2.2.2 Mechanical properties of the ECM
The physical properties of the ECM, such as density, heterogeneity, and stiffness,
that affect cell behavior is also an area of current investigation. Type I collagen
(collagen) is the most abundant protein in the extracellular matrix [90]. The collagen
molecule is a triple helical protein approximately 300 nm long and 1.5 nm in diameter
[90]. Due to its molecular sequence, collagen molecules have a tendency to form
covalent bonds with each other and self-assemble into larger fibrils [90, 152]. Collagen
fibrils also associate into larger bundles of matrix fibrils, referred to as fibers, that
have been estimated to be between 100 and 1000 nm thick [44].
MatrigelTM is a heterogenous gelatinous protein substrate manufactured to cul-
ture cells in in vitro experiments of angiogenesis. It is largely composed of collagen
and laminin and contains growth factor concentrations, all of which provide an envi-
ronment conducive to cell survival. It is a popular choice for observing angiogenesis
because of its ability to stimulate complex cellular behaviors. In experiments of en-
dothelial cells on MatrigelTM, increasing the stiffness of this gel or disrupting the
organization of the cellular cytoskeleton, inhibits the formation of vascular cell net-
works [165, 164]. It has also been shown that matrices with lower fiber density
transfer more strain to the cell [130]. Cells respond to alterations in the mechanical
properties of the ECM, for example, by upregulating their focal adhesions on stiffer
substrates [37]. For anchorage-dependent cells, including endothelial cells, increasing
the stiffness of the ECM therefore results in increased cell traction and slower migra-
tion speeds [37]. Moreover, experiments of endothelial cells cultured on collagen gels
demonstrate that directional sprouting, called branching, is induced by collagen ma-
trix tension [85]. Thus, via integrin receptors, the mechanical properties of the ECM
influence cell-matrix interactions and modulate cell shape, cell migration speed, and
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the formation of vascular networks.
Cells also have the ability to condition the ECM for invasion by producing prote-
olytic enzymes which degrade specific ECM proteins [117]. In addition, cells can syn-
thesize ECM components, such as collagen and fibronectin [164, 86], and can further
reorganize the ECM by the forces they exert on it during migration [164, 165, 130].
Collagen fibrils align in response to mechanical loading and cells reorient in the direc-
tion of the applied load [130]. Tractional forces exerted by vascular endothelial cells
on MatrigelTM cause cords or tracks of aligned fibers to form promoting cell elon-
gation and motility [164]. Experimental studies of matrix remodeling demonstrate
the importance of cell-matrix interactions in controlling cell migration, proliferation,
and apoptosis and clarify the need for further investigation of the effects of local
matrix structure on cell migration [25, 78]. As more experimental data is amassed,
the ECM is emerging as the vital component to morphogenic processes.
Understanding how individual cells interpret biochemical and mechanical signals
from the ECM is only part of the whole picture. Morphogenic processes also require
multicellular coordination. In addition to the guidance cues cells receive from the
ECM, they also receive signals from each other. During new vessel growth, cells
adhere to each other through cell-cell junctions, called cadherins, and in order to
migrate, cells must coordinate integrin mediated focal adhesions with these cell-cell
bonds. This process is referred to as collective or cluster migration [45]. During col-
lective migration, cell clusters often organize as two dimensional sheets [45]. The next
section reviews relevant intracellular signal transduction pathways, the mechanism
by which cells integrate and coordinate information from other cells, environmental
growth factors, and the ECM.
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2.3 Intracellular Signal Transduction Pathways in Angiogenesis
The cellular processes that occur during tumor angiogenesis are tightly coordi-
nated and regulated by signaling molecules, such as tumor secreted growth factors.
Signaling molecules activate endothelial cell surface receptors and initiate intracel-
lular signaling cascades. Intracellular signaling leads to gene transcription, the pro-
duction of enzymes and angiogenic factors, increased cell survival, migration, and
proliferation [58]. We know that endothelial cell binding of VEGF induces prolifera-
tion, cell migration, and the expression of proteases that degrade the ECM, but this
is an oversimplification that neglects the role of different VEGF isoforms, other sig-
naling molecules present in the ECM, and the various types of cell surface receptors.
Signal transduction is the mechanism through which cells translate molecular
stimuli to activate intracellular response mechanisms. This process usually involves
a rapid, ordered sequence of biochemical reactions inside the cell. These biochemical
reactions occur on the order of milliseconds during ion flux, and up to minutes for
the activation of protein mediated kinase cascades. Signal transduction is part of
a complex communication system responsible for regulating fundamental cellular
activities, including metabolism, protein synthesis, division, migration, and survival.
The capacity of cells to perceive and precisely respond to their environment forms the
basis for development, tissue repair, immunity, and normal tissue homeostasis [14].
Cells are equipped with a class of proteins called cell surface receptors that act as
sensory detectors and signal transducers that enable the cell to respond to external
stimuli. There are different types of receptors which are classified according to their
function and by the molecules they bind. Transmembrane receptors are one type
of cell surface receptor and are so called because they bind, or ligate, extracellular
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molecules stimulating a biochemical response across the cell membrane to activate
internal signaling cascades. Examples of transmembrane receptors include receptor
tyrosine kinases (RTK), integrins, toll-like receptors, and G protein-coupled recep-
tors. Another class of receptors are intracellular receptors, which are located inside
the cell and are further divided into cytoplasmic receptors and nuclear receptors.
Located in the cell nucleus, nuclear receptors are activated by hormones and can
bind to DNA to regulate gene expression and protein production. Nuclear receptors
are also called transcription factors. Cytoplasmic receptors, as their name suggests,
are located in the cell cytoplasm and are a general class of receptor that binds sol-
uble ligands in the cytoplasm. Steroid hormone receptors in the cytoplasm are one
example.
One aim of this dissertation is to investigate the mechanisms by which, in response
to VEGF and other signaling molecules, an endothelial cell decides to migrate versus
proliferate and how vascular development is subsequently effected. Because of their
importance in regulating key events during angiogenesis, we focus on three specific
transmembrane receptors: VEGF specific RTK receptors, integrin receptors, and
vascular endothelial (VE) cadherins.
2.3.1 The VEGF receptors
Although there is a large body of experimental literature describing the behavior
of endothelial cells in response to VEGF binding different VEGF specific receptors
on the cell’s surface [20, 39, 50, 66, 46], the mechanisms by which an endothelial
cell can respond differently to what seems to be the same chemical signal are still
unclear. VEGF is an endothelial cell specific protein which has several isoforms
generated by alternative exon splicing. VEGF121, VEGF165, VEGF189, and VEGF206
are four common forms. VEGF121 is a freely diffusible protein produced by tumor
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Figure 2.5: A depiction of the various tumor-secreted and matrix bound VEGF isoforms and their
interaction with endothelial cell receptors (VEGFR1, VEGFR2, NRP1/NRP2) [39].
It is still unclear how receptor-VEGF ligation transmits different signals to regulate
endothelial cell behavior.
cells, whereas VEGF189, and VEGF206 are predominantly bound to and sequestered
in the ECM. The most common isoform is VEGF165. VEGF165 is also secreted by
hypoxic tumor cells, but it is unique in that it is a diffusible protein that can also
bind to the ECM. Matrix bound VEGF may be released when tumor or endothelial
cells proteolytically cleave ECM molecules. VEGF released in this way generates
a diffusible and viable form of VEGF locally available for use by endothelial cells
[107, 63].
As shown in Figure 2.5, endothelial cells are activated via two receptor tyrosine
kinases, fms-like tyrosine kinase-1 and fetal liver kinase-1, which are often referred
to as VEGFR1 and VEGFR2, respectively [171]. VEGF binds to these receptors
triggering intracellular signaling pathways. One example is the VEGF-Bcl2-CXCL8
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signaling pathway, which mediates pro-angiogenic and pro-survival phenotypes in
endothelial cells [120]. VEGFR2 is considered to be the main signaling receptor
for endothelial cells. Neuropilin (NRP1 and NRP2) are VEGF165 isoform specific
receptors that enhance the binding of VEGF165 to VEGFR2 and VEGF165 mediated
chemotaxis [39]. The possibility that NRP acts as a co-receptor to VEGFR2 is
proposed as a possible explanation for the greater mitogenic potency of VEGF165
relative to VEGF121 [39]. There is evidence that VEGFR1 may act as a decoy
receptor since it binds VEGF but does not induce a mitogenic signal. It may also
act to suppress VEGFR2 signaling by competing for available VEGF [107].
2.3.2 Integrin receptors
Integrins are transmembrane receptors that promote the adhesion of cells to ex-
tracellular molecules. They are crucial components for signal transduction from
the ECM. There are many different types of integrins and many cells have multi-
ple types on their surface. Integrin binding to the ECM regulates the expression of
cyclin-dependent kinases and activation of the MAPK signal transduction pathway,
which control cell cycle progression and growth [64]. Integrins are one such receptor
family and are stimulated by binding to the various proteins of the ECM [137, 108].
Integrins are heterodimers composed of α and β subunits. Each subunit has a large
extracellular domain, a transmembrane segment, and two smaller cytoplasmic tails
[144]. Integrin receptors mediate transmembrane signal transduction via “inside-
out” and “outside-in” signaling. Biochemical signals originating within the cell can
affect integrin-ligand binding affinity (inside-out) and consequently modulate cellular
adhesion to the matrix. For example, intracellular signaling and adaptor proteins,
such as α-actinin, vinculin, and focal adhesion kinase (pp125FAK), associate with
the cytoplasmic integrin domain forming an integrin-activating complex or focal ad-
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hesion complex [118, 144]. This activating complex induces spatial changes in the
cytoplasmic tails, which in turn, alters the configuration of the extracellular domain
and the binding affinity of the integrin receptor. Endothelial cells attach directly
to the collagen fibers in the ECM through the α1β1 and α1β2 integrin receptors
[152]. Intracellular signaling pathways are then initiated that influence cell survival,
growth, and that regulate the actin cytoskeleton necessary for cell motility (outside-
in) [25, 34].
2.3.3 Vascular endothelial (VE)–cadherins
Cells must adhere to each other to form cohesive multicellular structures and tis-
sues. In particular, to maintain a tight barrier between the blood in the blood vessel
and the extracellular space, endothelial cells must secure tight junctions with each
other. The mechanism for such adherence in endothelial cells is through transmem-
brane receptors called VE-cadherins. The VE-cadherin transmembrane receptor is
endothelial cell specific. Inside the cell, these receptors can associate with the protein
β-catenin to regulate cadherin binding to the cell’s actin cytoskeleton [98]. Exter-
nally, cadherins form homodimers with the cadherin proteins present on adjacent
cells, connecting the actin cytoskeltons of neighboring cells and thereby providing a
mechanism for intercellular communication.
2.3.4 Receptor cross-talk
During signal transduction, signaling molecules are not always specific to a sin-
gle transduction pathway. Often these signaling components are shared between
different pathways. For example, signals originating from an integrin receptor can
influence the signals received from growth factor ligation to the VEGF receptors.
This phenomenon is referred to as cross-talk. Figure 2.6 is a picture of the focal ad-
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Figure 2.6: An example of cross-talk between different signaling pathways (adapted from KEGG
Pathway Database [122]).
hesion signaling network taken from the KEGG Pathway Database [122] and shows
some of the cross-talk between growth factor and integrin receptors. This database
synthesizes a vast amount of disjoint information taken from multitudes of different
experimental laboratories using different cell lines to produce such signaling path-
ways. These types of networks should be viewed only as a starting point or a road
map to direct further research.
During angiogenesis, the growth factor, integrin, and cadherin signaling pathways
are highly connected and provide regulatory feedback to each other [47]. For ex-
ample, in response to VEGF, endothelial cells upregulate the expression of integrin
receptors [107]. Hutchings et al. 2003 [66] found that integrins can additionally serve
as receptors for immobilized VEGF165 and VEGF189 present in the ECM. Through
the RTK receptor, VEGF activates the MAPK signal transduction pathway that
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stimulates proliferation and cell survival. It has also been demonstrated, however,
that cell survival and proliferation critically depend on adherence to the matrix,
since even in the presence of saturating concentrations of growth factor, loss of an-
chorage to the ECM results in cell cycle cessation and apoptosis [25, 64]. Another
example of receptor cross-talk in angiogenesis occurs through cadherin activation.
Cadherins bind to actin, which is an important structural and signaling molecule
for cytoskeleton reorganization. Therefore cadherin receptors not only facilitate cell-
cell communication but also influence motility. Moreover, there is evidence that
cadherins also induce signals that mitigate growth factor activation and repress cell
proliferation [173]. This process is called contact inhibition. The coupled signals
from growth factor, integrin, and cadherin receptors are interpreted by the cell to
determine cell phenotype and dynamically regulate angiogenic processes [147].
2.4 Historical Milestones in the Angiogenesis Field
Angiogenesis has been an active field of research for many decades. The term
angiogenesis was first coined in 1787 to describe new blood vessel growth. In 1971,
Judah Folkman, the pioneer and grandfather of angiogenesis research, hypothesized
that tumor growth is angiogenesis dependent. His hypothesis was the impetus for
focus research on tumor-induced angiogenesis and the discovery of the mechanisms
controlling new blood vessel growth. To present a broad overview of the progression
of the experimental advances in angiogenesis research, some historical highlights are
summarized below [67].
• 1787 - British surgeon Dr. John Hunter first uses the term angiogenesis to
describe blood vessels growing in the reindeer antler
• 1971 - Surgeon Dr. Judah Folkman hypothesizes that tumor growth is depen-
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dent upon angiogenesis. His theory, published in the New England Journal of
Medicine, is initially regarded as heresy by leading physicians and scientists.
• 1989 - One of the most important angiogenic factors, VEGF, is discovered by
Dr. Napoleone Ferrara and Dr. Jean Plouet. VEGF turns out to be identical
to a molecule called Vascular Permeability Factor discovered in 1983 by Dr.
Harold Dvorak.
• 1992 - The first clinical trial of an anti-angiogenic drug (TNP-470) begins in
cancer patients.
• 1997 - First angiogenesis stimulating drug (becaplermin, Regranex) is FDA
approved for treatment of diabetic foot ulcers.
• 1997 - Dr. Michael O’Reilly publishes a research finding in the journal Nature
showing complete regression of cancerous tumors following repeated cycles of
anti-angiogenic therapy using angiostatin and endostatin.
• 1999 - Massive wave of anti-angiogenic drugs in clinical trials: 46 anti-angiogenic
drugs for cancer patients; 5 drugs for macular degeneration; 1 drug for diabetic
retinopathy; 4 drugs for psoriasis.
• 1999 - Wave of pro-angiogenesis drugs in clinical trials: 5 drugs for coronary
artery disease; 5 drugs for peripheral vascular disease; 1 drug for stroke; 10
drugs for wound healing.
• 1999 - Laboratory research, led by Dr. Robert Kerbel and Dr. Judah Folk-
man, shows that some traditional cytotoxic chemotherapies may inhibit tumor
angiogenesis when administered at low-doses.
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• 1999 - Dr. Richard Klausner, Director of the U.S. National Cancer Institute,
designates the development of antiangiogenic therapies for cancer as a national
priority.
• 2003 - The monoclonal antibody drug Avastin (Bevacizumab) becomes the first
anti-angiogenic drug shown in large-scale clinical trials to inhibit tumor blood
vessel growth and to prolong survival in cancer patients.
The field of angioigenesis continues to be an area of intense research. New anti-
angiogenetic drugs are being developed and are in various stages of clinical testing.
In addition, experimental and theoretical researchers continue to actively search for
promising, new therapeutic targets in hopes that we may gain control of angiogenesis
and contain or cure cancer. Although cancer provides compelling motivation for
further research in and resource allocation to the study of angiogensis, the control of
angiogenesis has important implications to other physiological processes, including
embyrogenesis, arteriogenesis and wound healing. In addition, understanding the
mechanisms that regulate new blood vessel growth may lead to new insights for
advancing both pro- and anti-angiotherapies critical to the treatment of diabetic




A major challenge is to integrate the vast amount of basic science information
available and relevant to angiogenesis to advance understanding of the system as a
whole. This challenge is even more onerous due to the fact that this information
is generated by a number of different research groups, each focusing on a small
piece of the puzzle. The result is disjoint and compartmentalized data at multiple
scales and hierarchies: from gene transcription and protein synthesis, to cellular
response and dynamics, to tissue and organ level organization. Mathematical models
and computational simulation can be used as translational tools to synthesize these
research results into a unified whole.
3.1 Modeling Biological Systems Mathematically
Differential equation models describe deterministic relationships of continuously
changing quantities. Ordinary differential equation (ODE) models, which involve a
single independent variable, are often employed as a starting point to describe bio-
logical systems. One of the advantages of using ODEs is that much is known about
their behavior. ODE models are simple and elegant and generally require fewer pa-
rameters than their spatial counterparts (agent-based models or partial differential
equations). This is an important consideration when experimental data are obtained
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from a well-mixed compartment where spatial information is lacking, for example in
the blood, or from a tissue homogenate, such as the spleen or lymph node. When
sufficiently simple, ODEs have the added benefit of being analytically tractable, and
techniques such as those employed in bifurcation theory can be used to predict pa-
rameter values that switch a system from one steady state to another. However, using
ODE models assumes that the populations they describe are homogeneous and uni-
formly distributed over the simulation space for all time. This is an assumption that
may not be biologically realistic, and that may significantly influence the resulting
dynamics. The assumption can be wholly mitigated by employing partial differen-
tial equation (PDE) models. PDEs are used to describe systems whose dynamics
depend on multiple independent variables. Most physical processes are functions of
several independent variables, distributed in multiple dimensions, or in both space
and time. However, as the ODEs and PDEs become more complicated, they are
more computationally challenging and the advantages to using differential equation
models diminish.
An alternative to differential equation models are agent-based or individual-based
models. Agent-based models (ABMs) are used to describe populations of interacting
agents, such as insects and people, using simple rules that dictate their behaviors.
Agent actions are asynchronous, that is, they do not evolve at constant time steps.
Instead, agents respond dynamically and independently to changing environmental
or discrete event cues. From a simple set of rules, ABMs can exhibit highly com-
plex and emergent phenomena. As experimental assays are developed that increase
understanding of biological systems, the level of description needed for realistic and
relevant models becomes increasingly more complex. Thankfully, the expanding com-
putational ability of computers make possible the use of ABMs for more complex
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systems. As a result ABMs are quickly gaining in popularity [145, 62, 176]. More-
over, because ABM implementation is achieved at the agent level, the description of
the agents and rules tends to mimic the language used to describe the real system,
that is, the description is more physical in character than mathematical. For ex-
ample, models using differential equations consider rates of creation, rates of death,
rates of binding, rates of diffusion for whole populations of agents, whereas an ABM
considers the rules guiding the actions of the agent: will it bind this cell, will it
move towards that cell? The familiar and natural modeling language used in agent
based models not only makes ABMs approachable and useful to experimentalists and
clinicians, but also engages them in the modeling process.
3.2 The Role of Agent Based Models in Multi-Scale Systems
Bridging multiple scales is a formidable modeling challenge. Because agent-based
models are constructed by considering the behaviors of individual system compo-
nents and can be developed for each biological subsystem or hierarchy, they are also
naturally well suited for linking these different models together. For example, merg-
ing ABMs focusing on different biological scales has been used to translate the results
of and facilitate collaboration between experimentalists working on various aspects
of the acute inflammatory response [7]. In this work, a group of agent based mod-
els were developed to simulate intracellular signal transduction pathways that were
then incorporated into ABMs for different cell types. Subsequently, these cellular
models were integrated to simulate tissue and whole organ function during the acute
inflammatory response.
Another modeling technique that has emerged in response to the computational
challenge presented by multiple scales integrates differential equation models with
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ABMs to couple the dynamics occurring on different time and length scales [125,
2, 75, 12, 82, 176]. This technique has been applied to the development of models
describing tumor growth, a complex biological system with important clinical appli-
cations [2, 75, 176]. In Jiang et al. [75], a three-dimensional model of avascular tumor
growth was developed that spans three distinct scales. A lattice Monte Carlo model
is used to describe tumor cell growth, adhesion, and viability. These cell dynamics
are regulated at the intracellular level by a Boolean network for protein expression
that controls the cell cycle. At the extracellular level, nutrients, metabolic waste,
and growth factor and inhibitory chemical concentrations are described by a sys-
tem of reaction diffusion equations. Growth curve measurements and measurements
of the size of the proliferating rim and necrotic core regions from simulated tumors
agree with the quantitative results generated from tumor spheroid experiments. This
model predicts what environmental conditions tumor cells require for survival, and
the molecular weight of potential growth promoters and inhibitors regulating tu-
mor cell viability. As demonstrated by these results, validated models of biological
systems can be used for prediction and to guide future experimental pursuits.
Because of the expense of in vivo and in vitro experimentation, mathematical
modeling and simulation are becoming important and critical research tools. For
quantitative results, all modeling approaches rely on accurate parameter estimation.
Without parameter values based on experimental data, models may provide quali-
tative information, but not necessarily quantitative results. This is a difficult aspect
of modeling that often requires interpretation and/or interpolation of experimen-
tal data to obtain accurate parameter values. Models need to be calibrated and
researchers should confirm that their parameter values are within physically rele-
vant ranges. Consequently, it is useful to perform a sensitivity analysis in order to
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identify key parameters and to understand the effect of parameter uncertainty and
variability on the observed outcomes. In addition, every effort possible should be
made to quantitatively validate model results with independent experiments or with
reports in the literature, using different data than those that were used for model
calibration. Model validation ensures that the model correctly reflects the workings
of the biological process or system and provides a better understanding of the mod-
els capabilities, limitations, and appropriateness for addressing a range of important
questions. Validation is an essential step towards developing a predictive model. Fi-
nally, and perhaps most importantly, modelers should strive to make experimentally
verifiable predictions. Validated models provide a framework for formulating and
testing hypotheses, may offer new perspectives or interpretations of existing results,
and may suggest or guide future experiments.
3.3 Existing Mathematical Models of Angiogenesis
A great number of factors must be tightly coordinated to promote tumor-induced
angiogenesis. No single model has yet incorporated every aspect of every process
involved in sprouting angiogenesis, nor is this level of complexity necessary for a
model to be useful or predictive. Focused investigations on particular mechanisms
and processes advance the development of a number of angiogenesis models. For
instance, Levine et al. models growth factor mediated protease production, incor-
porating an important biochemical mechanism for ECM degradation and regulation
of endothelial cell proliferation [95, 96]. Cell receptor level treatment of this critical
biochemical pathway derived from first principle Michaelis-Menten chemical kinetics
is a significant contribution to angiogenesis models. Other advances in angiogenesis
modeling are being achieved at a more macroscopic level. The development of a dy-
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namic adaptive tumor-induced angiogenesis model took into account hemodynamic
forces, such as shear stress and variable blood viscosity, in the dynamic remodeling
of vascular architecture [109]. These and other existing mathematical models offer
many insights into the processes driving angiogenesis and highlight necessary con-
ditions for angiogenesis to occur, such as endothelial cell proliferation, haptotaxis,
and chemotaxis [8, 155], by concentrating on very specific mechanisms influencing
capillary sprout development.
Mathematical investigations of tumor-related angiogenesis have employed dis-
crete, continuous, and mechanical models to describe a variety of dynamics believed
to affect angiogenesis. Continuum models, that is, models that use differential equa-
tions, rely on the principles of mass conservation and chemical kinetics and, in con-
trast to discrete models, allow for the investigation of aggregate behavior without
having to keep track of individual cells. In one dimension, these models can produce
important averaged quantities, such as blood vessel, endothelial cell sprout and tip
densities, and capillary network expansion rates. However, one-dimensional models
are unable to capture information about the form and structure of the developing
capillary network. Two-dimensional models, while providing a more realistic descrip-
tion of the capillary networks formed during angiogenesis, fall short of producing
hallmark network behavior, such as repeated sprout branching. In two and three
dimensions however, continuum model predictions can be compared to qualitative
data obtained from in vitro and in vivo experiments. One disadvantage, of course, is
that the detailed morphological features of individual cells cannot be studied within
a continuum framework.
The discrete analogue of continuous models are models in which cellular behaviors,
such as growth and motility, occur according to a predefined set of rules. These
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models have the advantage of being computationally fast and efficient, but their
greatest advantage is that they allow the motion and behavior of individual cells to be
studied. As a result, discrete models are especially useful for generating more realistic
capillary structures by incorporating rules for sprout branching and anastomosis,
and may lead to insights about endothelial cell movement and capillary structures
not offered by other types of models [155, 9]. One disadvantage however, is that
assigning rules or probabilities to events may “artificially” generate some phenomena;
for example, the branching in Anderson and Chaplain 1998 [9] is not an inherently
emergent phenomenon, but a prescribed one. More realistic capillary morphology has
been attained in two dimensions, but these models, have been unable to reproduce
branching and the brush border effect without artificial rules [9, 158]. Most models
of angiogenesis largely neglect the dynamic interaction between endothelial cells and
the extracellular matrix. Until very recently, models only considered haptotaxis, a
key interaction between endothelial cells and the ECM through fibronectin [9, 95].
Even at this simple level of description, the capillary networks generated by numerical
simulations agree well with the morphology of capillary networks observed in vivo.
These results strongly suggest that cell-matrix interactions cannot be ignored if a
predictive model of tumor-induced angiogenesis is to be achieved.
There are also mechanical models of angiogenesis that emphasize physical forces,
such as cell traction and motility, to generate vascular networks [105]. At the macro-
scopic level, mechanical models have been used to describe the macroscopic changes
in vessel wall structure and vascular tree formation as a result of changes in blood
pressure and vessel wall stress [109]. At the molecular level, mechanical models have
been employed to study the mechanisms by which forces applied to endothelial cells
alter gene expression and the effects on the signaling pathways. Another variation
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of mechanical modeling of angiogenesis attempts to capture the key interactions be-
tween the mechanical forces generated by the cell and the ECM. Murray and his
co-authors have shown that a purely mechanical theory is capable of predicting pat-
terned networks of endothelial cells similar to those observed in vitro [106]. Holmes
and Sleeman [61], combine this approach with a model proposed by Chaplain, and
develop a mechano-chemical model of tumor-induced angiogenesis. This model is
the first attempt to reconcile the mechanical and chemical aspects of angiogenesis.
However, this model neglects to address ECM degradation, and a cell-biased diffusion
tensor is included arbitrarily rather than derived from first principles. There are a few
successful efforts to model vascular networks by focusing on the mechanical proper-
ties of the ECM, such as elasticity and stiffness [115, 106]. In Manoussaki 2003 [105],
a model incorporating both chemical and mechanical forces, specifically endothelial
cell traction on a viscoelastic ECM, produces network structures that resemble cel-
lular network structures observed in in vitro experiments. However, this work only
considers tractile forces in a continuum model framework geared towards vasculoge-
nesis and does not fully investigate the role of chemotaxis and sprouting vessels in
tumor-induced angiogenesis. Another leading effort in tumor-induced angiogenesis
modeling is described in Sun et al. 2005 [158]. In this model, the anisotropy and
heterogeneity of the ECM is explicitly treated and the model captures the dendritic
structure of capillary network formation. However, sprout branching still only occurs
as a result of imposed rules. A new branch is generated when both the age of the
sprout is above some prescribed age and the variation of the tip velocity transverse
to the existing sprout orientation is greater than a certain threshold value. Although
the structure of the ECM is incorporated into their model, direct endothelial cell-
matrix interactions are not, and consequently, the model is unable to capture the
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individual cell dynamics that allow cells to respond differently according to their
specific local microenvironment.
3.4 Cell-Based Modeling Approach to Simulate Angiogenesis
Mathematical modeling and experimental observations provide convincing evi-
dence that both mechanical and chemical processes may govern tumor-induced an-
giogenesis, and that interactions between tumor cells and endothelial cells within
the host environment cannot be ignored. While significant progress has been made
toward a complete model of tumor-induced angiogenesis, there is still much work to
be done in developing a model that (i) couples multiple time and length scales, (ii)
generates realistic capillary structures including branching and anastomoses without
a priori prescribing rules and probabilities to these events, and (iii) considers the
complex chemical and mechanical interactions that occur between endothelial cells
and the ECM.
A cell-based model is a type of ABM, where the agents are individual biological
cells. However, in contrast to an ABM where an agent is represented by a single
point on a lattice, a cell in a cell-based model occupies many lattice sites. This type
of representation preserves the unique identity and behavior of each cell, properties
that make ABMs powerful. In addition, a cell-based model characterizes and cap-
tures dynamic changes in a cell’s size and shape. Figure 2.2 emphasizes that the
processes involved in angiogenesis happen at the level of individual cells. Because
the typical sprout is only a few endothelial cells long and one to two cells wide, a
cell-based model provides a better description of the cellular dynamics during early
angiogenesis than continuum models, which deal with cell densities. In addition,
discrete and continuum models of angiogenesis that model sprout tip cells or cell
37
densities are predicated on the fact that the tip cell governs the motion of the entire
capillary sprout. These models assume that the rest of the cells in the capillary sprout
are inactive. However, the endothelial cells in the sprout dynamically contribute to
vascular structure through the forces of cellular adhesion, cell signaling, and the lo-
cal restructuring of the ECM [102]. To reproduce realistic vascular networks, these
models must assign probabilities to rules for branching [8, 9, 155, 109]. A cell-based
model is able to account for individual cell interactions with and influence on their
local environment. Consequently, cell specific biochemical and biomechanical dy-
namics are easily incorporated. A cell-based model also has the capacity to simulate
emergent dynamics or structures, for example sprout branching. Another advantage
to cell-based modeling is that adding another scale to the system, for example by
incorporating intracellular signaling as was done in Jiang et al. [75], is a relatively
straightforward extension. As discussed earlier in the context of agent-based models,
a cell-based model of angiogenesis can assist in our understanding and synthesis of
the large amounts of existing composite empirical data.
CHAPTER IV
First Cell-Based Model of Tumor-Induced Angiogenesis
4.1 Model Architecture
The processes involved in angiogenesis naturally suggest a three tier time and
length scale architecture. At the extracellular level, angiogenic factors diffuse through
the stroma. At the cellular level, cellular dynamics include interactions between cells
and cell interaction with the ECM. At the intracellular level, signal transduction
pathways within each cell control cell behavior. In this chapter, we develop a cell-
based model structured in terms of these multiple scales by modeling the extracellular
and intercellular environments. This cell-based model is a hybrid model, that is, it
utilizes the advantages of both discrete and continuous modeling. At the extracellular
level, a partial differential equation describes diffusion, uptake, and half-life decay of
tumor-secreted VEGF. Cellular level dynamics are captured using a discrete lattice
Monte Carlo model (the cellular Potts model) that considers cell migration, growth,
proliferation, cellular adhesion, and extracellular matrix degradation. The extra-
and intercellular environments are integrated and directly impact each other. In
Chapter VIII, an intracellular level is added to capture signaling pathways that
control cell cycle and other signaling dependent decisions that occur inside the cells.
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4.2 Model Domain and Geometry
We initiate the simulations with a single endothelial cell that has degraded the
basement membrane of the primary blood vessel, which lies adjacent to the left hand
boundary. Adjacent to the right hand boundary rests a mature avascular tumor
that delivers VEGF to the stroma. Figure 4.1 shows the initial configuration and
geometry of the domain. Using a two dimensional domain provides a first approx-
imation to capillary sprout formation in vivo and allows us to compare our results
with both experimental models on planar substrates (e.g., [174, 91, 138]) and other
two dimensional computational models [9, 155, 158]. Our model has the flexibility
to examine capillary sprout development at different length scales. The avascular
cornea of the rodent eye is a classical angiogenesis assay, which allows the process
of neovascularization to occur over long distances (1−2 mm) in a normally avascu-
lar tissue [11, 116]. However, tumors that form in other tissues, for example in the
lung, brain, stomach, and breast, are much closer to the existing vasculature. Our
interest is on individual cell interactions during early sprouting angiogenesis. Sprout
initiation and branching have been shown to occur over distances ranging from 20
to 100 µm [79, 91]. Therefore, in our model, the distance between the parent blood
vessel and the tumor is approximately 165 µm. This distance is slightly larger than
the diffusion limit for oxygen (∼100 µm). We choose this length scale so that we
can focus on cell-cell and cell-matrix interactions, to replicate the hypoxic conditions
that may arise in vivo, and to allow sufficient space for the new sprouts to grow 100
µm without encountering an artificial boundary.
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Figure 4.1: The geometry of the initial domain. An endothelial cell bud (red) grows into the tissue
from a parent blood vessel adjacent to the left boundary; an avascular tumor resides
adjacent to the right hand side of the domain and supplies VEGF to the stroma. The
space between represents the stroma and is composed of extracellular matrix fibers
(yellow), tissue specific cells (dark blue) and interstitial fluid (light blue).
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4.3 Extracellular Dynamics (VEGF)
The evolution of VEGF sets up a chemical gradient between the tumor and the
parent blood vessel and constitutes the extracellular environment to which the en-
dothelial cells respond. VEGF is secreted by the tumor and diffuses through the
stroma where it decays at a constant rate and is also taken up by endothelial cells.





= D∇2V − λV −B(x, y, V )
where V = V (x, y, t) denotes VEGF concentration. The coefficient of diffusivity
for VEGF in tissue, D > 0, is assumed to be homogeneous throughout the simula-
tion domain. The rate VEGF decays, λ > 0, is also assumed to be constant, and
B(x, y, V ) is a function describing endothelial cell binding and uptake of VEGF.
The maximum amount of VEGF that can be bound and internalized by an en-
dothelial cell per unit of time is denoted by β. To compute β, we consider the number
of VEGF receptors per endothelial cell and the rate at which VEGF-receptor com-
plexes can be internalized and surface receptors recycled. Vascular endothelial cells
express both VEGFR1 and VEGFR2. While VEGFR2 is VEGF specific, VEGFR1
is not and can bind adhesion molecules and other growth factors [20]. In our calcula-
tion of β, we use the total number of VEGFR1 and VEGFR2 receptors for a human
colon microvascular endothelial cell (311,200) [168, 46]. However, in the model, we
do not consider multiple VEGF isoforms or growth factors, or the explicit binding
of adhesion molecules, both of which compete for available binding sites and may
reduce the amount of VEGF an endothelial cell can bind. That being said, it is
difficult to ascertain whether β provides an over or underestimate of endothelial cell
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VEGF uptake in vivo because VEGF activated endothelial cells upregulate the num-
ber of VEGF receptors they express. Moreover, the actual number of endothelial cell
VEGF receptors depends on cell size, tissue of origin, and vessel size [46]. We use an
instantaneous VEGF-receptor complex internalization rate of 4.3 x 10−4 per second,
and 45 kDa as the molecular weight for VEGF165 [40, 20]. The value of β is computed
in the following manner. The maximum amount of VEGF that can be bound per
endothelial cell, βmax, is given by
βmax = molecular weight of VEGF165 ∗# VEGF receptors
= 7.47225 ∗ 10−8 ∗ 311, 200
= 0.02325 pg/cell
and the endothelial cell VEGF uptake per MCS due to receptor recycling, βr, is
βr = VEGF rate of receptor recycling ∗ βmax
= I ∗ βmax
= 1.548 ∗ 0.02325
= 0.1293 pg/cell/hr .
The total amount of VEGF an endothelial cell can bind in an hour is
β = βmax + βr = 0.02325 + 0.1293 = 0.06 pg/cell/hr
Receptor binding occurs very rapidly compared to the timescale of endothelial cell
migration and proliferation. Thus, we assume that an endothelial cell instantly
binds an amount of VEGF equal to the lesser of available chemical concentration V
or the maximum amount that can be bound to endothelial cell surface receptors and
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internalized, β. This function is given by
B(x, y, V ) =

β, if β ≤ V and {(x, y) ⊂ endothelial cell};
V, if 0 ≤ V < β and {(x, y) ⊂ endothelial cell} ;
0, if {(x, y) 6⊂ endothelial cell}.
Initially, there is no VEGF in the stroma. The amount of VEGF supplied to the
right hand boundary of the domain was estimated by assuming that in response to
a hypoxic environment, quiescent tumor cells secrete a constant amount of VEGF
and that VEGF decays at a constant rate. It is reasonable to assume that the
concentration of VEGF within the tumor has reached a steady state and therefore
that a constant amount of VEGF, denoted S, is available at the boundary of the
tumor. To determine S, we calculate the amount of VEGF secreted by a hypoxic
tumor cell, s, in picograms (pg) and multiply this by an estimate for the number of
hypoxic cells in a mature avascular tumor. So,
s = 624.3 pg/106cells
= 6.243 ∗ 10−4 pg/cell
and therefore
S = s ∗# hypoxic tumor cells secreting VEGF/boundary lattice sites
= 6.243 ∗ 10−4 ∗ 10, 724/L1
= 6.695/L1 pg/boundary lattice site
VEGF secretion rates for hypoxic human cancer cells are taken from experimental
data [93] and the number of hypoxic cells secreting VEGF is estimated based on the
total number of quiescent cells in an avascular tumor as measured in Jiang et al.
[75], where cell quiescence occurs as a result of hypoxic conditions. At a distance of
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165 µm and given that a mature avascular tumor grows to approximately 1−2 mm
in diameter [107], the supply of VEGF from the tumor is approximated by a line
source. Accordingly, the following initial and boundary conditions are used:
V (x, y, 0) = 0,
V (0, y, t) = 0, V (L1, y, t) = S, V (x, 0, t) = V (x, L2, t) .
These initial and boundary conditions for VEGF have frequently been employed in
previous models of tumor-induced angiogenesis [9, 22, 23]. A dimensional analysis
indicates that the concentration of VEGF in the stroma will also very quickly reach a
steady state profile due to rapid diffusion (see Section 4.9). Numerical computations
confirm this. Consequently, the steady state solution is a good approximation to
Eq. 4.1 and we use the steady state VEGF profile as an initial condition for the dis-
crete model as was similarly done in Stokes and Lauffenburger [155] and in Anderson
and Chaplain [9].
4.4 Modeling the Stroma and Extracellular Matrix
The explicit modeling of the stroma and the extracellular matrix fibers is a novel
feature of this model. The stroma is composed of matrix fibers, interstitial fluid, and
tissue specific cells creating an inhomogenous composition and structure. We include
tissue cells in our model to mimic a more anatomically accurate extracellular environ-
ment for the growing and migrating endothelial cells. The properties associated with
these cells are tissue specific and depend on the particular biological processes being
studied. For example, specialized cells, such as mast cells, fibroblasts, macrophages,
or pericytes, could be modeled to capture the effects of other guidance cues on sprout
formation or to examine their roles in sprout maturation and stability. Our current
focus is to study how the composition of the stroma affects sprout morphology and
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migration, and therefore, at this stage a “general” tissue cell is modeled to provide an
additional level of structure to the stroma. We assume that tissue cells are roughly
the same size as an endothelial cell [4], are immobile, and are more difficult to invade
than matrix fibers and interstitial fluid. Consequently, tissue cells compete for space
and create intercellular pressure on and resistance to the migrating and proliferating
endothelial cells. Matrix fibers comprise approximately 37% of the stroma and the
architecture of the ECM is anisotropic, with regions of varying densities [4]. A single
collagen fibril is approximately 300 nm long and 1.5 nm wide and is substantially
smaller than an endothelial cell, which is approximately 10 µm in diameter [4]. Thus,
to model the mesh-like anisotropic structure of the ECM, we assume that many in-
dividual collagen fibrils and other matrix proteins are bound together constituting
larger cords or bundles of matrix fibers that have been estimated to be between 100
and 1000 nm thick [44]. We randomly distributed 1.1 µm thick fiber bundles at
randomly chosen discrete orientations ranging from 0 to 180 degrees until 37% of
the stroma was occupied. The left picture of Figure 4.2 shows the heterogeneity and
random distribution of Type I collagen and the right picture shows that the model
representation of the matrix fibers captures this structure.
4.5 Cellular Potts Model for Cellular Dynamics
The processes involved in new capillary formation occur at the level of individ-
ual cells. Accordingly, we use the cellular Potts model to capture the interactions
between endothelial cells or between an endothelial cell and the stroma (matrix
fibers, tissue cells and interstitial fluid). The cellular Potts model is a discrete lattice
Monte Carlo model developed by Glazier and Graner and is based on an energy min-
imization principle [53]. The cellular Potts model has already been used to model
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Figure 4.2: Left: Magnification of Type I collagen fibers. Right: Model representation of hetero-
geneity and random distribution of ECM fibers of constant width.
a multitude of biological phenomena including differential adhesion-driven cell re-
arrangement [53], cellular differentiation and growth of tissues [60], fruiting body
formation of Dictyostelium [74], avascular tumor growth [75], cancer invasion [161],
and vasculogenesis [111, 110].
In this dissertation, we extend the cellular Potts model to simulate tumor-induced
angiogenesis. Our work is distinct from that presented in Merks et al. [111, 110],
which models the reorganization of randomly dispersed cells into a vascular network
pattern, simulating in vitro vasculogenesis. In contrast, our work focuses on the pro-
cesses that generate the sprouting of new capillaries from a pre-existing vasculature
in vivo (angiogenesis). Moreover, our model considers cell growth and division, dy-
namics that are not modeled in Merks et al. [111, 110] and we explicitly model the
ECM, a component critical to vascular formation.
The cellular Potts model partitions the computational domain into endothelial
cells, matrix fibers, tissue cells and interstitial fluid which are situated on a lattice
and are denoted by type τ = {e, m, t, f} respectively. To account for individual
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cells, each cell is further associated with a unique identifying number, denoted by σ,
that is assigned to every lattice site occupied by that entity (see Figure 2 in JIang et
al. [74] for an example). Matrix fibers and interstitial fluid are collectively identified
by 1 and 0 respectively. Under this framework, each entity has a finite volume, a
deformable shape, and competes for space. Intercellular interactions occur only at
the cell’s surface and have a cell type dependent surface (or adhesion) energy given
by Jτ,τ ′ , which is a measure of the coupling strength between the entities τ and τ
′.












The first term in Eq. 4.2 is the contribution to total energy resulting from cell ad-
hesion at cell surfaces. The second term takes into account the fact that cell growth
and deformation require energy, where aσ denotes cell σ’s current volume and A
T
σ is
a designated “target” volume. We assume that the target volume of an endothelial
cell undergoing mitosis is the volume that it would grow to in the absence of external
forces and given sufficient nutrition and is designated as twice its initial volume.
Additionally, we know that VEGF acts as a chemoattractant for endothelial cells
[172]. The effective energy required for chemotaxis, ∆EChemotaxis, can be derived as
follows: In our model, cell movement is governed by energy gradients and, over time,
cells move to reduce the total energy of the system. Empirical evidence indicates
that VEGF concentration gradients induce endothelial cells to move in the direc-
tion of increasing concentration with a velocity proportional to the VEGF gradient.
Because the cells must move through the highly viscous ECM, their motion is over-
damped and the force required for motion is proportional to velocity, ~FChemotaxis ∝ ~v.
Consequently, the force is proportional to the chemical gradient. We can construct
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an effective chemotaxis potential that is proportional to the local chemical gradient:
∆EChemotaxis = µσ [V (~x)− V (~x ′)] .
The parameter µσ < 0 is the effective chemical potential, which influences the
strength of chemotaxis relative to other parameters in the model. ~x ′ and ~x rep-
resent the two neighboring lattice sites randomly selected during one trial update in
a Monte Carlo step and are described in detail below.
The cellular Potts model evolves in time using repeated probabilistic updates of
unique cell identification numbers, σ, on the lattice. One update occurs as follows: a
lattice site, ~x, is selected at random and assigned the σ from one of its unlike second
nearest neighbors, ~x ′, which has also been randomly selected. The total energy of
the system is computed before and after σ is changed. If the total energy of the
system is reduced as a result of this change, the update is accepted. If the change in
sigma increases the energy of the system, we accept the update with a Boltzmann
probability. Thus the probability of accepting an update is given by
Pacceptance =
 1, if ∆E < 0;e−∆E/kT , if ∆E ≥ 0,
where ∆E is the change in total energy of the system as a result of the update, k is
the Boltzmann constant and T is the effective temperature that corresponds to the
amplitude of cell membrane fluctuations. This probability influences the likelihood
of energetically unfavorable events taking place [161]. A total of n proposed updates,
where n is the number of sites on the lattice, constitutes one Monte Carlo step (MCS)
and is the unit of time used in the model.
In the model, endothelial cells will move to promote stronger over weaker adhe-
sive bonds, shorter over longer cell boundaries, and toward regions of higher chemical
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concentrations. Only endothelial cells are allowed to grow, move and invade; ECM,
tissue specific cells and interstitial fluid do not grow or actively invade each other
or endothelial cells. Endothelial cells interact both mechanically and biochemically
with the ECM. Effective mechanical forces exerted on the ECM by endothelial cells
as they migrate are incorporated as a result of the matrix fibers’ resistance to com-
pression given by γm. Biochemical interactions include VEGF binding to, uptake
by, and activation of endothelial cells, endothelial cell matrix degradation, and the
chemical bonds between endothelial cells and between endothelial cells and matrix
fibers, which are designated by Jee and Jem, respectively. Haptotaxis is naturally
incorporated through this adhesion term whenever an endothelial cell interacts with
a matrix fiber. The endothelial cells also interact with the tissue cells via surface
adhesion and competition for space. In addition, each endothelial cell carries its own
internal cell clock, which is used to determine where the cell is in its mitotic cycle
and whether or not cell division can occur. The endothelial cell cycle is not explicitly
modeled, but this model can be modified to incorporate intracellular signaling cas-
cades regulating the cell cycle and cell cycle dependent events as was done by Jiang
et. al. [75] in their multi-scale model of avascular tumor growth. Cell division occurs
when a proliferating cell has doubled in size and has gone through one complete cell
cycle, which we take to be 18 hours [170]. Cell division produces two daughter cells;
one daughter cell keeps the cell ID of the parent and the other is assigned its own
unique ID. Because endothelial cells demonstrate an increased rate of survival in the
presence of VEGF [48], endothelial cell death is not considered in the model.
This model also distinguishes between tip and stalk cell phenotypes [50]. A tip
cell is defined as the leading endothelial cell and when activated by VEGF, the tip













Figure 4.3: A schematic that shows the interface between the discrete and the continuous models.
The continuous model for VEGF and the discrete model of cellular dynamics are used
as initial conditions for each other at every time step to produce a coupled system of
extra- and intercellular dynamics.
capable of degrading the matrix fibers thereby establishing local adhesion gradients
and further promoting its migration through the stroma [154, 56]. Proliferation
occurs behind the tip cell [124, 151] and this phenomenon is captured by allowing
those stalk cells to proliferate. In the model, if the cell is proliferating, it does not
move chemotactically [11, 124, 50] and vice versa. The remaining stalk cells, as
long as they are VEGF activated, only move in response to cell-cell and cell-matrix
adhesion, and through random membrane fluctuation.
4.6 Hybridization: Interfacing the Discrete & Continuous Models
The continuous model describing the VEGF profile and the discrete model of
cellular dynamics are used as initial conditions for each other at every time step to
produce a coupled system of extra- and inter-cellular dynamics. At time zero, the
steady state solution to Eq. 4.1 provides the initial VEGF profile used in the discrete
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cellular model. Within the discrete model, each endothelial cell uniquely responds
to the amount of VEGF present by deciding whether there is sufficient VEGF to
become activated. VEGF must be present in quantities above a threshold level, va,
for endothelial cell activation to occur. Once activated, each individual endothelial
cell decides whether it is a tip cell and will migrate and degrade the ECM, or if it is a
proliferating cell, and will grow and divide. After the discrete model evolves through
one Monte Carlo step in time, the function for endothelial cell VEGF uptake and
binding, B(x, y, V ), is re-derived based on the new distribution of endothelial cells
on the lattice. A new spatial profile for VEGF at the next time step is obtained by
solving Eq. 4.3 using the updated function B(x, y, V ). The lattice is then updated
with the new VEGF profile. As the continuum and discrete models feedback on each
other, each endothelial cell responds to its evolving microenvironment.
4.7 Parameters
Whenever possible, we take parameters from experimental data. A list of all
parameter values used in this model is provided in Table 4.1, including references.
If no reference is given, the parameter is a relative value chosen to recapitulate
observed phenomenological behaviors. By equating the time it takes an endothelial
cell to divide during the simulation with the endothelial cell cycle duration of 18
hours, Monte Carlo steps are calibrated to real time units. In the simulations, 1
Monte Carlo step is equivalent to 1 hour.
The value for endothelial cell activation va is based on our numerical solutions to
Eq. 4.1 and is chosen to activate the initial endothelial cell. A smaller relative value
for Jτ,τ ′ establishes a stronger cell surface bond. Endothelial cells will bind more
tightly to each other than they will with other constituent types, whereas interstitial
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fluid has very little binding affinity. The membrane elasticities, γτ , are chosen to
reflect the relative compressibility of the constituent. A larger value makes it more
difficult for a constituent to deviate from its target volume and consequently more
difficult to invade. Interstitial fluid is relatively easy to invade compared to the tissue
specific cells. The chemotactic potential, µσ, is chosen so that its contribution to
total energy is on average equal to the contribution to total energy due to cell growth.
Table 4.1: Table of Parameters. Dimensions are given in terms of L=length, T=time, M=mass
and E=energy. For instance, the adhesion terms have dimensions of energy per unit
length of cell membrane. An asterisk designates a parameter that varies across numerical
experiments; all other parameters are held fixed. The exact parameter values used in a
simulation are given in the discussion corresponding to that experiment. Unless otherwise
noted, all simulations used the same parameter set, initial configuration of matrix fibers
and tissue cell distribution, and follow the assumptions described in the previous section.
EC denotes endothelial cell.
Parameter Symbol Dimensions Model Value
VEGF Diffusion D L2/T 3.6x10−4 cm2/h [148]
VEGF Decay λ T−1 .6498 h−1 [148]
VEGF Uptake β M/cell/T .06 pg/EC/hr [20, 46, 168]
VEGF Source S M/L .035 pg/pixel [93, 75]
Activation Threshold va M .0001 pg
Proliferation Threshold vp M .005 pg
Adhesion
EC−EC Jee E/L 1
EC−Fluid Jef E/L 32
EC−Matrix Jem E/L 16
EC−Tissue Jet E/L 31
Fluid−Fluid Jff E/L 35
Fluid−Matrix Jfm E/L 35
Fluid−Tissue Jft E/L 32
Matrix−Matrix Jmm E/L 5
Matrix−Tissue Jmt E/L 30
Tissue−Tissue Jtt E/L 2
Membrane Elasticty
EC ∗ γe E/L4 1.0
Matrix γm E/L4 0.4
Fluid γf E/L4 0.1
Tissue Cell ∗ γt E/L4 1.2
Chemotaxis ∗ µ E/conc −1.5x105
Boltzmann Temperature kT E .01
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4.8 Discussion
There are a great many number of factors and dynamics at play during angio-
genesis. In this model, we do not attempt to introduce every dynamic known to
influence angiogenesis. A primary aim of this dissertation is to understand the roles
of cell-cell and cell-matrix interactions on angiogenesis. We therefore focus our in-
vestigations on those specific cell-cell and cell-matrix dynamics that occur at the
very onset of angiogenesis. We incorporate several key biochemical dynamics: (i)
VEGF binding to, internalization, and recycling of endothelial cell surface recep-
tors, (ii) VEGF mediated cellular activation, migration, and proliferation, and (iii)
proteolytic extracellular matrix degradation.
This model constitutes the first cell-based model of tumor-induced angiogenesis.
This model is distinct from previous models of tumor-induced angiogenesis in several
ways. First, this model captures single cell biochemical and biomechanical dynam-
ics allowing individual cells to interact with and influence their local environment.
Second, the stroma is explicitly modeled, including structural variations, such as
the anisotropy of the matrix fiber distribution, and tissue specific cells. Third, a
distinction is made between sprout tip and stalk cells and the unique behavior each
cell phenotype exhibits is incorporated into the model. Finally, this model is capa-
ble of simulating capillary sprout branching and anastomosis, which are larger scale
structures that emerge only as a result of the featured cellular and molecular level
dynamics; no rules specifically incorporating branching or anastomosis are imposed.
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4.9 Dimensional Analysis of VEGF Dynamics
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From the literature, we obtain the following experimental values for our parameters
D = 10−7 cm2s−1 and λ = 0.65 h−1.
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If we choose the characteristic time scale to be equal to one Monte Carlo step and
the characteristic length scale to be on the order of 1 pixel, we have










































 1 and therefore we can use the solution to
0 = ∆Ṽ − B̃
to approximate the VEGF field in our model.
4.10 ANGIO – Simulation Software Developed in Python
The implementation of this theoretical model is a program called ANGIO. ANGIO
uses more than 2000 lines of Python code, a high-level open source programming
language, to simulate angiogenesis. To use ANGIO, a number of freely available
Python modules must be installed. Specifically, the proper functioning of ANGIO
relies on Python, PyLab, NumPy, SciPy, Matplotlib, and ScientificPython. In ad-
dition, IPython, an interactive shell for the Python programming language, aids in
de-bugging and real-time simulation visualization and analysis. ANGIO is designed
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to run locally, at the University of Michigan, or at Los Alamos National Laboratory.
At a command prompt, typing ‘> python ANGIO.py’ requires the user to specify
where ANGIO is being run. This determines from what directory input files are
read and to which directory the output data files are written. This program also has
the built-in flexibility to specify the size of the computational domain at run-time
and the user is prompted to provide this information. Cell type specific parameters,
including adhesion and compressibility properties, and the number of Monte Carlo
steps need to be modified within ANGIO in a function called ANGIO.parameters().
One advantage to using Python is that changes in the input files or the actual pro-
gram code do not require the user to recompile the program. During the simulation,
ANGIO solves the PDE describing VEGF dynamics, uses this as an input for cellu-
lar decision making, runs the Metropolis algorithm for the cellular dynamics, which
then feeds back into the PDE as an input parameter. At each time step, ANGIO
writes data files for the VEGF concentration, the distribution of endothelial cells, the
composition of the stroma, cell properties, and data arrays identifying tip, prolifer-
ating, migrating, quiescent, and apoptotic cells. On the Mathematical Modeling and
Analysis Group server at Los Alamos National Laboratory, a 900 MCS simulation
takes approximately 1 hour.
4.10.1 Fourier transform solutions to the PDE
ANGIO makes use of Python’s scientific computing libraries and packages to solve
the partial differential equation describing the spatio-temporal profile of VEGF at
each MCS. ANGIO.RDEsolve() solves the non-dimensional quasi-steady state reac-









= λV + B(x, y, V ) .
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The inputs into ANGIO.RDEsolve() are the size of the domain (x, y), the MCS we
wish to solve for, the profile for endothelial cell consumption of VEGF, B(x, y, V )
the function for endothelial cell VEGF binding from the cellular model, and whether
the source of VEGF from the tumor boundary is a line source, a point source, or
parabolic. This function employs fast Fourier transforms to efficiently solve this
parabolic partial differential equation and returns the new spatial profile for VEGF
at the next time step.
4.10.2 Visualization techniques
ANGIO also has the built-in functionality for visualizing the simulation data.
There are two functions that provide different quality two dimensional images: AN-
GIO.quikplot() and ANGIO.plotit(). ANGIO.quikplot() is exactly what it sounds
like, it is a plotting function designed to create a sequence of *.png files for quick
visualization and result interpretation. This function takes a directory path as an
input and uses the pylab.matshow() command to produce an image using the stan-
dard jet colormap. It does not create publication ready images. On the other hand,
ANGIO.plotit() uses a custom colormap developed specifically for these simulations
of angiogenesis, which colors endothelial cells red, tissue cells dark blue, matrix fibers
yellow, and interstitial fluid light blue. ANGIO.getcm() can save the images in mul-
tiple formats (png, jpg, etc.) at a specific resolution (dpi) and is appropriate for
images intended for publication.
Another visualization technique we use to render publication quality images is a
software program called MayaVi. MayaVi is a free visualization platform written
in Python that uses the visualization toolkit (vtk) for its graphics. MayaVi has a
GUI interface and can be imported and manipulated within Python. Using MayaVi
does however require some data pre-processing. In particular, vtk files have to be
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written for use in MayaVi. Once this is done, MayaVi is an extremely powerful
graphical imaging solution and can be easily automated to handle large numbers of
files. MayaVi generated all the final simulation images in this dissertation.
CHAPTER V
Cell-Based Model Exhibits Emergent Phenomena:
Branching and Anastomosis
5.1 Using Simulation as an Investigative Tool
Although the fundamental processes that occur during angiogenesis are well es-
tablished, there is still considerable ambiguity and debate regarding how biochemi-
cal and biomechanical mechanisms are coordinated to control vascular development.
Recent efforts in experimental research have intensely focused on advancing our un-
derstanding of these mechanisms in hopes of discovering novel anti-angiogenesis ther-
apies. However, as new experimental assays capable of examining the cellular and
molecular level dynamics during angiogenesis are developed, discordant data have
been published. Below we review some of the experimental observations which have
generated confusion and given rise to dogma. We then formulate specific hypotheses
and test these with our computational model.
A common perception has been that a freely soluble form of VEGF is solely
responsible for both the activation and the differentiation of function seen in en-
dothelial cells during tumor-induced angiogenesis. This belief, however, is being
revised as experiments demonstrate that sequential activation of various endothelial
cell surface receptors by multiple ligands are required for angiogenesis. Experiments
show that the same VEGF receptor (VEGFR2) is responsible for mediating very dif-
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ferent cellular functions, including endothelial cell growth, mitogenesis, migration,
and increased survival [167, 39]. Some studies propose that the outcome of VEGFR2
signaling depends on the particular VEGF isoform present [39, 50]. The effects of
different VEGF isoforms on vascular structure have been examined and significantly
different capillary morphologies were observed in the presence of matrix bound versus
soluble VEGF [91]. To further complicate matters, other investigations show that
local growth differentials can exist even in areas saturated with soluble angiogenic
factor [64].
There is convincing experimental evidence that endothelial cell proliferation is a
necessary process for tumor vascularization [151]. It is generally believed that during
angiogenesis, proliferation occurs right behind the tip cell and only after the endothe-
lial cells have already migrated into the stroma some distance [151, 124]. Presently,
however, discrepancies persist concerning the precise location of the proliferating
cells during angiogenesis. Experimental models report mitotic activity occurring at
the base of a newly formed sprout [79, 124], some distance behind the sprout tip
[124, 65], localized immediately behind the sprout tip cell [124, 151] and at the tip
[11, 138]. Another area where contradictory experimental data exist is whether pro-
liferation and migration are mutually exclusive events. Some studies demonstrate
that endothelial cell migration is a process separate and independent from prolif-
eration, that is, an endothelial cell will either migrate or proliferate, but not both
[11, 50]. More recent empirical evidence suggests that a proliferating cell is also
capable of migrating [79, 138]. Remarkably, both proliferation and migration are
mediated by VEGF. Although the exact mechanism is still unclear, the activation of
VEGFR2 is interpreted differently by capillary tip cells that migrate versus stalk cells
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gesting that VEGFR2-mediated signaling is necessary for
tip cell filopodial extension. A neutralizing VEGFR1 anti-
body had no effect on tip cell morphology or their filopodia
(Fig. 6, l and m). We conclude that the extension and
maintenance of tip cell filopodia depends on VEGF-A sig-
naling via VEGFR2.
Figure 6. Illustration of filopodia induction in hyaloid vessels of VEGF164tg. (a) Wild-type littermate showing normal smooth surface of 
the hyaloid vessels (arrows) lying on the inner surface of the retina. Filopodia are only present in the intraretinal vascular plexus (asterisks). 
(b and c) Hyaloid vessels in VEGF164tg are studded with filopodia (arrows and inset). Bundles of filopodia are involved in sprouting and 
fusion (arrowhead), leading to an aberrant hyperfused vascular structure. Bars, 20 !m. VEGF is necessary for filopodia extension: (d–g) acute 
sequestering of VEGF by intraocular injection of soluble Flt-1–IgG chimeric protein leads to filopodia retraction already after 6 h (earliest time 
point investigated). (h–k) VEGF sequestering inhibits tip cell filopodia in the aortic ring assay. (l–o) Acute neutralization of VEGFR2 (n and o) 



































Figure 5.1: Neutralization of VEGFR2 (n & o) but not VEGFR1 (l & m) lea s to retraction of tip
cell filopodia [50].
and stalk cells have istinctly diff rent gene expression profiles [50]. Tip cells can
be distinguished from stalk cells by their proliferative quiescence, their prominent
expression of VEGFR2 mRNA, and by the existence of filopodia. These filopodia,
which can be as long as 100 µm, sense chemical gradients and guide endothelial cell
migration [50]. The existence of filopodia on sprout tip cells indicates a migratory
phenotype. In situ experiments suggest that VEGFR2 is most strongly expressed in
tip cells and that VEGFR2 mediated signaling is necessary for tip cell filopodia ex-
tension (Figure 5.1) [50]. These studies also show that VEGF expression is strongest
near the sprout tip and very low behind the sprout tip [50]. The work of Ruhrberg
et al. [134] suggests that filopodia in conjunction with ECM bound VEGF plays an
important role in the capillary sprout branching observed in angiogenesis. Despite
convincing experimental evidence that growing vascular sprouts have specialized tip
structures, differentiation between tip cells and stalk cells has received very little
attention in models of vascular development.
Our presentation of and discussion on conflicting experimental data suggest the
following research hypotheses:
H1: The presence of matrix bound and soluble VEGF results in different vascular
morphologies.
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H2: The location of the proliferating region of cells has an impact on capillary mor-
phology and the rate of capillary sprout extension.
H3: The composition of the stroma, such as ECM density and the presence of other
tissue cells, influences endothelial cell migration and capillary formation during
angiogenesis.
Cell based modeling can assist our understanding and synthesis of such empirical
data because it allows us to study the impact of the location of the proliferating region
on capillary formation. To the best of our knowledge, no other model has explored
the effects of various proliferating regions or segregation of function on capillary
morphology. We investigate the role various VEGF isoforms play in the guidance
and formation of capillary sprouts, and begin to address questions such as: How
does the binding and release of bioavailable VEGF affect local chemical gradients?
What are the respective effects on vascular structure of diffusible and matrix bound
VEGF? What mechanisms induce proliferation in one cell but not its neighbor? And,
can the presence of matrix bound or cleaved soluble angiogenic factors distinguish a
proliferating region, possibly explaining both the observed growth differentials and
the reports of different proliferating regions?
5.2 Results
5.2.1 Realistic capillary sprout morphology captured
Figure 5.2 depicts a typical simulation demonstrating the model’s ability to repro-
duce realistic capillary sprout morphologies. So that we could attribute any changes
in sprout morphology directly to the mechanism or parameter being tested, unless
otherwise noted, all simulations used the same parameter set, initial configuration
of matrix fibers and tissue cell distribution, and follow the assumptions described in
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Chapter IV. Sprout migration is facilitated as the tip cell degrades the matrix fibers
and effectively migrates via haptotaxis up these local adhesion gradients. Compar-
ing simulations with and without ECM degradation, we found that tip cell ECM
degradation increased the average rate of sprout extension toward the tumor by 5%,
a small but statistically significant effect. The resulting morphology of the capil-
lary sprout is determined by several mechanisms: tip cell migration toward positive
VEGF and adhesion gradients, cellular adhesion to the ECM, and competition for
space. Coordination of or competition among these mechanisms affects cell shape
and orientation and can be readily observed during movies of the simulations For
instance, interplay between haptotaxis and chemotaxis can result in endothelial cell
elongation, a characteristic cell shape for migrating cells, without needing a rule pre-
scribing an elongated cell shape as is done in Merks et al. [110](arrow in Figure 5.2).
Whenever possible, we make every effort to compare cell and sprout dynamics
and morphologies observed during simulations with observations from experimental
assays. On average, simulated capillary sprouts are 14.2± 2.44 µm (mean± standard
deviation) in diameter and 1−2 cells wide, which compares quantitatively well to
measured VEGF induced vessel diameters [91, 101]. We quantify and report the rates
of sprout extension under various simulation conditions. Sprout length is determined
by measuring the distance from the center of mass of the initial endothelial cell at
the base of the sprout to the tip cell’s center of mass at the end of the simulation.
Average sprout extension velocity is then calculated as the final sprout length over
time. Sprout extension rates are presented and discussed in Section 5.2.3 below.
In Section 5.1, several key hypotheses are formulated that are driven by confusing
or conflicting results from empirical data. In the following subsections, we use our
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Figure 5.2: Representative simulation showing the model’s ability to reproduce realistic capillary
sprout morphologies. Sprouts migrate along matrix fibers up chemical gradients of
VEGF. The structure of the matrix guides sprout migration and affects cell shape and
orientation. The arrow identifies a cell that has elongated due to chemotactic forces
and adhesion to the matrix. Parameters used are as given in Table 4.1 except γe = 0.7
and γt = 0.8. Snapshot at 16.6 days.
model to test these hypotheses by relaxing the relevant baseline assumption(s) set
forth in Chapter IV.
5.2.2 Local VEGF gradient influences capillary sprout morphology
Recent studies focus on the role of various VEGF isoforms in cellular function
[20, 50] and morphogenesis [91] and find that VEGF in soluble versus bound form
has a different effect on vascular appearance. There is evidence that steep VEGF
gradients can be generated due to either high matrix binding affinity isoforms or
as a result of additional soluble VEGF cleaved from the matrix [91, 63, 50]. Since
we model capillary sprout formation starting from a single cell, cell densities in the
simulations are very low. Numerical solutions to Eq. 4.1 indicate that cell uptake of
diffusible VEGF for low cell densities has only a very slight effect on the chemical
profile at any time. Consequently, only very shallow gradients of freely diffusible
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VEGF are established. Other mathematical models of angiogenesis simulate steep
chemical gradients, but these form strictly as a result of VEGF consumption by a
large number of endothelial cells [95, 158]. In addition, different tumor geometries
(linear versus circular) are assumed that also produce different VEGF gradients [9].
All of these models, however, focus on the effects of VEGF gradients on capillary
network development and vascular patterning. They are not able to explore the
effects of different VEGF gradients on individual cell behavior (stalk, proliferating,
and tip cells) or on the changes in sprout morphology that occur as a result of single
cell dynamics. Using our model, we investigate the effects of different VEGF gradient
profiles on cellular function and how cellular function affects sprout morphology (H1).
In this investigation, we do not explicitly model different isoforms or the bind-
ing of VEGF to the matrix. Instead, shallow VEGF gradients are constructed by
assuming endothelial cells bind a diffusible VEGF isoform. The resulting gradients
are very shallow (Figure 5.3a). To mimic a VEGF isoform that is sequestered in the
ECM, we begin with the same initial VEGF profile but no longer provide a constant
source of VEGF. Consequently, once an endothelial cell binds to and internalizes a
VEGF molecule, VEGF is depleted over time thereby establishing steep local con-
centration gradients (Figure 5.3c). As in the baseline simulations, each cell decides
independently whether or not it has enough VEGF to become activated, va. Now, an
activated cell additionally decides whether there is enough VEGF present to stim-
ulate proliferation, vp. We no longer specify a proliferating region just behind the
sprout tip, but instead allow the concentration of VEGF to determine endothelial
cell proliferation [50]. No experimental data is available for the threshold amount of
VEGF required for proliferation, therefore we choose a value to stimulate prolifer-
ation approximately 48 hours after the initial cell began migrating into the stroma
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[151, 124]. If there is insufficient VEGF, a cell will deactivate and become inert.
Figure 5.3b shows the endothelial cell response to soluble VEGF. As the sprout
grows, a greater number of endothelial cells are activated and stimulated to prolifer-
ate. Because more cells are growing, the entire sprout is on average 46% larger and
the sprout is more invasive. The average diameter of the sprout is 60 µm. Further-
more, because only shallow gradients are formed, the tip cell does not have strong
directional preference from chemoattractant gradients. The resulting morphology is
a swollen sprout, a morphology consistent with vascular hyperplasia [91]. We also
see lateral and backward cell movement following adhesive gradients. Backward mi-
gration, or migration back towards the parent vessel, is an observed phenomenon in
vivo (see Figure 1 in [158]) and is also numerically simulated in Sun et al. [158].
Figure 5.3d depicts the capillary morphology that results from steep extracellular
gradients of matrix bound VEGF. The morphology is strikingly different. As VEGF
is depleted, there is a reduction in the size of the proliferating region and some cells
eventually became inactive. In addition, steep gradients provide strong migrational
cues to the tip cell and the result is a less invasive sprout with an average diameter
of 20 µm. For shallow gradients, increasing the proliferating threshold effectively
introduces a delay in the dynamics. In both cases, however, the ultimate capillary
morphology is unchanged. The morphologies we observe agree well with the experi-
mental observations in Lee et al. [91], experiments that test the angiogenic responses
to different VEGF isoforms in vivo (see Figure 5.4). Lee et al. [91] demonstrates
that endothelial cell receptor activation by soluble VEGF induces significant cell
proliferation and broad invasion of the stroma (vessel diameter of 109 µm), whereas
receptor activation by matrix bound isoforms result in filopodia extension, limited




Figure 5.3: Markedly different capillary sprout morphologies result from shallow (a) versus steep
(c) VEGF gradients. Swollen, invasive sprouts result from shallow VEGF gradients
that develop when freely soluble VEGF is expressed (b), whereas when matrix bound
VEGF isoforms are assumed, steep gradients develop and result in narrower capillary
sprouts (d). Both results concur with the experimental observations of Lee et al. [91]
shown in Figure 5.4. Parameters are given in Table 4.1. Snapshots at (b) 9.4 and (d)
16.6 days.
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Figure 5.4: Results from experiments testing the angiogenic responses to different VEGF isoforms
in vivo [91]. Left: Endothelial cell activation by VEGF164, a matrix bound isoform,
results in limited stromal invasion and average vessel diameters of 15 µm. Right: Soluble
VEGF113 induces significant cell proliferation and broad invasion of the stroma (vessel
diameters 109 µm). Compare with simulated sprout morphologies shown in Figure 5.3.
(vessel diameter of 15 µm). Moreover, endothelial cells in shallow VEGF gradients
lose their directional guidance cues [50]. This observation agrees with the results of
[50], where tip cell filopodia lose their polarity and excessive filopodia extend from
stalk cells in response to shallow gradients of VEGF in transgenic mice expressing
only VEGF120.
5.2.3 Average rates of sprout extension are affected by proliferating region and co-
operation of cellular functions
As previously discussed, experimental models report conflicting results regarding
the precise region of proliferating cells during angiogenesis. We use our model to
investigate the effects of various proliferating regions on capillary morphology and
on the average rate of sprout extension toward the tumor (H2). We look at capillaries
that develop with proliferation occurring (i) only at the tip of the growing sprout,
(ii) immediately behind the sprout tip, (iii) three cell lengths behind the advancing
tip, and (iv) at the base of the sprout. Because newly formed sprouts have not
yet re-synthesized a basement membrane, proliferation in these different regions is
biologically feasible. Empirical evidence quantifying the distribution of cell divisions
during sprout formation shows that proliferation can occur at the tip, behind the
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tip, and at the base of newly formed sprouts [79]. As in our baseline simulations, if
a cell is proliferating, it does not move chemotactically. We run all simulations for
the same duration and use the same parameter set (Table 4.1).
Figure 5.5 shows the resulting sprouts when proliferation occurs at the base (top
inset) and at the tip (lower inset) of the sprout. We find that the position of the
proliferating region does not significantly influence sprout morphology. Figure 5.5
also shows the relationship between the proximity of the proliferating region to the
tip and sprout extension speeds toward the tumor. The data indicate that as the
proliferating region moves further away from the migrating tip, the average rate of
sprout extension toward the tumor increases. These results suggest some interplay
or competition between the mechanical or biochemical forces exerted by the migrat-
ing tip and the proliferating cells. The migrating tip moves toward the source of
chemoattractant and the neighboring cells are pulled along via cell-cell adhesion.
On the other hand, proliferating cells do not necessarily grow directly toward the
chemical source. This is because it requires less energy for the cells that make up
the capillary sprout to grow into matrix and fluid than to invade the space occupied
by other cells. In addition, a proliferating cell does not migrate and consequently
anchors neighboring cells via cell-cell adhesion. When a proliferating cell is adjacent
to a migrating cell, each phenotype has to overcome the forces exerted by the other.
However, once the proliferating region is far enough away, there is no statistically
significant change in sprout extension speed, suggesting that the forces exerted by
each phenotype have only short range effects.
To investigate the validity of this explanation, we perform a numerical experiment
identical to (i) above except that migration and proliferation are no longer indepen-
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Figure 5.5: The relationship between the average rate of sprout extension and the location of the
proliferating region. The further the proliferating region from the migrating tip, the
faster the average rate of sprout extension due to the interplay between the chemotac-
tic forces exerted by the migrating tip and competition for space by the proliferating
cells. Error bars represent standard deviations from the mean using a sample of 12
simulations. Parameters are as given in Table 4.1 except γe = 0.7 and γt = 0.8.
and migration are not isolated cellular functions [79]. We find that when proliferat-
ing cells also move chemotactically, the average rate of sprout extension increases to
7.7 µm/day, significantly faster than any of the speeds observed for all proliferating
regions tested. This rate represents a 36.5% increase above the rate observed in
(i) and a 7.4% increase over the fastest average speed observed (i-iv). This finding
supports the view that proliferating and migrating cells exert short range competing
forces on each other and further suggests that coordination of these cellular functions
could have a significant effect on the rate of capillary extension. Our examination
does not rule out the possibility that multiple proliferating regions may exist.
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5.2.4 Stroma composition & ECM structure:
Mechanisms for capillary sprout branching and anastomosis
As shown in Figure 5.6a, our model is able to reproduce branching structures.
An exciting feature of this model is that branching occurs naturally as a result of
known cellular and molecular level dynamics, not as a result of predefined proba-
bilistic rules. To our knowledge, no other model of tumor-induced angiogenesis has
simulated sprout branching without a priori prescribing a phenomenological rule.
Movies of capillary sprout evolution are evaluated to examine the possibility that
heterogeneities in the stroma induced branching. We observe that the direction of
sprout migration is predominantly determined by chemotaxis and endothelial cell
adhesion to and movement along the matrix fibers. As the leading cells encounter
variable matrix densities and other stromal cells, the sprout changes direction to
find a path of lower resistance through the stroma. Regions of higher density matrix
impose a barrier to forward migration, whereas regions of relatively low densities do
not provide enough adhesion or cellular support for migration. Both extremes cause
the sprout to change direction and lead to more tortuous sprout morphologies. We
hypothesize that matrix fiber heterogeneity or intercellular pressure by tissue cells
provides an opportunity for the redirection of the entire sprout or of individual cells
(H3). It is possible that it is this redirection or migration of individual cells that leads
to branch formation. Whether or not a branch emerges depends on the combination
of local forces acting on the individual cells. Forces induced by cell-matrix adhesion
coupled with chemotaxis or intercellular pressures may facilitate cellular migration
away from the main body of the developing sprout. Compared to other models of
tumor-induced angiogenesis that simulate the “brush border” effect [9, 158], which
is an increased incidence of branching as the sprout approaches the tumor [116], the
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length of our computational domain is much shorter. Consequently, in our small
simulation domain, we do not expect to reproduce the brush border effect captured
on longer length scales (1−2 mm) that allow multiple branching points to form.
To investigate the possibility that the tessellated structure of the stroma may have
generated the observed capillary sprout branching, we conduct three additional nu-
merical experiments: sprout formation 1) in the absence of tissue specific cells, 2) in
the absence of matrix fibers, and 3) within a homogeneous extravascular environment
(no matrix and no tissue cells). We then examine the effects of altering the compress-
ibility of the tissue cells. All simulations are identical except for the absence of tissue
cells or matrix fibers. Figure 5.6b-d show representative final images from numerical
experiments 1−3 respectively. In the first experiment, we completely remove the tis-
sue cells from the stroma. Figure 5.6b shows that a branch still emerges, but in this
case it develops solely in response to chemotactic gradients and cell-matrix adhesion.
We then observe sprout formation in the absence of matrix fibers (Figure 5.6c). In
this simulation, the tip cell is slowed by and deforms itself to accommodate a tissue
cell. The resistance from the tissue cell is enough to redirect the leading cells and the
sprout splits forming a branch. In the last experiment, we simulate sprout formation
in the absence of both tissue specific cells and matrix fibers (Figure 5.6d). This ex-
periment examines sprout migration due to chemotaxis and cell-cell adhesion alone.
As may be expected, the sprout is more linear and cells appear more elongated due
to the effects of chemotaxis, but the sprout is also larger in diameter and much slower
(see Table 5.1). This is because the absence of an extracellular matrix results in a loss
of adhesive guidance cues generally provided by the matrix fibers and consequently
a decrease in tip cell polarity. Interestingly, we also observe greater persistence in




Figure 5.6: Numerical simulations ruling out the possibility that branching is induced solely by
the tessellated structure of the stroma. For an identical parameter set, (a) depicts a
branch emerging from the main capillary as a result of anisotropies in the stroma, (b)
demonstrates that the structure of the matrix fibers alone can induce branching, and
(c) shows branch formation induced by resident tissue cells. No branching occurs in
a homogeneous extracellular environment due to a loss of adhesive guidance cues (d).
Parameters are given in Table 4.1. Results suggest two plausible mechanisms for sprout
branching: the resistance created by other cells in the tissue and the structure of matrix
fibers. Snapshot at 16.6 days.
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direction. This is not surprising when presented with the extensive evidence that
the ECM plays a crucial role in sprout guidance and morphology. In support of our
hypothesis that inhomogeneities in the stroma are a mechanism for branching, we
do not see sprout branches in the absence of variable stromal structure. Table 5.1
compares the average extension speeds and average sprout diameters for the various
stromal compositions. The rates of sprout extension for sprouts developing without
an extracelluar matrix are significantly slower than those that develop with the ad-
ditional migratory cues provided by the matrix fibers. Average extension speeds and
average diameters are not statistically different for sprouts growing in the absence
of an ECM. The average rate of sprout extension due to chemotaxis is 5.33 µm/day.
The possibility for endothelial cells to additionally employ extracellular matrix fibers
for migration results in a 18−28% increase in average extension speed. In another
Table 5.1: Table comparing average migration speeds and average sprout diameters for different
stromal compositions. Averages are computed from a sample of 12 simulations with
identical parameters and initial conditions. Average migration speed of the sprout is
calculated as sprout tip displacement at the end of the simulation from the initial en-
dothelial cell per time.
Ave. Migration Speed Ave. Sprout Diameter
Stromal Composition mean ± std error mean ± std error
(µm/day) (µm)
No fibers, no tissue cells 5.33 ± 0.075 19.29 ± 0.26
Tissue cells only 5.41 ± 0.074 19.08 ± 0.46
Matrix fibers only 6.33 ± 0.131 14.41 ± 0.26
With fibers & tissue cells 6.84 ± 0.131 14.20 ± 0.70
series of numerical experiments, varying the compressibility of the tissue cells does
not result in any significant differences in capillary development.
Figure 5.7 shows the development of capillary sprouts from five endothelial cell
buds. As the sprouts extend toward the tumor, two neighboring sprouts merge and
form a loop, a process called anastomosis. Anastomosis is also simulated by other
mathematical models of angiogenesis, where the lateral motion of the sprout tip
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Figure 5.7: The development of capillary sprouts from five endothelial cell buds. Two neighboring
sprouts merge to form a loop, a process known as anastomosis. In this simulation,
anastomosis was a preferred lower energy state structure given the known physical
dynamics at the cellular level. Parameters are given in Table 4.1. Snapshot at 16.6
days.
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is influenced by positive adhesive gradients created by endothelial cell fibronectin
uptake [9, 158] and by matrix heterogeneities [158]. In our model, the lateral motion
of the sprouts similarly occurs as a result of local adhesive gradients that naturally
exist due to matrix anisotropies, but also occurs as a result of the positive gradients
created through endothelial cell matrix degradation. Sprout migration is further
directed by endothelial cell surface binding to matrix fibers and by the resistance from
extravascular tissue cells. When two neighboring sprouts encounter each other, they
may or may not merge to form a loop. That is, whether or not anastomosis will occur
depends on the dynamics of individual cell-cell and cell-matrix binding, coupled with
chemotactic and haptotactic gradients. As with branching, loop formation emerges
naturally as a collective result of single cell behaviors and is a preferred lower energy
state structure. We would like to point out that as the sprouts that form loops
mature, blood would begin to circulate and the forces associated with the flow of
blood could cause side branching. Consistent with Bautch et al. [79], our simulations
show that blood flow is not necessary for tip branching and anastomosis.
Our numerical studies indicate that the anisotropic structure of the matrix fibers
strongly influences the direction and morphology of the migrating capillary sprout.
During simulated endothelial cell migration, resistance from tissue cells and endothe-
lial cell adhesion to matrix fibers, both alone and in concert, is sufficient to cause
branching and anastomosis to occur. In addition, regions of either high density or
very low density matrix alone can inhibit and redirect endothelial cell movement
inducing capillary sprout branching. These results suggest that the anisotropy of
the matrix fibers and the composition of the stroma may be important mechanisms
leading to capillary sprout branching and anastomosis.
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5.2.5 Sensitivity analysis
The sensitivity of the results to the particular parameter set chosen is studied
by varying one parameter at a time. First, holding matrix fiber density constant,
we randomly generate alternative ECM structures as described in Section 4.4 and
find that our results do not qualitatively change. Further studies show that the
results are insensitive to changes in γf , γm, and γt, but cell size depends on γe and
cell shape depends on Jem. Larger values of γe (requires more energy to grow) yield
smaller cells and the smaller the value for Jem (stronger bond), the more elongated
the cell. Varying the chemical potential, µσ, affects both shape and size. As µσ is
increased by an order of magnitude, the cells become much larger and more elongated
and sprout extension is rapid and pervasive. Increasing µσ increases the ratio of
chemotactic potential to growth and adhesion and causes the system energy changes
to be dominated by the effects of chemotaxis. Very little difference is seen in cell size
and shape until µσ is decreased three orders of magnitude, at which point cells become
rounder and sprout extension is stunted. Significantly decreasing µσ is equivalent to
having no chemotactic forces in the system. The results are not sensitive to the value
of kT until this value is increased more than two orders of magnitude. At this point
the cells break up because larger values of kT correspond to greater cell membrane
fluctuations.
5.3 Discussion
Tumor angiogenesis is an important step in cancer development. Recent experi-
mental advances highlight the increasingly complex and still largely unresolved mech-
anisms driving tumor angiogenesis. We formulate specific hypotheses relevant to the
investigation of biomechanical and biochemical mechanisms. We present a cell-based
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model of tumor angiogenesis incorporating endothelial cells, stroma tissue, ECM and
interstitial fluid, as well as VEGF dynamics. This model reflects a realistic repre-
sentation of the complex and dynamic nature of the tumor microenvironment with
multiple cell types and reciprocal cellular and molecular interactions. We demon-
strate its capacity to capture realistic dynamics and capillary sprout morphologies,
such as preferential sprout migration along matrix fibers, cell elongation, and more
complex events, such as branching and anastomosis, that occur during angiogenesis.
Our model provides a framework for incorporating biochemistry and biophysics in
investigations of mechanism.
We provide evidence that differences in the matrix binding affinity of VEGF iso-
forms could affect the VEGF profile and show that vastly different capillary mor-
phologies result in the presence of steep versus shallow extracellular chemical gradi-
ents. Our model reproduces narrow sprouts in the presence of steep VEGF gradients
and swollen sprout formation due to well distributed concentrations of VEGF; both
morphologies and mechanisms are consistent with those observed empirically [91, 50].
Results from our model emphasize the importance of capturing not only the correct
chemical profile, but also the correct mechanisms inducing the extracellular chem-
ical profiles. Models of angiogenesis inducing steep gradients as a result of VEGF
uptake by a large number of cells may be neglecting a vital mechanism responsible
for the modulation of endothelial cell function and vascular form. To date, math-
ematical models have focused on the effects of tumor secreted VEGF in a freely
diffusible form. If we hope to understand the mechanisms regulating capillary for-
mation, models must incorporate other VEGF isoforms and allow for VEGF binding
to and liberation from the ECM. Using this model as a starting point, we can ex-
amine the the role of different VEGF isoforms on the spatial profile of bio-available
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VEGF and on cellular function regulation. In addition, this model can be used
to test the hypothesis that the proteolytic release of matrix bound VEGF isoforms
naturally defines a proliferating region of endothelial cells resulting in local growth
differentials.
The underlying mechanisms by which a proliferating region is established dur-
ing angiogenesis are still unknown. We identify experimental models of angiogenesis
that report cell proliferation from distinctly different regions of a developing sprout.
Using our model, we explore the effects of various proliferating regions on capillary
sprout growth. Results from our numerical simulations show that as the prolifer-
ating region moves further from the sprout tip, sprout extension is more rapid due
to diminishing competing intercellular forces. Results also show that the location of
the proliferating region does not influence sprout morphology. We demostrate that
capillary sprout extension is significantly more rapid when cellular functions (migra-
tion and proliferation) are not mutually exclusive. These results highlight just how
tightly regulated the processes involved in angiogenesis are and indicate the need
for studies of the relative importance of chemotaxis and proliferation on capillary
development. Furthermore, in our numerical experiments, the proliferating region
advances because it is a fixed distance from the sprout tip throughout the simulation.
In vivo, however, it may be that as the sprout extends toward the tumor, the prolif-
erating region remains fixed, that is, the region lags further and further behind the
advancing tip [65]. Coupled with our finding that sprout extension speed is affected
by the location of the proliferating region, this could possibly explain the increase
in capillary migration speeds seen empirically as capillary networks approach the
tumor.
The composition and structure of the stroma through which the new capillaries
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must grow in order to reach the tumor is highly tissue dependent. We examine the
role of tissue inhomogeneities by explicitly modeling the interactions between en-
dothelial cells and the stroma, specifically the matrix fibers, resident tissue cells and
interstitial fluid. Our studies reveal that local anisotropies in the stroma, such as
variable matrix fiber density and the presence of other tissue cells, influence sprout
migration and morphology during angiogenesis and may be mechanisms for sprout
branching and anastomosis. Although the morphology of branching and anastomosis
has been fully described [124, 79], little is understood of the cellular and molecular
mechanisms inducing the formation of these sprout structures. In our model, anasto-
mosis and branching occur because they are preferred lower energy state structures
given the chemical and mechanical dynamics incorporated at the cellular level. These
results underscore the importance of modeling cell-matrix and cell-cell dynamics, and
demonstrate that a cell-based physical model can help provide insight into the pro-
cesses controlling angiogenesis.
At present, quantifying our results and validating our model is not a straightfor-
ward task. Measurements of microvessel densities over time, branching points/mm/time,
and capillary network expansion rates exist for vascular networks that form on larger
spatial scales. However, our model focuses on cell-cell and cell-matrix interactions
at the very onset of angiogenesis, when the newly formed sprouts consist of only
a few cells. Over the spatial scale of our model, which is significantly smaller, we
do not expect multiple branch points to form. Assays and quantitative measures of
early single sprout morphology under conditions that mimic the early events that
occur in vivo during tumor-induced angiogenesis have not been well developed. In
particular, to our knowledge there has been no systematic study of collective cell or
sprout migration and morphology that quantifies the effects of chemotaxis. In ad-
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dition, experimental models that measure individual cell migration rates cannot be
directly compared to the rate at which a capillary sprout travels or extends toward a
tumor, because cell-cell dynamics are not considered in assays of single cell motility
and during sprout extension migrating cells are adhered to other cells that may be
anchored to the matrix or moving in different directions.
Average speeds of in vivo and in vitro vessel growth are reported at 0.1−0.3
mm/day [79, 42]. The average rate of sprout extension in our model is considerably
slower. This difference can be attributed to a combination of several factors. First,
in our simulations, cell proliferation occurs for only one cell. Simulating multiple
proliferating regions or proliferation in multiple cells does increase the rate of sprout
extension in our model. Figure 5.3b shows an increased sprout extension rate when
there are more proliferating cells. This sprout has migrated the same distance as
the sprout in Figure 5.3d but in only 9.4 days versus 16.6 days. However, prolifer-
ation alone does not explain the difference in sprout migration rates. Other factors
that contribute to sprout extension speeds are the ECM density, cell elongation, and
blood flow. Endothelial cells can elongate up to 10 times their normal length [79] and
the density and alignment of matrix fibers has a major effect on cell migration rates
[44]. In Chapter VI we investigate the effects of cell elongation on sprout extension
speeds, measure sprout velocity through matrices of varying densities and patterns,
and predict an optimal density for maximum sprout migration speeds. Another dy-
namic that has a significant impact on simulated sprout extension speed is the ability
to capture sheet or collective migration of a group of cells as is observed in vascular
sprouting [85]. An important mechanism in both single cell and collective migration
is the detachment from the ECM and subsequent retraction of the trailing edge of
the cell [45]. Preliminary studies of simulated single cell migration and sprout forma-
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tion incorporating these cellular motility mechanisms suggest that sprout migration
speeds may more than double. Chapter VI presents a formal investigation of sprout
formation using an extended model that incorporates cell detachment from the ECM
and collective migration and our results confirm that sprout extension rates signifi-
cantly increase. In fact, simulations of sprout development using the extended model
reproduce sprout velocities consistent with empirical data.
CHAPTER VI
Topography of Extracellular Matrix Mediates Vascular
Morphogenesis
The extracellular matrix plays a critical role in orchestrating the events neces-
sary for wound healing, muscle repair, morphogenesis, new blood vessel growth, and
cancer invasion. In this study, we investigate the influence of extracellular matrix
topography on the coordination of multi-cellular interactions in the context of angio-
genesis. To do this, we validate our spatio-temporal cellular model of angiogenesis
against empirical data, and within this framework, focus on the effects of extracellu-
lar matrix topography on capillary sprout morphology and average extension speeds.
We vary the density of the matrix fibers to simulate different tissue environments and
to explore the possibility of manipulating the extracellular matrix to achieve pro- and
anti-angiogenic effects. The model predicts specific ranges of matrix fiber densities
that maximize sprout extension speed, induce branching, or that interrupt normal
angiogenesis. We then explore matrix fiber alignment as a key factor contributing to
peak sprout velocities, and in mediating cell shape and orientation. We also quantify
the effects of proteolytic matrix degradation by the tip cell on sprout velocity and
demonstrate that degradation promotes sprout growth at high densities, but has an
inhibitory effect at lower densities. Our results are discussed in the context of ECM
targeted pro- and anti-angiogenic therapies that can be tested empirically.
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Experimental assays of angiogenesis are performed in a variety of in vivo animal
models [11, 116] and in vitro matrix gels [164, 25, 100, 78]. The actual densities of
these model extracellular matrices vary. Physiological values for the volume fraction
of collagen fibers in healthy tissues range from 0.026 in the myocardium, 0.142 in
skeletal muscle, 0.293 in the corneal stroma, to 0.661 in the dermis [94]. To aid
our understanding of vessel growth in various tissues and to evaluate the efficacy
of manipulating the extracellular matrix as a pro- and anti-angiogenic therapy, we
focus our investigation on how the topography of the ECM influences, via cell-matrix
adhesion, individual and collective cellular responses during early angiogenic sprout
development.
In this chapter, we extend the cellular model of angiogenesis from chapter IV to
investigate the effects of ECM topography on cell-matrix interactions during vascular
morphogenesis. We show the dependence of sprout extension speed and morphology
on matrix density, fiber network connectedness, and fiber orientation. Notably, we
observe that varying matrix fiber density affects the likelihood of capillary sprout
branching. As a result, the model predicts an optimal density for capillary network
formation and suggests high fiber anisotropy as a mechanism for sprout branching.
We also identify unique ranges of matrix density that promote sprout extension or
that interrupt normal angiogenesis and show that maximal sprout extension speeds
are achieved within a density range similar to the density of collagen found in the
cornea. Finally, we quantify the effects of proteolytic matrix degradation by the tip
cell on sprout velocity and demonstrate that degradation promotes sprout growth at
high densities, but has an inhibitory effect at lower densities.
This chapter is organized in the following manner. First, we discuss several key
improvements to our cellular model of angiogenesis and validate this extended model
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against empirical measurements of sprout extension speeds in vivo. We then use our
model to investigate the effect of ECM topography on vascular morphogenesis and
focus on mechanisms controlling cell shape and orientation, sprout extension speeds,
and sprout morphology. Based on our findings, we suggest and discuss several ECM
targeted pro- and anti-angiogenesic therapies that can be tested empirically.
6.1 Extended Cellular Model of Angiogenesis
To more accurately capture the cell-cell and cell-matrix interactions that occur
during vascular morphogenesis, we have implemented several additional features to
the cell-based model of angiogenesis introduced in Chapter IV. We extend that
model to incorporate endothelial cell recruitment from the parent vessel and stalk
cell migration, mechanisms that facilitate sprout extension. We use this extended
model as a framework to study how ECM topography influences intercellular and
cell-matrix interactions.
The extended model uses a lattice-based cellular Potts model describing individ-
ual cellular interactions coupled with a partial differential equation to describe the
spatio-temporal dynamics of vascular endothelial growth factor. At every time step,
the discrete and continuous models feedback on each other and describe the time
evolution of the extravascular tissue space and the developing sprout. The discrete
model evolves by the Metropolis algorithm: the lattice updates are accepted proba-
bilistically if the update reduces the total energy of the system. The system energy,
E, includes a term describing cell-cell and cell-matrix adhesion, a constraint for cel-
lular growth, and an effective chemotaxis potential that is proportional to the local
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In the first term of Eq. 6.1, Jτ,τ ′ represents the binding energy between model con-
stituents. For example, Je,e describes the relative strength of cell-cell adhesion that
occurs via transmembrane cadherin proteins. Similarly, Je,f is a measure of the bind-
ing affinity between an endothelial cell and a matrix fiber through cell surface integrin
receptors. Each cell is associated with a unique identifying number, σ; δσ,σ′ is the
Kronecker delta function. Thus (1 − δσ,σ′) ensures that the adhesive energy only
accrues at cell surfaces. The second term describes the energy expenditure required
for cell growth and deformation. aσ denotes cell σ’s current volume and A
T
σ is a
specified “target” volume. For proliferating cells, the target volume is double the
initial volume. In the third term, the parameter χσ < 0 is the effective chemical
potential and influences the strength of chemotaxis relative to other parameters in
the model. V = V (x, y, t) denotes the concentration of VEGF. A source of VEGF,
S, is supplied to the stroma from the right hand boundary. A gradient of VEGF is
established as VEGF diffuses through the stroma with diffusivity coefficient D > 0,
decays at a constant rate λ > 0, and is taken up by endothelial cells, B(x, y, V ). The
spatial profile of VEGF satisfies a partial differential equation of the form:
∂V
∂t
= D∇2V − λV −B(x, y, V ).
Initial and boundary conditions for VEGF are V (x, y, 0) = 0 and V (0, y, t) =
0, V (L1, y, t) = S, V (x, 0, t) = V (x, L2, t). The physical meanings and values of
the parameters used in this extended model are listed in Table 6.1.
Thusfar, the extended model is identical to the previous model and a complete
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description of the model assumptions, including a biochemical derivation of the func-
tion for endothelial cell binding and uptake of VEGF, is given in Chapter IV. We
implement several additional features to improve the biological realism of that model.
One improvement is the implementation of stalk cell chemotaxis. Stalk cells are not
inert, but actively respond to chemotactic signals [50]. As a consequence, cells mi-
grate as a collective body, a phenomenon called collective or cohort migration [85].
This modification, however, also makes it possible for individual cells, as well as the
entire sprout body, to migrate away from the parent vessel, making it necessary to
consider cell recruitment from the parent vessel.
During the early stages of angiogenesis, cells are recruited from the parent vessel
to facilitate sprout extension [124]. Bautch et al. [79] measured the number and
location of cell divisions that occur over 3.6 hours in in vitro vessels 8 days old (see
Section 6.2.1 herein for a detailed description of these experiments). They defined
the sprout field as the area of the parent vessel wall that ultimately gives rise to
the new sprout and the sprout itself. The sprout field was further broken down
into regions based on distance from the parent vessel and was classified as distal,
proximal, and nascent. Bautch et al. reported that 90% of all cell divisions occur
in the parent vessel and the remaining 10% were located in the nascent area of
the sprout field, at or near the base of the sprout. On average, total proliferation
accounted for approximately 5 new cells in 3.6 hours, or 20 cells in 14 hours. This
data suggests that there is significant and sufficient proliferation in the primary vessel
to account for and facilitate initial sprout extension. This data does not suggest that
proliferation in other areas of the sprout field does not occur at other times. Indeed,
it has been established that a new sprout can migrate only a finite distance into the
stroma without proliferation and that proliferation is necessary for continued sprout
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extension [151]. We model sprout extension through a cell-cell adhesion dependent
recruitment of additional endothelial cells from the parent vessel. As an endothelial
cell at the base of the sprout moves into the stroma, cell-cell adhesion pulls a cell
from the parent vessel along with it. We assume, based on the data presented in
[79], that there is sufficient proliferation in the parent vessel to provide the additional
cells required for initial sprout extension while maintaining the physical integrity of
the parent vessel.
As in our previous model, once a cell senses a threshold concentration of VEGF,
given by va, it becomes activated. We recognize that cells have distinct phenotypes
that dictate their predominate behavior. We distinguish between tip cells, cells that
are proliferating, and stalk cells. Tip cells are functionally specialized cells that
concentrate their internal cellular machinery to promote motility [50]. Tip cells are
highly migratory pathfinding cells and do not proliferate [50, 79]. The remainder of
the cells are designated as stalk cells and use adhesive binding to and release from
the matrix fibers for support and to facilitate cohort migration. Stalk cells also sense
chemical gradients although these cells are not a highly motile phenotype as are the
specialized tip cells. Proliferating cells are located behind the sprout tip [50, 79] and
increase in size as they move through an 18 hour cell cycle clock in preparation for
cell division [170]. Cells that are proliferating can still migrate [79]; it is only during
the final stage of the cell cycle that endothelial cells stop moving and round up for
mitosis [communication with C. Little]. Since we assume that the presence of VEGF
increases cell survivability, we do not model endothelial cell apoptosis.
Cells must simultaneously integrate multiple forces, namely, intercellular adhe-
sion, chemotactic forces, and tractional forces as cells adhere to matrix fibers. To do
so, cells deform their shape and dynamically regulate adhesive bonds. In the model,
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it is also possible that in concert these forces may cause a cell to be pulled or split
in two. To balance these external forces, we introduce a continuity constraint that
preserves the physical integrity of each individual cell. This constraint expresses
that it is energetically expensive to compromise the physical integrity of a cell and










where α is an effective intracellular adhesion energy related to the cytoskeletal matrix
of a cell. aσ represents the current size of the endothelial cell with unique identifying
number σ, and a′σ is a breadth first search count of the number of continuous lattice
sites occupied by that endothelial cell. Thus, a′σ 6= aσ signals that the physical
integrity of the cell has been compromised and a penalty to total energy is incurred.
As described in detail in Chapter IV, we model the mesh-like anisotropic structure
of the extracellular matrix by randomly distributing 1.1 µm thick bundles of indi-
vidual collagen fibrils at random discrete orientations between -90 and 90 degrees.
Model matrix fibers comprise approximately 40% of the total stroma and the dis-
tribution of the ECM is inhomogeneous with regions of varying densities. To relate
the density of this model fibrillar matrix to physiological values, we measure matrix
fiber density as the ratio of the interstitium occupied by matrix molecules to total
tissue space, 0 ≤ ρ ≤ 1, and compare it to measured values of the volume fraction
of collagen fibers in healthy tissues [94].
6.1.1 Parameter calibration
A list of values for the model parameters is provided in Table 6.1, including
references. Parameters are taken from experimental data whenever possible. If no
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reference is given, the parameter is a relative value chosen to emulate the physical
properties and behaviors of cells. The membrane elasticities, γτ , are chosen to reflect
the relative compressibility of the cell, fiber, or of interstitial fluid. The chemotactic
potential, χσ, is chosen so that its contribution to the change in total energy is
the same order of magnitude as the contribution from adhesion or growth. The
difference between the concentration of VEGF at two adjacent lattice sites is on the
order of 10−4. To balance adhesion and growth, χσ must be on the order of 10
6. We
calibrated this parameter to maximize sprout extension speeds while maintaining
the physical integrity of the cells. By equating the time it takes an endothelial cell
to divide during the simulation with the endothelial cell cycle duration of 18 hours,
we convert Monte Carlo steps to real time units. In the simulations reported in this
chapter, 1 Monte Carlo step is equivalent to 1 minute.
6.2 Results
6.2.1 Model validation
The canonical benchmark for validating models of tumor-induced angiogenesis is
the rabbit cornea assay [52, 11]. In this in vivo model, tumor implants are placed
in a corneal pocket approximately 1−2 mm from the limbus. New vessel growth
is measured with an ocular micrometer at 10x, which has a measurement error of
± 0.1 mm or 100 µm. Initially, growth is linear and sprout extension speeds are
estimated at a rate of 0.5 mm/day, or 20.8 ± 4.2 µm/hr. Sprouts then progress
at average speeds estimated to be between 0.25−0.50 mm/day, or 10.4−20.8 ± 4.2
µm/hr. More recent measurements of sprout extension speeds during angiogenesis
are reported in Bautch et al. [79]. In this study, embryonic stem cells containing
an enhanced green fluorescent protein are differentiated in vitro to form primitive
vessels. Day 8 cell cultures are imaged within an ∼160 µm2 area at 1 minute intervals
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Table 6.1: Table of Parameters. Dimensions are given in terms of L=length, T=time, M=mass
and E=energy. Unless otherwise noted, all simulations used the same parameter set and
initial conditions. EC denotes endothelial cell.
Parameter Symbol Dimensions Model Value
Length Scales L1,L2 L 166µm, 106µm
VEGF Diffusion D L2/T 3.6x10−4 cm2/h [148]
VEGF Decay λ T−1 .6498 h−1 [148]
VEGF Uptake β M/cell/T .06 pg/EC/hr [20, 46, 168]
VEGF Source S M/L .035 pg/pixel [93, 75]
Activation Threshold va M .0001 pg
Adhesion
EC−EC Jee E/L 30
EC−Fluid Jef E/L 76
EC−Matrix Jem E/L 66
Fluid−Fluid Jff E/L 71
Fluid−Matrix Jfm E/L 85
Matrix−Matrix Jmm E/L 85
Membrane Elasticty
EC γe E/L4 0.8
Matrix γm E/L4 0.5
Fluid γf E/L4 0.5
Chemotactic Sensitivity χ E/conc 1.11 · 106
Tip Cell E/conc −1.45 χ
Stalk Cell E/conc −1.42 χ
Proliferating Cell E/conc −1.40 χ
Intracellular Adhesion α E/L 300
Boltzmann Temperature kT E 2.5
for 10 hours and show sprouting angiogenesis over this period. The average extension
speed for newly formed sprouts is 14 µm/hr and ranges from 5 to 27 µm/hr. For
cell survival growth factor is present and is qualitatively characterized as providing
a diffuse, or shallow, gradient. No quantitative data pertaining to growth factor
gradients or the effect of chemotaxis during vessel growth are reported [79].
We use the above experimental models and reported extension speeds as a close
approximation to our model of in vivo angiogenesis for quantitative comparison and
validation. We simulate new sprout formation originating from a parent vessel in
the presence of a diffusible VEGF field, which creates a shallow VEGF gradient.
Average extension speeds are measured over a 14 hour period in a domain 100 µm
by 160 µm. As was done in Bautch et al. [79], we calculate average sprout velocities
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as total sprout displacement in time and measure sprout displacement as the distance
from the base of the new sprout to the sprout tip. Figure 6.1 shows average sprout
extension speed over time for our simulated sprouts. Reported speeds are an average
of 10 independent simulations using the same initial VEGF profile and parameter
set as given in Table 6.1. Error bars represent the standard error from the mean.
The average extension speeds of our simulated sprouts are within the ranges of
average sprout speeds measured by both Bautch et al. [79] and Gimbrone et al.
[52]. Figure 6.1 indicates that average sprout extension speed changes as a function
of time. Within the first two hours, speeds average ∼ 30µm/hr and the new sprout
consists of only 1−2 endothelial cells. At two hours, sprouts contain an average of 3
cells and at 4 hours, there are a total of 5−6 cells. Over time, as cells are added to the
sprout, cell-cell adhesion and cumulative cellular adhesion to the extracelluar matrix
start to play a role and sprout extension speeds slow. The inset in Figure 6.1 shows
the geometry of the computational domain and simulated sprout development at 7.8
hours. Endothelial cells (red) migrate into the domain from a parent blood vessel
(left boundary); a source of growth factor is available and diffuses from the right
boundary. The space between represents the stroma and is composed of extracellular
matrix fibers (green) and interstitial fluid (blue). As shown, simulated sprouts are
approximately one cell diameter wide, which compares quantitatively well to reported
VEGF induced vessel diameters [91, 101]. A natural result of the cell-based model
is that cells exhibit rear retraction, which refers to the ability of a cell to release its
trailing adhesive bonds with the extracellular matrix during migration. In moving
multicellular clusters, rear retraction is a collective process that involves many cells
simultaneously [45]. Collective migration, another characteristic dynamic observed







Figure 6.1: Average extension speeds of the simulated sprouts agree with empirical measurements
[79, 52]. Parameters are chosen to maximize extension speeds. Reported speeds are
an average of 10 independent simulations using the same parameter set. Error bars
represent the standard error from the mean. (Inset) Geometry of the 2D computational
domain and simulated sprout development at 7.8 hours. Endothelial cells (red) migrate
into the domain from a parent blood vessel (left boundary); a source of growth factor is
available and diffuses from the right boundary. The space between represents the stroma
and is composed of extracellular matrix fibers (green) and interstitial fluid (blue).
94
On average, our simulated sprouts migrate 160 µm and reach the domain bound-
ary in approximately 15.6 hours, before any cells in the sprout complete their cell
cycle and proliferate. We do not expect to see proliferation in the new sprout because
the simulation duration is less than the 18 hour cell cycle and we set the cell cycle
clock to zero for newly recruited cells to simulate the very onset of angiogenesis. In
our simulations, sprout extension is facilitated by cell recruitment from the parent
vessel. Between 15 and 20 cells are typically recruited, which agrees with the number
of cells we estimate would be available for recruitment based on parent vessel cell
proliferation reported by Bautch et al. [79]. In those experiments [79], proliferation
in the parent vessel is measured for day 8 sprouts, which likely has cells at various
stages in their cell cycles. Proliferation in the new sprout is another mechanism for
sprout extension. Thus, we consider the possibility that cells recruited from the par-
ent vessel may be in different stages of their cell cycles by initializing the cell cycle
clock of each recruited cell at randomly generated times. We observe no differences
in extension speeds, sprout morphology, or the number of cells recruited as a result of
the assumption made for cell cycle initialization (t = 0 or t random). This suggests
that, in our model, stalk cell proliferation and cell recruitment from the parent vessel
are complementary mechanisms for sprout extension.
By adjusting key model parameters, we are able to simulate various morphogenic
phenomena. For example, by increasing the chemotactic sensitivity of cells in the
sprout stalk and decreasing the parameter controlling cellular adhesion to the matrix,
Jem, we are able to capture stalk cell migration and translocation along the side
of a developing sprout. This phenomena, where stalk cells weaken their adhesive
bonds to the extracellular matrix and instead use cell-cell adhesion to facilitate rapid







Figure 6.2: For a different parameter set, fewer cells are recruited from the parent vessel and cells
elongate. Here cells are approximately 40 µm in length and the average extension speed
at 14 hours is 6.8 µm/hr. J{ee,em,ef}={42,76,66}, χtip = 1.55 χ, χ{migr,prolif} = 1.45 χ.
is described as preferential migration to stretched cells [28]. Figure 6.2 shows the
morphology for one particular set of parameter values corresponding to weaker cell-
cell and cell-matrix adhesion and stronger chemotaxis. Here the average extension
speed at 14 hours is 6.8 µm/hr, fewer cells are recruited from the parent vessel, and
cells elongate to approximately 40 µm in length. This length scale is consistent with
experimental measurements of endothelial cell elongation [158].
Figure 6.3a shows images from experiments using human fibroblasts stained for
actin (e) and tubulin (f) on micro-machined grooved substratum [121]. These ex-
periments demonstrate that cells alter their shape, orientation, and polarity to align
with the direction of the grooves (double-headed arrow), exhibiting topographic, or
contact, guidance. Figure 6.3b is a simulation designed to mimic these experiments
by isolating the cellular response to topographical guidance on similarly patterned









Figure 6.3: Panel (a): Fibroblasts stained for actin (e) and tubulin (f) showing that cells alter
their shape, orientation, and polarity to align with the direction of the grooves (double-
headed arrow). Images reprinted from Oakley et al. [121] with permission from Elsevier.
Compare with panel (b), which is a simulation of the cellular response to topographical
guidance on similarly patterned substratum and demonstrates the flexibility of the
model to capture a variety of different morphological phenomena.
respond only to topographical cues in the extracellular matrix. Simulated cells alter
their shape and orient in the direction of the matrix fibers. Figure 6.3b bears a
striking resemblance to the cell shapes captured in Figure 6.3a. We are also able to
simulate interstitial invasion/migration by a single cell by turning off proliferation
and cell recruitment but leaving all other parameters unchanged. This is especially
relevant in the context of fibroblast recruitment during wound healing and tumor cell
invasion (e.g., glioblastoma, the most malignant form of brain cancer [35]), where
understanding cell-matrix interactions and directed motility are critical mechanisms
for highly motile or invasive cell phenotypes.
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6.2.2 Model predicts ranges of matrix fiber density that may inhibit angiogenesis
We design a set of numerical experiments allowing us to observe the onset of
angiogenesis in extravascular environments of varying matrix fiber density. We con-
sider matrix fiber densities given as a fraction of the total interstitial area, ρ. As a
measure of matrix orientation equivalency, the total fiber orientation in both the x
and the y direction is calculated as we increase the matrix density. The total x and
total y fiber orientation do not vary with changes in total matrix density. Besides
varying the matrix density, all other parameters are held fixed. All simulations last
the same duration corresponding to approximately 14 hours.
The average rate at which the sprout grows and migrates, or its average extension
speed, is calculated as the total tip cell displacement in time. Average extension
speeds in microns per hour (µm/hr) versus matrix fiber density are graphed in Fig-
ure 6.4a at various times (2, 5, 10, 14 hours) during sprout development. We identify
qualitative measures to describe and differentiate between various capillary sprout
morphologies, such as the thickness of the sprout, its tortuosity, and whether sprout
branching or anastomosis occur. Following Bautch et al., we define a sprout branch
as one or more cells that extend, or bud, from the primary sprout body at least 10
µm [79]. We report capillary sprout thickness and the incidence of branching versus
the fraction of matrix fibers present in the stroma in Figure 6.4b.
Figure 6.4 demonstrates that the density of the matrix impacts the average rate at
which a capillary sprout extends and the resulting sprout morphology. At very low
ratios (< 0.10), the matrix fibers are sparse, disconnected filaments (Figure 6.5a).
In a study of vasculogenesis using endothelial cells plated on varying densities of
collagen or fibronectin, cell attachment, spreading, and tube formation were maximal




Figure 6.4: Panel (a) shows the dependence of average sprout extension speed on the density of the
extracellular matrix. The model predicts that average extension speeds are maximal in
the fiber fraction range ρ = 0.3− 0.4. Above ρ = 0.6, extension speeds are significantly
reduced and for ρ < 0.1 and ρ > 0.8 normal angiogenesis is interrupted suggesting that
modulating matrix density may be an effective anti-angiogenesis therapy. Panel (b)
quantifies morphological properties of the sprout showing sprout thicknesses in normal





























Figure 6.5: Plots showing the effect of the mechanical properties and heterogeneity of the ECM
on sprout morphology and viability. Snapshots at 14 hours. From top left to bottom
right: (a) ρ = 0.05, interruption of normal angiogenesis and loss of sprout viability; (b)
ρ = 0.2, high matrix heterogeneity induces branching (arrow points to new branch); (c)
ρ = 0.25, anastomosis/lumen formation; (d) ρ = 0.6, more homogeneous matrix fiber
network produces linear sprouts; (e) ρ = 0.7, higher matrix homogeneity causes loss of
strong guidance cues resulting in wider and slower sprout formation; and (f) ρ = 0.99,
complete inhibition of angiogenesis at high matrix density.
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matrix densities below 100 ng/cm2, cells detached from the substrate and lost their
viability [68]. Our model predicts a coincident interruption of normal angiogenesis
and loss of sprout viability at very low matrix fiber densities (< 0.10). Matrices with
lower fibril density transfer more strain to the cell [130]. Effects of the high transfer
of strain can be seen in Figure 6.5a, which shows severe cell elongation at ρ = 0.05.
Compare with the inset in Figure 6.1, which is an identical simulation except for
an increase in the ECM density (ρ = 0.4). This higher density matrix transfers less
strain to the cells and consequently cells are rounder. Additionally, because there
are more focal adhesion sites in this denser matrix, cells are able to maintain their
cell-cell contacts and develop as a cohesive body. We do not report migration speeds
for ρ < 0.1 or ρ > 0.8 because sprouts show developmental defects, that is, cells
are severely elongated or detach from each other and do not form a cohesive sprout
body.
For 0.15 ≤ ρ ≤ 0.25, the fiber network is highly inhomogeneous, and a large
amount of strain gets transferred to the cells. As a result we see an increase in cell
spreading and a thickening of the new sprout as compared to those morphologies seen
for ρ < 0.15 (compare Figures 6.5a and 6.5b). These values of ρ correspond to the
same fraction of collagen present in subcutaneous tissue (ρ = 0.212) and some skeletal
muscle (ρ = 0.09−0.189) [94]. Remarkably, we see a distinct range of densities, 0.20−
0.30, where new buds develop from the main sprout body and branches begin to form
(see arrow in Figure 6.5b). This observation suggests that mechanical mechanisms,
such as a high degree of fiber heterogeneity and ECM tension transfer to cells, may
promote branching and is consistent with reports that collagen matrix tension induces
directional sprouting in endothelial cells [85]. Figure 6.4b quantifies the incidence
of branching for and the average thickness of sprouts developing in different matrix
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densities. At all densities, sprout thickness is within the normal physiological range of
1−2 cells wide. Figure 6.5c shows sprout development on a matrix where ρ = 0.25.
Morphologies that could be interpreted as lumen formation or anastomosis (loop
formation) are evident and are only seen at this density. Figure 6.4a shows (i) a
clear range of matrix density that encourages sprout migration and results in faster
average speeds and (ii) density ranges that present a physical barrier to migration
and inhibit sprout growth and results in slower extension speeds. The peak in the
graph at ρ = 0.35 indicates that sprout extension speeds are fastest at intermediate
densities between 0.3 ≤ ρ ≤ 0.4 and suggests an optimal matrix density for promoting
angiogenesis. For comparison, this range of matrix density is near the physiological
fraction of collagen fibers found in the cornea [94]. A possible mechanistic explanation
for the existence of a peak extension velocity is that the mechanical properties of
the ECM around ρ = 0.35 provide contact guidance cues that are aligned with
chemotactic forces. Referring again to Figure 6.4a, we see that peak migration speeds
are prominent at 2 hours, but are still evident, although to a lesser extent, at 10 and
14 hours. Thus, these results do not depend on time. Our finding that maximum
migration speeds depend on matrix density is supported by empirical measurements
of endothelial cell migration speeds on various fibronectin concentrations (0.5, 1, 5,
20, 40 µg/cm2) demonstrating peak migration speeds at intermediate concentrations
(5 µg/cm2) [149].
As matrix density increases, the network of connected fibers is extensive. Higher
fiber density translates into greater matrix homogeneity and a loss of strong guidance
cues from ECM heterogeneity. Chemotaxis then plays a stronger role in sprout
guidance thereby producing linear sprouts (Figure 6.5d). Consequently, we do not
observe any branching at densities above ρ = 0.35. At a fiber density of ρ = 0.70,
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less tension is transferred to the cells. Cells experiencing less tension are rounder.
Wider and slower sprouts form at this matrix density (Figure 6.5e). Above ρ = 0.75,
very high matrix densities actually establish a physical barrier to migration and
we see a corresponding reduction in sprout extension speed due to increased focal
adhesion contacts and strong tractional forces. Figure 6.5f shows complete inhibition
of angiogenesis at ρ = 0.99 as tractional forces dominate chemotactic incentives.
6.2.3 Network connectedness and matrix fiber alignment influence sprout extension
speeds
Based on our earlier observations, the density of ECM fibers affects capillary
sprout migration speeds. As matrix density is increased, a connected fibrous network
develops which could be a mechanism for differences in observed average speeds. We
hypothesized that peak extension speeds occur when the mechanical properties of
the ECM provide contact guidance cues that are aligned with the chemotactic forces.
To examine the effects of matrix fiber alignment on average rates of capillary sprout
elongation, we devise another set of numerical experiments. If matrix fiber alignment
plays a prominent role in sprout migration, we would expect more rapid rates of
sprout elongation when matrix fibers are aligned parallel to VEGF gradients than
when fibers are aligned perpendicular to the gradient. We look at three specific cases:
matrix fibers aligned perpendicular to VEGF gradients, matrix fibers aligned parallel
to the VEGF gradient, and a combination of horizontal and vertical fibers only. We
compare these test cases with the baseline simulations of sprout development on
matrices of random fiber orientation. We distinguish and refer to these three cases
by the angle that is formed between the fiber axis and the axis of the VEGF gradient,
that is, 0◦ denotes a matrix with fibers aligned with the gradient and 90◦ identifies a
matrix of fibers perpendicular to the VEGF gradient. These numerical experiments
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represent a simplified replica of the matrix fiber restructuring and fiber alignment
that occurs as a result of the tractional forces exerted by endothelial cells during
migration [164, 85]. All matrices have the same matrix fiber density.
As matrix fiber density increases, both the number of focal adhesion binding sites
available in the ECM and the connectivity of the fiber network increase. As a mea-
sure of connectivity, we consider the network connected if there exists a continuous
path along matrix fibers from the parent vessel to the source of chemoattractant.
As the density of matrix fibers increases, there will be a density that guarantees
network connectedness. This threshold density is known as a percolation threshold.
Our model fiber networks are constructed by randomly placing fibers at randomly
selected but discrete orientations: 0◦, ±30◦, ±45◦, ±60◦, and 90◦. Consequently, our
fiber network most closely approximates a triangular lattice. We estimate that the
percolation threshold in our fiber networks occurs between ρ = 0.30 − 0.35. Recall
that we define matrix density, ρ, as the fraction of total tissue space occupied by col-
lagen fibers. This can be interpreted as the probability that a matrix fiber occupies,
that is, a bond exists between, two neighboring lattice sites. The bond percolation
thresholds depend on lattice geometry and is 0.35 for a two-dimensional triangular
lattice [43]. The matrix percolation threshold observed in our random matrices cor-
responds to the bond percolation threshold for a two dimensional triangular lattice.
Interestingly, this percolation threshold is coincident with the density at which our
model predicts maximum sprout elongation rates. We believe that this is because,
at the percolation threshold, “tracks” of matrix form and provide strong contact
guidance cues to the developing sprout. This finding suggests that capillary sprout
extension rates are positively related to the connectedness of the network.
Figure 6.6a−c reports the average extension speed of new sprouts forming on
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these restructured matrices for ρ = {0.2, 0.4, 0.6} respectively. The baseline for com-
parison is the average extension speed for sprouts formed on matrices with random
fiber alignment and is plotted as a solid black line in each plot. At ρ = 0.2, there are
fewer focal adhesion sites in the ECM and the matrix fibers do not form a well con-
nected network. Consequently, at this density, matrix fiber alignment does not have
a strong effect on sprout extension speeds. At ρ = 0.4 and ρ = 0.6, sprouts achieve
statistically significant higher average extension speeds when the fibers are aligned
parallel to the VEGF gradient (0◦) than when fibers are aligned perpendicular to
the chemogradient (90◦). The slowest speeds occur on matrices with fibers aligned
perpendicular to the VEGF gradient. Interestingly, sprout extension speeds on a
matrix composed of randomly oriented fibers are almost as fast as those observed on
matrices aligned parallel to the gradient (0◦). The reason for this is clear if we con-
sider the vector describing the net force, or resultant force, due to fiber orientation.
For 0◦ and 90◦ matrices, the resultant forces are in the 0◦ and 90◦ directions respec-
tively. For matrices composed of fibers aligned in both 0◦ and ±90◦, the resultant
force is at ±45◦ angles. This explains why 0◦ matrices facilitate the fastest extension
speeds and 90◦ matrices the slowest. For matrices with a random fiber orientation,
the resultant force is at a ±11◦ angle. Since the resultant force for random matrices
is approximately aligned with the gradient (±11◦), this accounts for our observation
that the corresponding extension speeds are close to those speeds recorded on 0◦
matrices. In these computer generated matrices, the fibers are oriented at discrete
angles and thus have a net orientation. Biologically, we are not limited to these
discrete angles. Depending on the tissue type, fibers may already be aligned, for
instance in muscle, or the tissue may be isotropic and lack any structural orienta-





Figure 6.6: Evidence that mechanical cues, or contact guidance, from the ECM affects sprout ex-
tension. At ρ = {0.4, 0.6}, rates of sprout extension are more rapid when matrix fibers
are aligned parallel to VEGF gradients (0◦) than when matrix fibers are aligned per-
pendicular to the gradient (90◦).
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ρ = 0.4. This is because at ρ = 0.4 the fiber network is well connected and pro-
vides adequate focal adhesion sites, but still retains sufficient anisotropy such that
strong guidance cues are transferred through fiber orientation. At higher densities
(ρ = 0.6), even though there are ample focal adhesion binding sites, the matrix is
more homogeneous, matrix “tracks” become less evident, and strong migratory cues
from matrix anisotropies are lost. Consequently, the effect of matrix alignment on
average extension speed decreases. These results support our hypothesis that when
mechanical or contact guidance cues from the ECM are aligned with the direction of
chemotaxis, these forces cooperate and promote sprout extension.
6.2.4 Cell shape and orientation are linked to matrix fiber alignment
In light of the above results, we construct patterned matrix topographies to look
at the effect of unambiguous contact guidance cues on cell shape, orientation, and
sprout morphology. In these numerical experiments, instead of distributing fiber
bundles, we engineer matrix cord patterns that vary in width and orientation. As a
baseline, we augment a matrix of randomly distributed fibers with horizontal cords
7.2 µm thick (Figure 6.7a). Figure 6.7b−e shows sprout development on matrix cords
7.2 µm thick aligned horizontally, horizontal cords 2.2 µm thick, vertical cords 2.2 µm
thick, and crosshatched cords. Horizontal cords are aligned parallel to the VEGF
gradient (0◦); vertical cords are perpendicular to the gradient (90◦); crosshatched
cords form a ±45◦ angle with the gradient. Except for the topography of the ECM,
all other model parameters are unchanged.
We find a strong correspondence between fiber alignment and cell shape and ori-
entation. We define cell orientation as the axis of elongation. In Figure 6.7a, the
density of ambient fibers is great enough to form a well connected mesh and facil-
























Figure 6.7: Sprouts developing on patterned matrices reveal a strong correspondence between fiber
alignment and cell shape and orientation. The sprouts migrate toward higher concen-
trations of VEGF, however, cells elongate and are clearly oriented in the direction of
the matrix cords. These results demonstrate the important role of contact guidance and
tissue structure in determining cell shape and orientation. Snapshots at 12.5 hours.
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that requires more energy to overcome. The anisotropy of the fiber mesh promotes
variable cell shapes with no obvious cell orientation. In contrast, in the absence of
an ambient fiber mesh, cells quickly adhere to the matrix cords (Figure 6.7b). Cells
orient and elongate in the direction of the horizontal cords. Figure 6.7c shows the re-
sult of reducing cord thickness from 7.2 to 2.2 µm (roughly 1/2 cell diameter). Cells
dramatically elongate and orient in the direction of the VEGF gradient. Compare
these two cases to Figure 6.7a and notice that thinner more linear sprouts develop
when strong and unambiguous contact guidance cues are aligned in the direction of
chemotaxis. Next we examine the effects of matrix cords aligned perpendicular to
the gradient. The results are shown in Figure 6.7d. In this case, although the sprout
migrates toward higher concentrations of VEGF, cells elongate and are clearly ori-
ented in the direction of the matrix cords, perpendicular to the gradient. Figure 6.7e
depicts sprout formation on crosshatched matrix topography. Again, cells orient in
the direction of the matrix cords, here at ±45◦ angles with respect to the gradient.
The resulting morphology is a sprout approximately 2 cell diameters thick, notably
thicker than the sprouts that develop with strong contact guidance cues aligned in
the direction of chemotaxis (Figure 6.7b,c). Fiber orientation also modulates cell
recruitment. When cells elongate and orient in the direction of the VEGF gradient,
fewer cells are required from the parent vessel and sprout extension is largely due
to cell elongation. Compare Figure 6.7: (a) with no obvious cell orientation 15 cells
are recruited, (b) 11 cells are recruited when cells are oriented in the direction of
the VEGF gradient, (c) only 3 cells are recruited when cells dramatically elongate,
(d) 19 cells are needed when cell orientation is perpendicular to the chemoattractant
gradient, and (e) 19 cells are recruited when cells orient at ±45◦ with respect to
the gradient. These results demonstrate the important role of contact guidance and
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tissue structure in determining cell shape and orientation.
6.2.5 Changes in average extension rates due to tip cell matrix degradation varies as
a function of ECM density
During angiogenesis, endothelial cells not only realign matrix fibers, but they also
secrete matrix degrading proteases that break down extracellular matrix proteins
and facilitate sprout migration through the stroma [124]. To study the effect of
matrix degradation on sprout development, we implement matrix degradation by
allowing the tip cell to degrade ∼ 0.3 µm2 of matrix each minute. We choose this
rate of degradation based on the fact that focal adhesions are estimated to be 0.25
µm2 [152]. Average sprout extension speeds are recorded and compared with the
average extension speeds without matrix degradation for different matrix densities.
Figure 6.8 graphically represents average extension rate pairs for sprouts forming
with and without matrix fiber degradation at ρ = {0.2, 0.4, 0.7, 0.975} and shows
that the effect of matrix degradation depends on matrix density. At ρ = 0.7 and
ρ = 0.975, matrix degradation results in approximately a 37% increase in average
sprout extension speeds at hour 14. As matrix fibers are degraded, fewer cell-matrix
adhesion sites are bound and therefore cellular attachment is reduced resulting in
increased motility. At a matrix density of ρ = 0.4, tip cell matrix degradation only
seems to have a significant influence on extension speed at earlier times (0−5 hours).
This suggests that the increase in motility due to a loss of bound focal adhesion
sites is limited. On more sparse matrices, ρ = 0.2, matrix degradation actually slows
sprout extension. While this may seem counterintuitive, at lower densities, further
reducing fiber density reduces the effectiveness of the ECM to provide a cellular
support system that is necessary for normal sprout migration and formation. Thus,
depending on the density of the matrix, matrix degradation may result in faster or
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Figure 6.8: This plot shows that the effect of matrix degradation on average sprout extension speeds
depends on the density of the ECM. Solid lines represent average extension speeds
without matrix degradation and the corresponding colored dashed lines show average
speeds with tip cell matrix degradation. For ρ ≤ 0.25, matrix degradation has anti-
angiogenic effects. Above ρ = 0.4, degradation facilitates sprout progression.
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slower extension speeds. This is consistent with our finding that sprout extension
speeds vary as a function of matrix density (Figure 6.4a). Indeed, at ρ = 0.975,
the initial cell is not able to penetrate the stroma and angiogenesis is completely
inhibited. In otherwise identical simulations, however, when the tip cell actively
degrades the matrix fibers, the tip cell carves out a path through the ECM and a
sprout is able to form (Figure 6.9a). This result is empirically validated by very recent
experiments by Davis et al. showing that human endothelial cells in extracellular
collagen matrices degrade a path through the ECM. This path is referred to as a
vascular guidance tunnel [33]. Figure 6.8 also shows that for ρ = 0.7, tip cell matrix
degradation has the greatest effect after 10 hours.
In our model, without degradation we observe no branching at matrix fiber den-
sities above ρ = 0.35. Figure 6.9b shows the progress of sprout development at
14 hours with ECM degradation at ρ = 0.4. A new sprout branches from the pri-
mary sprout body, an event that emerges only as a result of featured cellular and
molecular level dynamics; no rule specifically incorporating branching is imposed.
Tip cell degradation reduces ECM density and sets up very high local anisotropies
in the matrix fiber structure, providing strong contact guidance cues to the devel-
oping sprout. This result provides additional support for our hypothesis that high
matrix anisotropies created by tip cell degradation may be a mechanism for sprout
branching.
6.2.6 Sensitivity analysis
To ascertain the variability or sensitivity of our results to the choice of parameters,
we vary one parameter at a time (holding fixed all other Table 6.1 parameters) and
record our observations. We look at sprout development for various Jee. Decreasing













Figure 6.9: Without degradation, angiogenesis is inhibited at ρ = 0.99 (Figure 6.5f). Panel (a)
shows that tip cell matrix degradation promotes sprout development at ρ = 0.99 by
carving out a path for migration. Panel (b) depicts sprout formation with ECM degra-
dation at ρ = 0.4 and suggests that high matrix anisotropy created by tip cell degrada-
tion may be a mechanism for branching. Snapshot at 14 hours.
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the cells move to increase their cell-cell contact area. For Jee ≤ 10, cell shapes are
grossly contorted and unrealistic. As Jee increases, cell-cell adhesion weakens. Cells
move to reduce their surface area contact with each other and are generally rounder.
For Jee ≥ 50, cell-cell adhesion becomes too weak relative to the chemotactic forces
acting on the cell and the tip cell migrates away from the main sprout. Similarly,
lower values of Jem correspond to stronger cell-matrix binding energies. For Jem ≤ 46,
cell shapes are abnormally distorted to increase the contact area between the matrix
fibers and the cell membrane. At Jem = 56, a relatively strong cell-matrix adhesion
bond, sprout morphology is noticeably thicker and more tortuous. Intermediate val-
ues (66 ≤ Jem ≤ 76) provide a good balance between contact guidance and release
of focal adhesion bonds and sprout morphologies and extension speeds are relatively
insensitive to parameter variability within this range. Above Jem = 76, contact guid-
ance is weak. A value of Jem = 200 is equivalent to inhibiting cell-matrix adhesion,
for example by blocking integrin receptors. Consequently, at Jem = 200, endothelial
cells do not adhere to matrix fibers at all and are unable to migrate, even in the
presence of chemotatic incentives. In this case, chemotaxis is the dominant force
governing sprout guidance and more linear sprouts develop. There is no statistically
significant change in average extension speeds as Jem varies within these ranges. The
results are insensitive to the binding energies between matrix fibers, Jmm, or between
interstitial fluid molecules, Jss. The results also do not depend on the compressibility
properties of the matrix fibers or interstitial fluid, γm,f , since the total mass of these
ECM components are conserved. We vary γe between 0.3 and 3. Decreasing γe makes
it easier for the cells to deviate from their target volume. Therefore at γe = 0.3, the
cells are larger overall and consequently fewer cells are recruited from the parent
vessel. Average extension speeds are not affected. This highlights that cell growth
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is another mechanism for sprout extension. Increasing γe produces smaller cells, and
consequently, more are recruited. At γe = 3, the tip cell migrates away from the
main body of the sprout. This is because of the chemotactic sensitivity differential
between the tip cell and the stalk cells. The relative pressure on a cell to maintain its
target volume is greater than the chemotactic forces acting on the stalk cells, but not
greater than the chemotactic incentives for the tip cell. Thus the tip cell detaches.
Figure 6.10 shows how the average extension speed of a sprout varies with increas-
ing χ. Average speeds are calculated at 14 hours. Above χ = 1.6 · 106, the physical
integrity of individual endothelial cells is compromised and the cells dissociate due
to the relatively strong chemotactic forces. Below χ = 1 · 104, chemotactic forces
provide insufficient migratory cues relative to the adhesion energies and growth con-
straint and the initial cell does not migrate into the stroma. At intermediate values,
sprouts migrate faster with increasing χ, but sprout morphologies are unaffected.
To determine the effect of change in the probability that energetically unfavorable
events occur, we vary the parameter kT , where k is the Boltzmann constant and
T is the effective temperature that corresponds to the amplitude of cell membrane
fluctuations. Increasing kT effects faster average sprout extension speeds, but no no-
ticeable changes in cell shape, the number of cells recruited, or sprout morphology.
6.3 Discussion
The extracellular matrix has attracted a great deal of attention from researchers
and experimentalists because of its vital role as a modulator of morphogenic pro-
cesses. Identifying and elucidating the mechanisms through which the ECM con-
tributes to changes in cell shape and function is of critical importance to many
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Figure 6.10: Plot showing the effect of varying the chemotactic sensitivity parameter, χ, on average
sprout extension speed at 14 hours. Below χ = 1·104 chemotactic forces are not strong
enough relative to the energies associated with adhesion and growth to induce motility.
Above χ = 1.6 · 106, chemotactic forces are strong enough relative to adhesion and
growth that the cells dissociate.
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morphogenic events, including angiogenesis, wound healing, embryogenesis, and tu-
mor invasion. We use a cell-based model of angiogenesis as a framework to explore
the effects of ECM topography on cell-cell and cell-matrix dynamics. This type of
modeling approach captures the precise morphology of the cells and of emergent
multi-cellular structures and allows a quantitative description of physical character-
istics, such as cell shape and orientation and sprout thickness. By adjusting key
parameters, the model captures (i) a frequent observation in embryogenesis whereby
cells use cell-cell adhesion to rapidly traverse along the sprout, (ii) single cell mi-
gration as seen in fibroblasts during wound healing, and (iii) different cell shapes.
Our results indicate that the density or connectedness of the matrix, local prote-
olytic matrix degradation, and fiber alignment affect extension speeds. We record
peak migration speeds in tissues that have a similar collagen content to that seen
in the cornea. We observe density dependent pro- and anti-angiogenic effects and
propose that high matrix fiber anisotropy provides strong contact guidance cues and
is a mechanism for initiating sprout branching. Finally, we provide strong evidence
that contact guidance influences cell orientation by examining sprout development
on engineered matrix patterns.
During morphogenesis, cells actively restructure and condition the extracellular
matrix for migration through proteolytic degradation and fiber reorganization and
alignment [160]. Our studies suggest that contact guidance cues are mediated by
changes in matrix fiber density and isotropy, network connectedness, and fiber orien-
tation. These findings collectively support the hypothesis that contact guidance cues
play a major role in determining sprout morphology and the average rate of capil-
lary sprout extension. Our results strongly suggest that the contact guidance cues
established through high matrix fiber inhomogeneity in the stroma may be a mech-
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anism for sprout branching. Applying our results in the context of tumor-induced
angiogenesis, local changes in ECM density that create matrix anisotropies in concert
with fiber alignment may contribute to the accelerated extension speeds reported as
sprouts approach the tumor. In addition, fiber density is not constant in the extratu-
moral environment. The density of the extracellular matrix is lower near the tumor
due to the secretion of matrix degrading proteases by tumor cells. If these lower
regions of matrix density are within the range we predict to be conducive to branch-
ing, this could help explain why an increase in branching, known as the brush border
effect, is seen in vivo as sprouts get close to the tumor. It is worth pointing out that
at a distance of 100 µm from a tumor 1mm in diameter, we specify a linear source
of VEGF. This choice ensures little or no gradient in the transverse or y−direction
and allows us to attribute lateral cell and sprout movement to the mechanical effects
of the matrix. Different spatial profiles of VEGF, for example a parabolic source or
local sinks and sources of VEGF in the ECM, could also contribute to branching and
varied morphological patterns. The effect of different VEGF profiles on angiogenesis
has been theoretically modeled by Anderson and Chaplain [9].
6.3.1 Clinical implications: ECM targeted angiogenic therapies
Increased understanding leading to the ability to control angiogenesis in vivo has
significant clinical implications. Angiogenesis is a crucial event to many physiological
processes. Embryonic development and endometrium vascularization, arteriogenesis
resulting from ischemia and vessel occlusion, wound healing and tissue repair are all
homeostatic processes that require new vessel growth for normal function. Angio-
genesis can also lead to pathological conditions. Tumor angiogenesis, proliferative
diabetic retinopathy and macular degeneration, psoriasis and rheumatoid arthritis
occur when angiogenesis is unhalted [47]. On the other hand, insufficient vessel
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growth can lead to heart attack, stroke, and impaired ulcer and wound healing. Ex-
isting angiogenic therapies can be broadly categorized as those that (1) target growth
factors or growth factor cell receptors that stimulate vessel growth, (2) block cell in-
vasion into the stroma, and (3) directly induce endothelial cell apoptosis. Because
of its established prominence in both homeostatic and aberrant angiogenesis, VEGF
and its receptors are prime therapeutic targets. There is overwhelming experimental
evidence that in order to form functional vessels, the various VEGF isoforms must
be precisely regulated and that the blockage of even a single growth factor might
limit tumor-induced vascular growth [124, 20, 50]. The most promising approaches
to anti-angiogenesis therapies are those based on blocking VEGF or VEGF receptors
[171]. VEGF neutralizing antibodies, soluble VEGF receptors, and receptor tyrosine
kinase inhibitors are examples of therapies currently being utilized or that are un-
dergoing clinical trials [81]. One problem associated with targeting growth factors
as therapeutic agents is that they are often constitutively expressed in vivo and can
be proteolytically released. Thus tight control is, in practice, hard to maintain. For
example, it is known that connective tissue, which contains some of the same fi-
brous proteins that are found in the ECM, can significantly inhibit cell migration
and prevent the formation of sprouts [124].
The ECM and cell-matrix associations also provide promising possibilities for an-
giotherapy, but have only more recently received attention as targets and are in
less advanced stages of clinical development. Consequently, modeling and simula-
tion have the potential to contribute to and propel further advancement. Current
therapeutic interventions aimed at cell-matrix interactions during angiogenesis focus
on tissue inhibitors of metalloproteinases and on integrin-mediated cellular adhesion
[47]. Blocking proteolysis is intended to inhibit cellular migration into the stroma and
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to prohibit MMP-dependent release and activation of ECM sequestered angiogenic
factors. The αvβ3 integrin receptor is significantly upregulated in angiogenic vessels
when compared to mature vessels [47], making this receptor a logical therapeutic
choice.
Using our model, we regulate cell-matrix binding affinity (Jem) and control the
number of focal adhesion binding sites available in the ECM (density modulation)
to test the efficacy of integrin specific anti-angiogenic therapies. Setting Jem = 200
is equivalent to blocking integrin receptors. Our simulations show that decreasing
the binding affinity of integrin receptors prevents endothelial cells from adhering to
matrix fibers and cells are unable to migrate even in the presence of chemotatic in-
centives. We also show that cellular motility is inhibited at high matrix densities
due to the greater number of focal adhesion binding sites available. Our simula-
tions suggest that regulating the affinity or number of cell-matrix focal adhesion
sites either biochemically or mechanically produces anti-angiogenic effects. In addi-
tion, our results indicate that regulating the cellular production of matrix degrading
proteases can shift sprout velocity curves for the purpose of promoting or inhibiting
angiogenesis. We show that at low matrix densities (ρ ≤ 0.25), matrix degradation
has anti-angiogenic effects, whereas above ρ ≤ 0.4, degradation facilitates sprout
progression.
In these studies, we isolate and examine variations in fiber density and structure,
and proteolytic matrix degradation as independent mechanisms that control vascular
morphogenesis. Nonetheless, the integrin, protease, and growth factors systems are
highly connected and provide regulatory feedback for each other [47]. Thus, there
is still a need for more in depth investigations on the relationship between extra-
celluar stimuli and cellular function. In particular, studies focusing on intracellular
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signaling and cross-talk between the integrin and growth factor receptors are of key
importance.
CHAPTER VII
Intracellular Signal Transduction and Its Role in Controlling
Cellular Behavior During Angiogenesis
7.1 Introduction
Another step towards understanding and controlling the processes that occur dur-
ing angiogenesis is to understand how individual cells respond to the biochemical
signals that come from their external environment, including chemo-activation and
messages from other cells and the extracellular matrix, to make decisions. Creating
a model framework to study the cellular response during angiogenesis is a major goal
of this dissertation. This investigation would be incomplete without consideration
of the intracellular signal transduction pathways that regulate how and when a cell
responds to key external biochemical signals involved in angiogenesis, and the influ-
ence of these environmental signals on cellular function. To do this, we construct
a Boolean network model that focuses on those pathways and molecular targets
affected by growth factor binding to receptor tyrosine kinases (RTK), ligation of
integrin receptors (ITG), and cell-cell communication via vascular endothelial (VE)
cadherins. To date, there is no mathematical model, Boolean or otherwise, designed
to investigate the cross-talk between the VEGF, integrin, and cadherin receptors in
deciding cellular behavior during angiogenesis. With this model we can investigate
questions such as: what are the critical pathways involved in how a cell decides
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whether its going to grow, move, or die once environmental signals are received; and
how does a cell’s external environment influence these decisions? These questions
will be explored in Chapter VIII where we couple this intracellular signaling network
model with the cellular model of angiogenesis from Chapter VI in a multi-scale model
of tumor-induced angiogenesis.
7.2 Review of Boolean Network Models
Boolean networks (BN) have a long standing tradition as idealized models of ge-
netic regulatory dynamics in cells. Random Boolean networks (RBN) are Boolean
networks with randomly assigned interactions and logical functions. Given the frag-
mented knowledge of gene regulation circuits at the transcription level in the 1960’s,
Stuart Kauffman originally introduced the notion of RBN to study the dynamical
properties of gene regulation networks from a global perspective [76, 77]. In general,
a BN model consists of N binary state variables s1, s2, . . . , sN , or nodes. Each can
take the values 1 and 0, corresponding to an “on-off” idealization of regulatory dy-
namics, for example whether or not particular genes are expressed or the presence
or absence of signaling molecules in the cell cytoplasm. The state of each node si,
where i = {1, . . . , N}, is regulated by k other regulatory elements (node inputs), with
0 ≤ k ≤ N , and si can influence 0 ≤ j ≤ N other elements (node outputs). Once
each node has been assigned a set of inputs, (si1 , si2 , . . . , sik), network dynamics are
typically given by synchronous updating of all network elements according to
(7.1) si (t + 1) = fi (si1(t), si2(t), . . . , sik(t)) ,
where fi is the Boolean function for node si. In RBN, fi is chosen at random from the
ensemble of all possible 2k Boolean functions of k inputs. For any initial configuration
of the N state variables, it takes the network a maximum of 2N − 1 time steps to
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settle to a periodic attractor of self-repeating states [77]. Two distinct dynamical
phases exist in RBN: an ordered phase, characterized by a small number of attractors
with short periods and a vanishing sensitivity to perturbations, and a chaotic phase
with both the number and average period of attractors growing exponentially with
N and perturbations (damage) propagating over the whole network [77, 36]. Of
special interest are critical RBN, which lie at the boundary between the two phases
[77, 36], as they exhibit the most realistic dynamical properties as models of biological
networks with respect to robustness and adaptive flexibility [77, 5].
RBN with either a constant number of inputs per node (homogeneous topol-
ogy) or with the number of inputs and outputs per node distributed according to
a Poisson distribution, and equal probability for each possible Boolean function to
occur, exhibit a percolation transition at a critical (average) connectivity Kc = 2
[36, 153, 103]. Random networks of discrete neural threshold gates exhibit a similar
percolation transition behavior [88, 87, 132, 131]. If Boolean functions are biased,
such that output states si = 1 occur with probability p and si = 0 with probability
1−p, the critical value for connectivity generalizes to Kc = 1/{2p(1−p)} [36]. Beyond
this mean field theory, recent research has revealed very complex scaling phenomena
at Kc [140, 162, 114, 141, 159]. In most studies, RBN dynamics are modeled us-
ing synchronous deterministic updates. Since in real biological networks stochastic
events at the molecular scale are ubiquitous, asynchronous and stochastic updat-
ing schemes attract considerable attention from researchers. In randomly generated
networks, dynamical attractors are often destroyed by asynchronous updates [51].
However, in models of biological networks treated as Boolean systems, attractors are
often insensitive to these perturbations. This indicates that evolution might have
selected network topologies such that the dynamics are robust against both noise
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and different time scales of regulatory events [3, 17]. Furthermore, there is evidence
that delays in information propagation contribute significantly to synchronization
and thereby stabilize dynamical attractors [83, 84].
RBN have been applied in a number of theoretical studies to gain insight into the
shaping of biological regulation networks by evolutionary processes, with emphasis
on robustness of expression patterns against mutations of regulatory wiring [16],
evolution of homeostatic regulation near percolation criticality [15], and application
to problems in morphogenesis [71, 133]. BN models have also been successfully
applied to model and predict the regulatory dynamics of several biological organisms,
integrating known exerimental data about the topology of the corresponding cellular
networks. Albert and Othmer [3] studied the segment polarity network of Drososphila
melanogaster and showed that the topology of regulatory interactions alone predicts
the observed gene expression pattern at a late developmental stage. Confirming
earlier results about the extreme robustness of this developmental module against
variations of kinetic constants over orders of magnitude [166], dynamical attractors
in this system are insensitive to large variations of time scales in the Boolean update
scheme (e.g. synchronous deterministic vs. asynchronous stochastic updates) [24].
Similar results were established in BN models of the yeast cell cycle network in the
presence of biochemical stochasticity [17, 31].
Most interesting for the study presented in this chapter is the recent work of Li,
Assmann, and Albert on Boolean models of signal transduction networks [97]. In
most signal transduction systems, quantitative information on the speed and duration
of biochemical reactions, the initial or resting state of internal nodes, and signal
transduction noise is scarce. This work presents and validates a Boolean network
model of signal transduction in plant guard cells as a theoretical tool that can be
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useful when more quantitative information does not exist. The authors analyze
the robustness of the network and show that the topology of the signaling network
determines the dynamic behavior of the system. This model is used to examine the
relationship between signal and cell function and to make predictions about unknown
or incompletely understood biochemical relationships in the network. This type of
model can be employed to describe signal transduction networks in other biological
systems where mostly qualitative data are available. We use this Boolean network
approach to model and analyze the signaling pathways believed to be critical to
cellular regulation and function during angiogenesis.
7.3 VEGF-Integrin-Cadherin Receptor Cross-Talk: A Boolean Network
Model
This study is the first to propose a network model that highlights the cross-talk
between growth factor, integrin, and cadherin receptors in angiogenesis. Figure 7.1
graphically represents the signal transduction network we have implemented for this
study. Arrows indicate an activating effect, whereas bars designate inhibition. Since
reaction rates for most of the kinetic interactions are not available in the experi-
mental literature, we employ a Boolean network model approach and later, in the
section on dynamical analysis, investigate whether a Boolean approach provides a
reasonable description of the dynamics. This network was developed with the aim
of synthesizing the empirical data available for endothelial cell signal transduction
during critical angiogenic processes using the sparsest graph consistent with all ex-
perimental observations. This model allows us, for the first time, to explicitly derive
an input/output table linking key environmental cues to cell phenotype during an-
giogenesis. Using this model, we also study the effect of different feedback schemes
between Rac1 and Rho, key mediators of cell migration whose relationship is not
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yet well understood. We systematically analyze the dynamical stability of this net-
work and find that the output states (i.e., cell phenotypes) are insensitive to initial
configurations and perturbations of internal nodes. At the same time, this network
exhibits a fast and flexible response to external signals. Further, network response
is stable under stochastic desynchronization of updates and moderate internal noise,
indicating that the network architecture is selected for high reliability of response in
a fluctuating environment.
The assignment of appropiate Boolean functions is relatively straight-forward and
the dependence relation for each node is given in Table 7.1 with references. Numbers
refer to nodes and si denotes the state (0 or 1) of node i = {0, . . . , 22} at time
(t − 1). A zero indicates the signal is off and a one indicates the signal is on. The
internal nodes are initialized to s = 1 with probability p = 0.5 otherwise the node
assumes s = 0. The current state of the network is stored in a one-dimesional array
scurr. As time advances, new states for each node are calculated in parallel according
to the Boolean dependence on its inputs (synchronous update) and are stored in a
one-dimesional array snew. Then, scurr = snew for all i = {0, . . . , 22}.
In the graphical screenshots of the simulations (for example Figure 7.3), time runs
from top to bottom and the columns represent the states of network nodes, with black
= off (0), and colored = on (1). The colors correspond to the color coding of the
nodes in Figure 7.1, which were chosen to highlight the signaling cascades that lead
from each receptor to the different cellular phenotypes. In Figure 7.1, green nodes
designate a signal that originated from activation of the VEGF receptor and the
red nodes identify a signal cascade from the integrin receptor. Yellow designates
nodes that can be activated from either receptor. The input signals are shown in
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Figure 7.1: Simplified signal transduction network linking external stimuli to a cell’s internal de-
cision making machinery. This network highlights the relationship between VEGF,
integrin, and cadherin receptors, allowing for cross-talk between the three to ultimately
decide the cell’s fate. In this network, an arrow between nodes signifies activation and
a bar shows an inhibitory effect.
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Table 7.1: Table of Boolean Network Interactions. Numbers correspond to nodes in Figure 7.1 and
the node’s Boolean dependence on other nodes is given. For instance, node #2 is turned
on if node #0 is on and node #8 is turned off if node #6 is on. Nodal relationships
are determined based on the current scientific literature and references are given. Most
of this information is derived for endothelial cells, but data from other cells lines are
included where information on the endothelial cell line is lacking.
Node # Dependence Function Reference
-1 external signal (VE-cadherin contact inhibition)
0 external signal (VEGF binding)





6 NOT s5 [30]
7 NOT s5 [27]
8 NOT s6 [30]
9 s3 OR s14 [30, 136, 27]
10 s9 AND NOT s16 [123, 92]
11 s10 AND NOT s17 (< threshold) / OR if (> threshold) [143, 92, 119]
12 s4 OR s11 [38]
13 s12 [27]
14 s1 [1]
15 NOT s1 [70]
16 s15 [157]
17 s14 [122]
18 s17 AND NOT s13 [70]
19 s18 OR s11 [6, 80]
20 s8 OR s13 [89]
21 s7 AND NOT s8 [30]
22 s19 [127]
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that signals contact inhibition is depicted in gray, followed by the VEGF receptor
signal (green) and the integrin receptor signal (red). The resulting phenotypes,
or attractors, appear in the three rightmost columns (20-22), from left to right:
proliferation, apoptosis, and migration, and are colored yellow.
7.4 Results
7.4.1 Cellular phenotype linked to external cues
This model allows us, for the first time, to explicitly derive an input/output (IO)
table linking key external cues to cell phenotype. Figure 7.2 shows the model predic-
tion of cell phenotype for various input signals. The input configuration is labeled
across the top and the net signal to Rac1 (above or below some threshold amount)
is given on the left. The bottom two rows show the effect of contact inhibition
on cell phenotype regulation. For example, if the cell only receives a signal from
its growth factor receptor (10), and the signal to Rac1 is above (>) the threshold
amount needed to activate Rac1, row 2 column 3 of Figure 7.2 tells us that the
cell will initiate apoptosis. The network output is (011), which indicates that, under
these conditions, intracellular signaling cascades result in apoptosis and motility. We
assume, however, that in the absence of any signal inhibiting apoptosis (promoting
cell survival), the signal for apoptosis dominates and overrides the signal for a cell
to move [49].
We verify three control cases: no external signal, VEGF signal only, and integrin
signal only. From column 1 of Figure 7.2, we see that in the absence of any growth
factor or integrin receptor signal, apoptosis is triggered and the cell dies. With a
signal from the growth factor receptor only (column 2), again, the cell initiates apop-
tosis. This says that growth factor is not enough to sustain cell viability; attachment
to the ECM is necessary. This result is known as anoikis, which is cell death triggered
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Figure 7.2: Table showing cell phenotype predicted by the baseline Boolean network for various
input configurations. This Boolean network model exhibits five distinct cell phenotypes:
apoptotic, proliferating, migrating, quiescent, and both proliferating and migrating.
by the cell losing contact with the ECM. Column 3 shows the phenotypes that result
when a cell only receives a signal from the ECM. In the absence of any growth factor,
as expected, we see apoptosis. The fourth column shows the predicted phenotype
when both the VEGF and integrin receptors are activated. When Rac1 is below
threshold and therefore not activated, cell proliferation is triggered; when Rac1 is
above threshold, the model predicts that the cell will both begin to grow and engage
its motility machinery. Contact inhibition has the effect of blocking cell prolifera-
tion. Thus, when there is contact inhibition and Rac1 is below threshold, there is no
signal at all and the cell becomes quiescent. Whereas when Rac1 is activated and
there is contact inhibition, the result is cell migration. Figure 7.3 shows a simulation
screenshot for each outcome.
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Figure 7.3: Screenshots of baseline network dynamics. Time runs from top to bottom. Input signals
are shown in the first three rows and the resulting phenotypes are shown in the last
three rows. Internal signals correspond in both number and color to Figure 7.1. Each
figure above corresponds with the rows and columns of Figure 7.2. The first three
columns show the results from our control cases: no external signal, VEGF signal only,
and integrin signal only respectively. As expected, apoptosis results in each case. The
fourth column shows the predicted phenotypes given that both the VEGF and the
integrin receptors are activated. From top to bottom: proliferation, proliferation and
migration, quiescence, and motility.
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7.4.2 Investigating the relationship between Rac1 and Rho
Cdc42, Rac1, and Rho are key mediators of cell migration. Experiments agree
that Cdc42 activates Rac1. How Rac1 and Rho interact and regulate migration,
however, is not yet well understood. Different experimental groups report different
relationships and feedback schemes between these three signaling molecules. Since
the relationship between Cdc42 and Rac1 is known, without any loss of information
we couple Cdc42 and Rac1 into a single node and refer to it as Rac. Reported
interactions include: Rac inhibits Rho [142, 104], Rac activates Rho [118], Rac and
Rho negatively feedback on each other [163], and Rac activates Rho, but Rho provides
negative feedback to Rac [139]. Using this network model, we study the effect of
different feedback schemes between Rac and Rho.
Figure 7.4 shows the predicted phenotypes for different Rac/Rho feedback schemes.
Panels (a)−(d) are the results when (a) Rac and Rho negatively feedback on each
other, (b) Rac provides positive feedback to Rho and Rho inhibits Rac, (c) Rac
activates Rho, and (d) Rac inhibits Rho. When there is a negative feedback loop be-
tween Rac and Rho (Figure 7.4a), the network dynamics are identical to the baseline
dynamics except for the case with both VEGF and integrin input signals activated
and Rac is below threshold (row 1, column 4). We now see two different attrac-
tors: one that signals the proliferative phenotype and one that predicts proliferation
(100) and oscillations in motility (10ω). The oscillatory state is designated by ω.
We ran 50,000 simulations and found that 85% of the time the system converges
to the fixed point attractor (100) and 15% of the time it converges to the periodic
attractor (10ω). Thus, the effect of introducing negative feedback into the system
between Rac and Rho is that a weak migratory signal emerges under very specific
conditions: VEGF and integrin receptors activated, Rac inactive, and no contact
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inhibition signal. When Rac provides positive feedback to Rho (Rho still inhibits
Rac), we see different phenotypes predicted only for the dual input signal cases when
Rac is activated (see Figure 7.4b). Here we see that the periodic attractor in row
1 column 4 is stable, meaning an oscillating signal for motility emerges with prob-
ability 1 compared to the 15% occurrence we observe with negative feedback. The
presence of oscillations in the migratory signal may indicate a weak migratory signal
or a reduction in the frequency of the migratory cell phenotype. When Rac strictly
activates Rho (Rho does not influence Rac), the phenotypes predicted match those
predicted by the baseline network, except that we see a strong signal for motility in
all dual input cases (Figure 7.4c column 4). Notice that the oscillations no longer
occur compared to the network results with positive feedback. Similar results are
seen when Rac inhibits Rho (Figure 7.4d column 4). These networks are unable to
generate quiescent cells or cells that are proliferating only.
7.4.3 Dynamical stability analysis
Network exhibits high robustness of signal transduction
One measure of network robustness is whether signal transduction depends on the
choice of initial conditions. To test this, the initial condition for each internal node
(2-19) is set to s = 1 with probability p = 0.5, otherwise it is set to s = 0. Thus
the number of 1’s in the initial conditions follows a binomial distribution. Of the 217
(131,072) possible initial condition configurations, 50,000 were tested at random for
each input state. We perform this analysis for each network, that is, the baseline
network and the networks corresponding to the different feedback schemes between
Rac and Rho. In all cases, dynamics converge to the final attractor states (i.e., the
corresponding output configurations) with probability p = 1 with one exception. For
the case in which both the VEGF and integrin receptors are activated, Rac is below
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Figure 7.4: IO table showing cell phenotype predicted for various Rac/Rho feedback configurations.
(a) negative feedback, (b) positive feedback, (c) Rac activates Rho, (d) Rac inhibits Rho.
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Figure 7.5: Screenshots of network dynamics when Rac provides negative feedback to Rho. Dy-
namics are identical to the baseline dynamics except for the case when both VEGF
and integrin receptors are activated and Rac is inactive (row 1, column 4). We now see
two different attractors: one that signals the proliferative phenotype (top), and another
that predicts proliferation and oscillations in motility (bottom).
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Figure 7.6: Screenshots of network dynamics when Rac provides positive feedback to Rho. Com-
pared to the baseline network, different phenotypes are predicted only for the dual input
signal cases when Rac is activated. The periodic attractor in row 1 column 4 is stable,
meaning an oscillating signal for motility emerges with probability 1 compared to the
15% occurrence we observe with negative feedback.
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Figure 7.7: Network exhibits a fast and stable response to changes in external stimuli. Screenshot
of the baseline network with Rac above threshold during a transient switch from simul-
taneous VEGF and integrin signals to a VEGF signal only (white arrow). After only 8
updates, the system has converged to a new attractor and the cell undergoes apoptosis.
threshold, and Rac and Rho negatively feedback on each other (row 1 column 4 of
Figure 7.4a), 85% of the initial configurations converge to the fixed point attractor
(100), while 15% converge to the periodic attractor (10ω). These findings imply that
the output states are a function of input signals only, that is, the network response
does not depend on the initial internal state of the nodes.
This network also exhibits a fast and flexible response to changes in external
cues. Figure 7.7 is a screenshot showing the results of a runtime change in the
external signal received during a simulation. These simulations use the baseline
network with Rac above the activation threshold and input signals from both the
VEGF and integrin receptors. After the system converges, in this case to growth and
migration (101), we obstruct the integrin receptor signal (see arrow in Figure 7.7).
The network converges to a new attractor commensurate with the input signal of
(10) and signals a change in phenotype from growth and migration to apoptosis. We
find that if, after convergence for a given input configuration, one input is changed,
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the dynamics converge after only a few updates to the attractor(s) that correspond to
the new input signal. Therefore, we conclude that the network demonstrates a high
sensitivity to transient temporal switching of, or perturbations to, external signals.
The insensitivity of the network dynamics to the initial conditions of the internal
states coupled with the ability to quickly and accurately respond to perturbations
in the input signals demonstrates that the network exhibits extremely high signal
transduction robustness.
Network response is stable under asynchronous updates
Whether and how the results depend on the updating scheme employed is another
measure of the dynamical robustness of a network. We test this by implementing
asynchronous, stochastic updates instead of in parallel (synchronous) updating. For
asynchronous updates, the state, s, of each network node is updated independently
according to the following rule:
si(t) =

fi(~ξi(t− 1)) with probability p,
si(t− 1) with probability 1− p,
where fi denotes the Boolean function for node i given input vector ~ξi. This says
that with probability p, the state at time t is switched according to the Boolean
function of the inputs at time t − 1, and with probability 1 − p, its state remains
unchanged.
Figure 7.8 shows an example of the dynamics using an asynchronous, stochastic
updating scheme with p = 0.4. Both the VEGF and the integrin receptors are
activated, Rac is above the threshold needed for activation, and there is a negative
feedback loop between Rac and Rho. After approximately 30 updates, the system
converges to its stationary state. Using asynchronous updating, we find deterministic
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Figure 7.8: Screenshot from a simulation using an asynchronous, stochastic updating scheme with
p = 0.4. We find that network dynamics are governed by the topography of the network,
not the updating scheme used.
(p = 1) convergence to the same attractors as for parallel (synchronous) updates.
Figure 7.9 shows that the convergence times scale linearly with the average update
frequency 1/p. That is to say that the interaction probabilities, p < 1, determine only
the time-scale for convergence, but do not affect the final output states. Thus, the
final states (attractors) depend on network topology only, not on the details of the
order of updates. These results suggest that signal transduction is very reliable even
when only small concentrations of signaling molecules are present, and interactions
of signal molecules are relatively rare, stochastic events.
Sensitivity to Noise
Another robustness test for network dynamics is to make the Boolean functions



























































































































































































































































































































































































































































































































each node changes its state according to:
si =

fi(~ξi) with probability 1− p,
1− fi(~ξi) with probability p,
This says that the node takes the “wrong” state (i.e., error in signal transduction)
with probability p. This can be interpreted as internal noise, for example, due to the
spontaneous production or decay of a signaling molecule. Typically, for a biological
cell, p will be very small, since all reactions rely on catalysis, with spontaneous
reaction rates being orders of magnitude smaller than those of catalyzed reactions.
Note that p = 0 corresponds to deterministic updates and p = 1/2 to completely
randomized updates.
Figure 7.10 shows the probabilities or rates, r, that a 1 appears in the output
table for each of the phenotypes. Plots (a)−(d) correspond to the 4 inputs states:
{(00), (10), (01), (11)}. For all input configurations, we find that growth and motility
cell phenotypes are less sensitive to an increase in p, compared with apoptosis, where
r crosses the line r = 0.5 for values between p = 0.05 and p = 0.1. Interestingly, this
indicates that the apoptotic response is highly sensitive to noise, suggesting that the
probability of programmed cell death increases in response to conflicting or confusing
signals. In a biological setting, we can interpret this result to mean it is highly
unlikely that a cell will undergo apoptosis erroneously. These sensitivity results also
signify that the apoptotic signal is a hypersensitive switch, which is consistent with
the findings of Wee and Aguda [169]. On the other hand, Figure 7.10 shows the
insensitivity of growth and motility to noise and thus the switching functions for











































































































































Due to the scarcity of quantitative data on the kinetics of the intracellular bio-
chemical reactions involved in key signal transduction pathways during angiogenesis,
we develop a simplified Boolean signaling network to describe the signaling pathways
critical to cellular regulation and function during angiogenesis. This model is the
first to couple VEGF, integrin, and cadherin signaling cascades and cross-talk and
is consistent with experimental observations. Using this model, we construct a state
table showing the one to one correspondence between receptor activation (inputs)
and cellular function (outputs) for this network and study the effect of different feed-
back configurations between Rho and Rac. We analyze the dynamical stability of the
network and find that the system is highly robust. The insensitivity of the network
dynamics to the initial conditions of the internal states coupled with the ability of
the network to quickly and accurately respond to perturbations in the input signals
demonstrates that the network exhibits extremely high signal transduction robust-
ness. We find that the final output state, or phenotype, is completely determined
by the input state and not affected by transient or accidental internal variations. In
addition, we determine that network response is stable under stochastic desynchro-
nization of updates and moderate internal noise (that is, errors in signaling cascades),
indicating that the network architecture is selected for high reliability of response in
a fluctuating environment.
CHAPTER VIII
Multi-Scale Model of Angiogenesis
8.1 Incorporating Intracellular Signaling
Introducing intracellular regulation into the cellular model provides another level
of biological realism to the system and creates a framework within which we can
investigate how the external environment guides critical cellular decisions, including
whether the cell is going to proliferate, migrate, or initiate apoptosis, and how these
decisions influence sprout morphology. Intracellular signaling is an important consid-
eration for more in depth investigations of the biochemical mechanisms controlling
angiogenesis. In Chapter VII, we develop and analyze a simplified Boolean signal
transduction network of the cross-talk between the VEGF, integrin, and cadherin
receptors. In this chapter, we interface the partial differential equation model for
VEGF dynamics, the lattice-based stochastic model describing cellular behaviors,
and this Boolean model of intracellular signaling pathways critical to angiogenesis.
With this integrated multi-scale model, we are able to capture processes occurring
across multiple time scales. Signal transduction occurs on the order of 10−2 − 102
seconds, whereas cell growth and division take place over tens of hours. Table 8.1




Table 8.1: This table shows the different time scales (in seconds, s) of biological processes that
occur during angiogenesis and the type of model we use to describe each process.
Process Time Scale Model Type
Signal transduction 10−2 − 102 s Boolean
VEGF diffusion 101 − 102 s continuous
Motility 102 − 104 s discrete, stochastic
Proliferation 104 − 105 s discrete, stochastic
In the model we present in Chapter VI, cell phenotype is prescribed phenomeno-
logically based on empirical data. In that model, we define a tip cell as the cell
leading the sprout, a proliferating cell as the cell(s) immediately behind the tip
cell, and all other cells as stalk cells. Each cell phenotype embodies a phenotype-
dependent behavior that is consistent with what is observed experimentally. Tip cells
are highly specialized motile cells that respond to chemoattractant gradients and se-
crete ECM degrading proteases; proliferating cells grow to twice their initial size
according to an 18 hour cell cycle clock and then divide into two daughter cells; and
stalk cells exhibit chemotactic migration, but not as sensitively as a tip cell. In the
multi-scale model of angiogenesis, we remove these phenomenological rules prescrib-
ing cellular phenotype by incorporating the results from the intracellular signaling
network analysis. Now cell function is determined based on the cell’s immediate
external environment. Moreover, with the introduction of intracellular signaling, the
multi-scale model additionally captures apoptosis, cell quiescence, multiple prolif-
erating regions, and multiple branch points. Consequently, the multi-scale model
provides a more biologically realistic representation of cellular dynamics and events
during angiogenesis. Cell quiescence and apoptosis have received very little atten-
tion in previous models of angiogenesis. Very recently, a continuum model of tumor
growth and vascular development was developed to explore the effect of blocking the
VEGF−Bcl-2−CXCL8 signaling pathway [72]. Although apoptosis has been con-
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sidered in models of vessel occlusion, the model by Jain et al. [72] is the first to
incorporate endothelial cell apoptosis at the cellular level during tumor angiogenesis.
The fact that our multi-scale model captures cellular quiescence and apoptosis opens
up a whole new area of investigation relevant to pro- and anti-angiogenic treatment
strategies.
Figure 8.1 is a flowchart representation of the multi-scale model architecture show-
ing the feedback mechanisms between the extracellular, intracellular, and intercel-
lular environments and the coupling of multiple time scales. We now remove the
phenomenologically based rules that determine whether a cell is a tip, proliferating,
or migrating cell. Instead, at every time step, each cell surveys its local landscape and
gathers information on the VEGF concentration, the availability of matrix molecules,
and the extent of its contact with neighbor cells. These environmental signals are
interpreted by the cell, via the signal transduction network, to determine cell pheno-
type. Because intracellular signal transduction happens on a faster time scale than
the other model dynamics, we assume cell signaling happens on the order of one
minute and incorporate the results of the signaling network analysis into this model
using a look-up table function. Given environmental cues that trigger the VEGF,
integrin, and cadherin cell surface receptors, cell phenotype is determined using the
table in Figure 7.2. To incorporate the signal transduction network presented in
Chapter VII, we must make some assumptions about how to measure receptor sig-
nal strength. We have empirical data for the number of endothelial cell VEGF
receptors and have already derived how much VEGF an endothelial cell can bind
during one Monte Carlo step [Chapter IV]. However, during angiogenesis, the num-
ber of integrin and cadherin receptors is dynamically regulated and widely varies,
depending sensitively on the cell’s environment and on time. In the absence of more
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detailed empirical data for receptor number, timing, and mechanism, we estimate
the strength of the signal from integrin and cadherin receptors by measuring the
matrix molecules immediately available to the cell and cell-cell contact respectively
and normalize these amounts by the cell’s size. These input signals are values that
range from 0 to 1. In addition, the node representing Rac1 in our signal transduction
network 7.1 can receive both an activating signal and an inhibitory signal. There is
no evidence indicating whether the molecular interactions of Rac1 are inhibition or
activation dominant. We model this uncertainty by randomly assigning the strength
of the inhibitory signal to Rac1 from Rho and assume that Rac1 is regulated by the
net signal. For instance, a net activating signal (> 0) will result in Rac1 activation.
After the phenotype of each cell is determined, cells respond in a phenotype-
dependent fashion. The phenotypes that we model include apoptotic (A), quiescent
(Q), migrating (M), proliferating (P), and cells that are able to proliferate and mi-
grate (MP). We model apoptosis by setting the cell’s target volume to zero and
removing any chemotactic incentives (χ = 0). Consequently, apoptotic cells will
decrease in size and disappear. When a cell becomes quiescent, it ceases growing
or moving in response to chemotactic signals, and will maintain its current volume.
Migrating and proliferating cells are treated as previously described in Chapter VI.
After a proliferating cell has doubled its size and completed a full cell cycle, it will
divide. Migrating cells move in response to VEGF but do not grow or divide. Ex-
periments of in vitro angiogenesis by Bautch et al. show cell proliferation can occur
in the leading sprout cells [79]. In Chapter V, we study cell motility and find that
in our model, cells that can both migrate and proliferate, exhibit the fastest migra-
tion speeds. These cells are the most flexible cells in terms of cellular mobility. We
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Figure 8.1: Flowchart showing how signals from a cell’s extracellular environment generate intra-
cellular signal transduction and determine cell phenotype. Depending on its phenotype,
endothelial cells exhibit different behaviors, which lead to changes in the extracellular
space. The extracellular, intracellular, and intercellular environments feedback on each
other coupling multiple timescales.
it is consistent with the chemotactic sensitivity of the tip cell phenotype of Chap-
ter VI. We examine the effect of assuming a higher chemotactic sensitivity for the
MP phenotype in our discussion of model validation (Section 8.2.1).
The stroma then evolves in time through one Monte Carlo step and the new spatial
profiles for the cells, VEGF, and ECM are used as inputs for the next iteration. As
this process repeats, cells respond to a dynamic environment and vascular sprouts
develop as the biological system evolves toward energy minimization.
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8.1.1 Parameter calibration
A list of values for the model parameters is provided in Table 8.2, including ref-
erences. Parameters are taken from experimental data or other published sources
whenever possible. If no reference is given, the parameter is a relative value chosen
to emulate the physical properties and behaviors of cells. The thresholds for signal
activation are a ratio of signal strength to current volume of the cell. The VEGF
receptor signal threshold, TR, is chosen in order to activate the initial endothelial
cell and is the amount of VEGF in picograms normalized by the size of the ini-
tial endothelial cell. The integrin receptor threshold, TI , and the threshold for the
strength of the VE cadherin signal necessary to trigger contact inhibition, TCI , are
chosen to reproduce reasonable sprout morphologies. By equating the time it takes
an endothelial cell to divide during the simulation with the endothelial cell cycle
duration of 18 hours [170], we convert Monte Carlo steps to real time units. In the
simulations reported in this chapter, 1 Monte Carlo step is equivalent to 1 minute.
8.2 Results
8.2.1 Cell phenotype distribution in time predicted by multi-scale cell-based model
The multi-scale model reproduces biologically realistic sprout morphologies and
sprout extension speeds. We validate this model by showing that average simulated
sprout extension speeds and sprout morphologies are consistent with those measured
experimentally [52, 79] (Figures 8.2 and 8.3). We measure average extension speed
as the total sprout displacement in time and report it in microns per hour (µm/hr).
See Section 6.2.1 for a detailed description of these experiments and our validation
method.
Figure 8.3 shows a simulated sprout developing at (a) 3.1, (b) 9.5, and (c) 14
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Table 8.2: Table of Parameters. Dimensions are given in terms of L=length, T=time, M=mass
and E=energy. Unless otherwise noted, all simulations used the same parameter set and
initial conditions. EC denotes endothelial cell and VI indicates parameter values that
were estimated in Chapter VI.
Parameter Symbol Dimensions Model Value
Length Scales L1,L2 L 166µm, 106µm
VEGF Diffusion D L2/T 3.6x10−4 cm2/h [148]
VEGF Decay λ T−1 0.6498 h−1 [148]
VEGF Uptake β M/cell/T 0.06 pg/EC/hr [20, 46, 168]
VEGF Source S M/L 0.035 pg/pixel [93, 75]
RTK Signal Threshold TR M/L 0.00095 pg/pixel
ITG Signal Threshold TI non-dim 0.20
VE Cadherin Threshold TCI non-dim 0.20
Adhesion
EC−EC Jee E/L 30 [VI]
EC−Fluid Jef E/L 76 [VI]
EC−Matrix Jem E/L 66 [VI]
Fluid−Fluid Jff E/L 71 [VI]
Fluid−Matrix Jfm E/L 85 [VI]
Matrix−Matrix Jmm E/L 85 [VI]
Membrane Elasticty
EC γe E/L4 0.8 [VI]
Matrix γm E/L4 0.5 [VI]
Fluid γf E/L4 0.5 [VI]
Chemotactic Sensitivity χ E/conc 1.11 · 106
MP Cell χMP E/conc −1.45 χ [VI]
Migrating Cell χM E/conc −1.42 χ [VI]
Proliferating Cell χP E/conc −1.40 χ [VI]
Quiescent Cell χQ E/conc 0
Apoptotic Cell χA E/conc 0
Intracellular Adhesion α E/L 300 [VI]
Boltzmann Temperature kT E 2.5 [VI]
hours. In panel (c), the sprout extension speed is 11.19 µm/hr and a new bud,
or branch point, develops from the main sprout (arrow). One major advantage
of this cell-based model is that we are able to track the different cell phenotypes
in time. Thus, we can determine whether the spatial distribution of different cell
phenotypes is correlated to sprout morphology or branching patterns. Let {MP, P,
M, Q, A} denote the migrating and proliferating, proliferating, migrating, quiescent,
and apoptotic cell phenotypes respectively. The distribution of cell phenotypes in
time for the simulation shown in Figure 8.3 given from the head of the sprout is
(a)={P, MP, P, M}, (b)={MP, MP, MP, MP, Q, M, P, P, MP, Q, M}, and (c)={MP,
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MP, MP, MP, MP, P, P, P, Q, P, M, M, Q, P, M}. The highly mobile MP cells
cluster at the head of the sprout. Naturally the question arises whether our choice
of chemotactic sensitivity for the MP cell type prescribes this clustering. Using
the chemotactic sensitivities calibrated in Chapter VI for tip and migrating (therein
referred to as stalk) cells, we consider the following cases: χMP > χM, χMP = χM =
1.45, χMP = χM = 1.55, and χMP < χM. We find that in all cases the MP phenotype
emerges at the sprout tips. Sprout morphology is not affected; all sprouts appear very
linear and there is no observable difference in cell shape, except for the case χMP =
χM = 1.45 in which cells are generally rounder and less elongated in appearance.
We attribute rounder cell shapes to the weaker chemotactic coefficient. There are,
however, differences in sprout extension speeds between these four cases. The results
are shown in Table 8.3. The fastest velocities (10.87 ± 0.198µm/h) occur when
χMP = χM = 1.55 and the slowest (10.145 ± 0.18µm/h) occur when χMP = χM =
1.45. Thus, χ is one regulator of sprout extension speed, but changes in χ of this
magnitude do not otherwise play a material role. This corroborates the finding from
our sensitivity analysis results for χ from Chapter VI. However, sprout migration
speeds are not significantly different between χMP > χM and χMP < χM indicating
that our choice of chemotactic sensitivity does not influence the fact that the MP
phenotype appears at the sprout’s tip. Thus, we conclude that MP cell clustering
at the head of the sprout occurs as a result of each cell’s local landscape and that
the environmental conditions near the sprout tip are conducive to cell migration
and proliferation. In addition, we observe that the MP cell phenotype is frequently
followed by a proliferating cell or region. Both of these phenomena are emergent.
In agreement with experimental findings that highly motile, often called “tip” cells,
lead the sprout and new branch formation [39], our model is further validated by the
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Figure 8.2: Multi-scale model validation: simulated sprout extension speeds agree with those ex-
perimentally measured [52, 79].
phenotype distributions we observe during simulations. Specifically, the patterns of
highly mobile MP cells clustered at the head of the sprout and are generally followed
by a region of proliferating cells (see Figure 8.3). Interestingly, the budding cell at
the branch point in Figure 8.3 is a proliferating cell. In one of the few experimental
studies to observe where proliferation occurs during new sprout development, Bautch
et al. shows that cell division occurs at the base of new sprout branches [79].
8.2.2 Model reveals link between matrix density, cell phenotype, and sprout branch-
ing
In Chapters V and VI, we showed that the structure and composition of the
stroma have a significant impact on vascular sprout development. We continue this
investigation using the multi-scale model and are able to consider now how ECM
topography, cell phenotype, and sprout morphology influence each other. As was
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Figure 8.3: The multi-scale model reproduces biologically realistic sprout morphologies and sprout
extension speeds consistent with those measured experimentally. Snapshots at a) 3.1,
b) 9.5, and c) 14 hours. At 14 hours, the sprout extension speed is 11.19 µm/hr and a
new bud branches from the main sprout. The budding cell is a proliferating cell (arrow).
Asterisks mark the MP phenotype.
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Table 8.3: Table comparing average sprout extension speeds as a function of phenotype dependent
chemotactic sensitivity. Results show that chemotactic sensitivity does not influence
the fact that the MP phenotype appears at the sprout’s tip. MP cell clustering at the
head of the sprout occurs as a result of each cell’s local landscape and is an emergent
phenomenon.
Chemotactic Sensitivity mean ± std error
χMP = χM = 1.55 10.87± 0.198
1.55 = χMP > χM = 1.45 10.54± 0.156
1.45 = χMP < χM = 1.55 10.40± 0.166
χMP = χM = 1.45 10.15± 0.18
densities. Fiber density is given as the fraction of interstitial tissue occupied by
matrix fibers, ρ, and corresponds to physiological quantities of collagen ranging from
0.0−0.53 g/ml. For these simulations, all parameters except matrix density are held
fixed. Simulations capture the first 14 hours of new sprout development.
We compare the average rates of sprout extension at different densities. The re-
sults are shown in Figure 8.4. Average extension speeds are given in microns per
hour (µm/hr) at various times (2, 5, 10, 14 hours) during sprout formation. Sprouts
developing on matrix densities ρ < 0.1 and ρ > 0.8 exhibit developmental defects,
such as severe cellular elongation or cell-cell contacts that cannot be maintained.
Consequently, no cohesive sprout body forms and we do not report extension speeds
for these density ranges. Sprouts extension speeds increase as matrix density in-
creases up to ρ < 0.3. This supports our finding in Chapter VI that the guidance
cues and fiber network connectivity provided as the density increases are instrumen-
tal in sprout development. We confirm our previous finding that sprout velocities
peak within an intermediate fiber density range. Multi-scale simulations show that
sprouts attain a maximum speed on densities between ρ = 0.35 − 0.45. This is
slightly different from our results from Section 6.2.2 that predicted peak velocities
between ρ = 0.3 − 0.4. These two results, however, are generally compatible and
strongly suggest there exists an optimal matrix density for promoting angiogenesis.
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Figure 8.4: Plot showing the dependence of sprout extension speeds on matrix fiber density. Multi-
scale simulations show that sprouts attain a maximum speed on densities between ρ =
0.35− 0.45.
Experimental verification is needed. Figure 8.4 indicates that peak migration speeds
are prominent at 2 hours, although still evident to a lesser extent at 10 and 14 hours.
Thus, these results do not depend on time. Empirical measurements of endothelial
cell migration speeds on various fibronectin concentrations (0.5, 1, 5, 20, 40 µg/cm2)
demonstrate peak migration speeds at intermediate concentrations (5 µg/cm2) [149]
and support our findings that maximum migration speeds depend on matrix den-
sity. Above ρ = 0.6, higher matrix densities start to present a physical barrier to
migration and we see a corresponding decline in sprout extension speed.
Next, we turn our attention to the relationship between fiber density and sprout
morphology. Confirming our finding in Chapter VI, developmental defects result on
matrices of density ρ ≤ 0.1 or ρ > 0.8. Figure 8.5 (a) and (f) are two examples. At
ρ = 0.1, most cells receive insufficient survival signals from the ECM and undergo
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Figure 8.5: Plots showing the relationship between matrix density and sprout morphology. From
top left to bottom right: (a) ρ = 0.10, insufficient integrin signal from the ECM results in
apoptosis and inhibition of angiogenesis; (b) ρ = 0.3, high matrix anisotropy contributes
to branching; (d) ρ = 0.4, cells coordinate chemotaxis and cell-matrix adhesion yielding
linear sprouts and maximum velocities; (e) ρ = 0.6, cells deform to navigate the denser
matrix; and (f) ρ = 0.9, complete inhibition of angiogenesis at high matrix density.
Snapshots around 14 hours.
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any frequency that would disrupt or alter sprout development. As matrix density
decreases from ρ = 0.3, the number of cells that receive apoptosis signals increases
until at ρ = 0.1, angiogenesis is completely inhibited. At the other extreme, high
fiber density, such as that shown for ρ = 0.9 (Figure 8.5f), presents a barrier to
cell migration causing cells to severely distort to make any headway. Our findings
continue to suggest that manipulating matrix fiber density may be a reasonable
target for pro- and anti-angiogenesis therapies.
Remarkably, we again find that sprout branching is highly correlated with a spe-
cific fiber density range. We define a new branch as one or more cells that extend, or
bud, at least 10 µm from the main sprout body [79]. The multi-scale model predicts
matrix densities 0.25 ≤ ρ ≤ 0.35 are highly conducive to sprout branching. This is
closely correlated to our prediction from Chapter VI where branching was restricted
to fiber densities between 0.2 ≤ ρ ≤ 0.3. Figure 8.5b shows sprout branching on
matrix density ρ = 0.3. Figure 8.6 is a time series of snapshots revealing the emer-
gence of new branches during simulated sprout development on a matrix density
ρ = 0.35 at (a) 4.7, (b) 7.8, (c) 9.4, and (d) 13.3 hours. At 9.4 hours, several new
buds have formed branch points and at 13.3 hours new branches are more fully de-
veloped. Whereas in Chapter VI we did not observe any branching above ρ = 0.35,
the multi-scale model predicts branching can occur on matrix densities as high as
ρ = 0.55. However, the incidence of branching above ρ = 0.3 in the multi-scale model
is considerably less frequent (35% compared to 80%) and absolutely no branching is
seen above ρ = 0.55 or below ρ = 0.3. In Chapter VI we proposed the possibility
that sprout branching is induced by high matrix anisotropy. This mechanical expla-
nation also applies to these results. On matrices with density ρ = 0.25− 0.35, high
matrix anisotropy contributes to sprout branching and tortuosity (Figure 8.5b, c).
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However, this explanation does not explain why branching occurs at higher densities,
albeit rare. The main difference between the model developed in Chapter VI and
this multi-scale model is the distribution of cell phenotypes, namely the presence
of multiple proliferating regions and multiple branch points. Thus, we may be able
to infer that the differences in their respective predictions are due to differences in
phenotype distribution. The hypothesis that sprout morphology is correlated to cell
phenotype is explored in greater detail in the next paragraph.
In contrast to tortuous and branching sprouts, as matrix density increases to ρ =
0.4, sprout formation becomes much more linear (Figure 8.5d). Incidentally, linear
sprout formation occurs in the fiber density regime that gives rise to maximum sprout
extension speeds. This may suggest that at ρ = 0.4, the cellular motility mechanisms,
chemotaxis and adhesion to matrix fibers, are well-coordinated by the cells, that is, at
ρ = 0.4, chemotactic and adhesive forces are present in a combination that promotes
motility. In addition, variations in the availability of adhesive binding sites in the
ECM that occur as fiber density is altered, combined with VEGF availability, may
elicit different molecular signals and therefore different cellular phenotypes. Different
phenotype distributions may yield different morphology. At densities ρ ≥ 0.6, cells
begin to alter their shape, elongating to navigate the denser matrix. Compare cell
shapes from Figures 8.5d, e, and f. Cell elongation increases with increases in fiber
density. At extremely high densities ρ = 0.9, sprout extension is stunted.
Recall that sprout branching and tortuosity is evident at ρ = 0.3− 0.35, whereas
ρ = 0.4 effects very linear sprout morphologies (Figure 8.5b-d). Matrix fiber hetero-
geneity is one factor contributing to these variations in morphology (linear versus
tortuous sprouts), however, morphological differences could also be a consequence of































Figure 8.6: Time series of simulated sprout development on a matrix with density ρ = 0.35 at a)
4.7, b) 7.8, c) 9.4, and d) 13.3 hours. At 9.4 hours, several new buds have formed branch
points and at 13.3 hours new branches are pronounced. Phenotype distribution from
right to left is (a)={MP, P, MP, M, Q, M, M}, (b)={MP, MP, Q, MP, MP, MP, M, Q,
M, MP, M}, (c)={MP, P, Q, MP, P, Q, M, MP, P, M, Q, M}, and (d)={MP, P, P, P,
M, P, M, M, M, P, M, Q, M, MP, Q, M}. Arrows point to proliferating cells; asterisks
identify the MP phenotype.
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cell-based model captures both changes in cell shape and function sprout develop-
ment, it allows us to examine how, if at all, vascular morphology is related to cell
phenotype. In Figure 8.6a-d, the spatio-temporal phenotype distribution given from
right to left is (a)={MP, P, MP, M, Q, M, M}, (b)={MP, MP, Q, MP, MP, MP, M,
Q, M, MP, M}, (c)={MP, P, Q, MP, P, Q, M, MP, P, M, Q, M}, and (d)={MP, P,
P, P, M, P, M, M, M, P, M, Q, M, MP, Q, M}. Asterisks identify the highly mobile
MP cells and arrows point to proliferating cells. In this simulation, after 4 hours (a),
the leading cell is an MP cell followed by a single proliferating cell. Another MP cell
has developed behind this pair followed by several migrating cells suggesting that
early sprout extension is largely powered by motility. That migration facilitates ini-
tial sprout extension is supported by experimental observations [151, 124]. Around
8 hours (b), there are six MP cells in the sprout, of which two have developed into
new buds. Again, the cells near the parent vessel are predominantly motile pheno-
types. Sprout extension is still driven by cellular migration. At 9.4 hours, several of
the MP cell phenotypes have received signals stimulating proliferation. Interestingly,
the mechanism for sprout extension shifts from a strictly motility driven extension
to cooperation between proliferation and migration. Again, this is generally consis-
tent with what is believed to occur in vivo where experiments show that cellular
proliferation is necessary for continued sprout extension [151, 124]. That being said,
exactly when and why sprout formation shifts from motility to proliferation driven
remains a conundrum. The buds develop and form several new branch points on the
sprout. Tip cell phenotypes lead these branch points, each followed by a prolifer-
ating cell. Finally, after 13 hours (d), several new branches emerge. At this stage,
both the number of migrating and proliferating cells have increased, however, the
sprout consists of proportionately more migrating cells. Viewing each branch as a
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new sprout in the early stages of extension, a shift back to motility is consistent with
our observations from (a) and (b). There is a distinct region of 3 proliferating cells
behind the MP cell, which leads the sprout. Another distinctive proliferating region
emerges in the posterior branch.
Figure 8.7 shows five sprouts developing simultaneously. The simulation on the
left is identical to the baseline simulations used to validate this model, except that
instead of one initial endothelial cell bud, there are five. At 14 hours, the new sprouts
are linear and only one has branched showing a 20% (low) branching incidence at
ρ = 0.4. In addition, no anastomosis occurs. In comparison, the simulations shown
in the center and right panels of Figure 8.7 capture sprout development at different
stages on matrices of density ρ = 0.3, where we typically observe branching. At this
matrix density, sprouts are observably more tortuous and the incidence of branching
is considerably greater. At 11 hours (center), new branch points are evident on
4 out of 5 sprouts (80%). In another simulation (right), two neighboring sprouts
merge forming a loop in a process called anastomosis. Again, multiple branch points
emerge. Except for a matrix density of ρ = 0.3, all parameters are identical to the
baseline parameters and are given in Table 8.2.
8.2.3 “Brush border” effect captured by multi-scale cell-based model
Our simulation domain is designed to model microvessel growth at the diffusion
limit for oxygen (∼ 100µm). Hence, in our simulations, even though proliferating
cells are growing and progressing towards mitosis, they reach the boundary of the
simulation domain prior to cell division. We now extend the stromal domain to
300 µm. This provides the space and time for sprout cells to complete division.
Except for the length of the domain (L1) and the duration of the simulation, these
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Figure 8.8: Brush border effect (increased branching) evident during sprout simulation on 300 µm
domain with ρ = 0.4. Snapshot taken at 26.5 hours after some cells have completed
mitosis. Parameters and matrix density are identical to the parameters used for multi-
scale model validation.
snapshot of sprout growth at 26.5 hours, after several cells have completed mitosis.
We observe cell division concentrated near the tip of the sprout and a subsequent
increase in sprout branching. The phenomenon of increased incidence of branching as
the sprout approaches the tumor is referred to as the “brush border” effect [124, 9].
Of special note is that the matrix fiber density in this simulation is ρ = 0.4, a
density not typically conducive to branching. The observation that proliferation
actually occurs near the sprout tip on a matrix density that induces branching less
than 20% of the time (see left panel in Figure 8.7) implies that the observed increase
in branching frequency could be correlated to cell proliferation. The “brush border”
effect is another emergent behavior of our cell-based model. To date, no other model
of tumor-induced angiogenesis has simulated the “brush border” effect except as




The sensitivity of these results to parameter variability follows the analysis re-
ported in Section 6.2.6. We additionally investigate the sensitivity of these results to
the choice of signaling thresholds, TR, TI , and TCI . Lowering the value of the VEGF
and integrin receptor thresholds can be interpreted as increasing the potency of these
receptors, for example, a lower threshold value for TI means that it requires fewer
bound integrin receptors to trigger the integrin signaling pathways. For comparison,
we count the number of cells in each phenotype class at 14 hours. When we vary
the integrin receptor activation threshold, TI , we find that the choice of TI affects
both the number of MP cells and the number of cells that undergo apoptosis. The
number of MP cells increases with increases in TI up to a maximum at intermediate
values 0.30 ≤ TI ≤ 0.35. For 0.10 ≤ TI < 0.40, although the distribution of cell
phenotypes in the sprout vary, sprout extension speed and sprout morphology do
not. At TI = 0.3, we see the first apoptotic cell. As TI increases, so does the number
of apoptotic cells. There is a corresponding decrease in the number of proliferating
cells as TI increases. For TI ≥ 0.45, the increase in apoptotic cells and interruption
of cell growth halts angiogenesis completely (see Figure 8.9a).
While apoptosis and cell migration are regulated by the choice of TI , the threshold
for contact inhibition, TCI , specifically regulates the number of proliferating cells in
the sprout. A small value for TCI indicates that cells are very sensitive to contact with
other cells and this contact will inhibit proliferation. For TCI ≤ 0.1, proliferation is
completely inhibited. The sprouts are entirely composed of migrating and quiescent
cells. Sprout speeds are suppressed (∼ 4.7µm/hr) and the sprout is several cells thick.
As TCI increases above 0.1, the number of proliferating cells increases. The sprouts
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Figure 8.9: Apoptosis has not received much attention in previous models of angiogenesis. (a)
As TI is increased above 0.45, there is a corresponding increase in apoptotic cells and
interruption of cell growth that halts angiogenesis. (b) Apoptosis is also regulated by
TR. In this simulation, at TR = 0.005 cells receive insufficient survival signals and
become apoptotic causing sprout regression. Snapshots at 14 hours.
166
thick. In addition, the number of proliferating cells increases as TCI increases up to
TCI ≥ 0.3. Above 0.3, there is no additional increase in the number of proliferating
cells. We do not observe any differences in extension speed with changes in TCI above
0.1.
As we vary the threshold for VEGF receptor activation, TR, we find that below
TR = 0.002, the extension speed and morphology are insensitive to changes in this
parameter. For TR ≥ 0.002 however, there is an increase in the number of apoptotic
cells and vessel growth is halted. Figure 8.9b shows a simulation snapshot at 14
hours using TR = 0.005. As cells receive inadequate survival signals, they enter
apoptosis and the developing sprout regresses. There does not appear to be any
other recognizable pattern or correlation with cell phenotype. We conclude that in
our model TR is a regulator of cell survival.
8.3 Discussion
We introduce an additional level of cellular regulation and biological realism into
our model by integrating the intracellular signal transduction network developed in
Chapter VII with the cell-based model of angiogenesis we extended in Chapter VI.
The result is a multi-scale cell-based model of tumor-induced angiogenesis. The
intracellular signaling network synthesizes what is known about the molecular path-
ways critical to angiognesis and provides a mechanism for cellular decision making.
Consequently, the distribution of cell phenotypes in the sprout are no longer phe-
nomenologically defined; cells regulate their behavior according to the signals they
receive from their external environment. Apoptotic and quiescence cell phenotypes
are incorporated into our model as a result of the intracellular signaling network.
These two cellular functions are rarely considered in other models of angiogenesis
167
and yet are important dynamics to capture for a model to be useful in testing anti-
angiogenesis therapies.
We employ this multi-scale model for a more in-depth exploration of the mech-
anisms mediating capillary sprout formation. In particular, our studies reveal a
correspondence between cell phenotype, sprout morphology, and matrix fiber den-
sity. Our model predicts that sprout branching occurs more frequently on matrix
densities exhibiting a high degree of anisotropy. In contrast, we find that linear
sprouts develop in a density regime coincident with that which elicits maximum
sprout velocities. We conjecture that morphological variations are not only due to
the mechanical forces arising from ECM anisotropy, but also to the differences in
cell phenotype distributions in the sprout that are created as matrix fiber density is
altered. A major question experimentalists are fervently pursuing is how the same
cellular receptors elicit very different cellular responses. Experiments show that the
same VEGF receptor (VEGFR2) is responsible for mediating very different cellular
behaviors, including endothelial cell growth, mitogenesis, migration, the production
of enzymes and angiogenic factors, and increased cell survival [40, 19, 39]. By varying
matrix density and examining cell phenotype and sprout morphology, we show how
the availability of adhesive binding sites in the ECM combined with VEGF availabil-
ity may elicit different molecular signals and therefore different cellular phenotypes.
Our findings implicate VEGF-integrin-cadherin receptor crosstalk and variations in
a cell’s immediate external environment as a potential explanation.
In Chapter V, we point out that proliferation is reported to occur in widely dif-
ferent parts of the sprout, and we use our model to examine the effect of varied
proliferating regions on sprout development. Our findings suggest that sprout ex-
tension is enhanced as the proliferating region migrates away from the specialized
168
and exclusively motile tip cells. The multi-scale model naturally allows for differ-
ent regions of proliferation in the sprout and the possibility that the proliferating
region may change and move around. Contact inhibition, which mediates prolifer-
ation cues, is also considered in the signal transduction network and is yet another
mechanism by which growth differentials may arise within a developing sprout. Be-
cause the distribution of cell phenotypes in the sprout is determined by individual
cellular response to local external stimuli, multiple branch points and regions of cell
proliferation emerge and induce more complex vascular structures. We find that cell
proliferation is frequently concentrated toward the sprout tip and new branches, and,
therefore, may contribute to multiple branch formation. Simulations of sprout de-
velopment on longer domains (300 µm) allow cells to complete mitosis. We observe
cell division concentrated near the tip of the sprout and increased sprout branching,
known as the brush border effect. No model of angiogenesis has simulated the brush
border effect without it being a prescribed consequence of the rules for branching.
Our findings suggest that cell proliferation plays an important role in the increase in
branching frequency as sprouts progress.
The sensitivity analysis reveals some interesting observations about how signal
transduction thresholds mediate cell phenotype. A higher receptor activation thresh-
old means that it is more difficult to initiate the signaling cascades associated with
that receptor. Biological interventions that act as mechanisms for threshold signal
transduction regulation include moderating the up/down regulation of total recep-
tors, the presence of other molecules that competitively bind the receptor, or medi-
ating the binding affinity of the receptor or ligand. We find that the threshold for
VEGF receptor activation, TR, is a regulator of cell survival. At TR = 0.002, blood
vessel growth is completely inhibited and the new sprout begins to regress after 20
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minutes. This finding suggests that reducing the binding affinity, introducing com-
petitive binding, or blocking the VEGF receptors, will interrupt normal angiogenesis.
In fact, targeting the VEGF receptors in these ways forms the basis for many anti-
angiogenic therapeutic strategies presently in use or in clinical trials. When we vary
the threshold that triggers contact inhibition, TCI , we find that for TCI ≤ 0.1, there
are no proliferating cells in the sprout and sprout extension speed is significantly de-
pressed. As TCI increases and the number of proliferating cells in the stalk increases,
sprout extension speeds also increase. This finding provides support that prolifer-
ation is necessary for continued sprout extension. Although they did not measure
sprout extension speeds, results from Sholley et al. [151] indicate a new sprout can
migrate only a finite distance into the stroma and that proliferation is necessary for
continued sprout extension. Our finding is generally consistent with this empirical
result. An interesting observation is that for TCI ≥ 0.3, we do not see any additional
increase in the number of proliferating cells. This suggests that the effects of further
decreases in cell sensitivity to contact inhibition (i.e., TCI increasing) saturate above
0.3.
TI represents the threshold for integrin receptor signal propagation. Our model
predicts that for intermediate values, 0.30 ≤ TI ≤ 0.35, the number of migrating
cells is maximal. Consider this prediction in the context of our previous finding
in Chapter VI that extension speeds are maximal for sprouts developing on matrix
densities 0.30 ≤ ρ ≤ 0.40. We can infer a positive correspondence between matrix
density and the number of cell-ECM contacts and this activation threshold TI . Also
in Chapter VI, we discuss cell proliferation and cell recruitment as complementary
mechanisms facilitating sprout extension. In our simulations, when 0.10 ≤ TI < 0.40,
sprout extension speeds did not significantly vary although the distribution of cell
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phenotypes in the sprout did. The total number of proliferating and migrating cells
in the sprout combined, however, remains approximately constant. This provides
additional support to our previous finding that proliferation and migration are com-
plementary mechanisms for sprout extension. For TI ≥ 0.45, simulations reveal an
increase in apoptotic cells and a consequent interruption of angiogenesis. This result
is consistent with what we might expect to occur based on experimental observa-
tions. In the model, when this threshold is set high, it is harder for the cell to receive
a signal from its integrin receptors and consequently the cell dies. Experimentally it
has been shown that endothelial cells will die when they are unable to adhere to the
extracellular matrix [64], that is, they are anchorage dependent cells. In the context
of angio-therapy, we can relate the effects of altering the threshold for integrin re-
ceptor signal transduction to the effects of interfering with integrin receptor binding
affinity. When empirical data for the number of receptors and receptor regulation for
specific matrix molecules becomes available, using the multi-scale cell-based model
we can test specific anti-angiogenic therapies that target integrin receptors.
CHAPTER IX
Summary
9.1 Impact of Dissertation Research
Anti-angiogenic and ECM-targeted strategies are clinically recognized as having
enormous potential in the treatment of cancer. Therapeutic advances in these areas
could have immediate effects on the lives of millions of cancer patients.
Mathematical modeling and simulation of angiogenesis are becoming increasingly
important in the development and testing of anti-angiogenic therapeutic strategies.
Ultimately, the aim is to link models of avascular tumor growth, angiogenesis, and
vascular tumor growth and metastasis for a complete and predictive model of tumor-
induced angiogenesis. While significant progress has been made over the last two
decades developing models of tumor-induced angiogenesis, no model couples multi-
ple time and length scales, generates realistic capillary structures including branching
and anastomoses without a priori prescribing rules and probabilities to these events,
and considers the complex biochemical and mechanical interactions that occur be-
tween endothelial cells and the ECM. Despite the large body of experimental research
on angiogenesis and convincing evidence pointing to the ECM as a critical component
of vascular development, previous mathematical investigations have largely treated
the ECM as a passive medium, ignoring the interactions between endothelial cells
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and the ECM and intracellular signaling pathways in capillary network formation.
Mathematical modeling and experimental observations provide convincing evidence
that both mechanical and chemical processes may govern tumor-induced angiogen-
esis and that interactions between tumor cells and endothelial cells within the host
environment cannot be ignored.
To advance the current state of mathematical models of tumor-induced angiogen-
esis, in this dissertation, we develop a multi-scale cell-based model of tumor-induced
angiogenesis that integrates a cellular model for cell dynamics explicitly describing
key interactions between cells and the ECM, an intracellular signal transduction
network highlighting receptor cross-talk for cell decision making, and extracellular
reaction-diffusion VEGF dynamics. This research makes significant and novel con-
tributions to and advances the field of mathematical modeling of angiogenesis in the
following ways. This model is the first cell-based model of angiogenesis. It facilitates
a mechanistic study of the impact of local interactions on the resulting global dy-
namics of this complex system. Our cell-based model captures changes in cell shape
and sprout morphology in time, details that cannot be observed with other models of
angiogenesis. Another major advance is that the model contains a more detailed and
explicit description of the interactions between cells and the extracellular matrix,
interactions that are critical mediators of morphogenic processes. This model also
is the first to include a signal transduction network that couples VEGF, integrin,
and cadherin pathways and links environmental cues to cell function to elucidate
the biochemical mechanisms responsible for new vessel growth. The addition of the
signaling network also introduces apoptotic and quiescent cell phenotypes into the
model. Cell quiescence and apoptosis have received very little attention in other
models of angiogenesis. From only a small set of simple cellular behaviors (growth,
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division, migration, and adhesion), the initial model presented in Chapter IV, cap-
tures emergent phenomena as evidenced by the formation of new sprout branches
and loop formation. These emergent phenomona are also observed with the addition
of quiescent and apoptotic cell phenotypes in the multi-scale model. This model is
the first to simulate sprout branching without prescribing a phenomenological rule
prescribing when and how a branch forms. This puts us in a unique position to
explore and predict the mechanisms responsible for new branch formation.
The research completed for this dissertation is relevant not only to those interested
in modeling angiogenesis and cell signaling, but also to the larger modeling commu-
nity because capturing dynamics that occur across multiple time and length scales
is a difficult computational and modeling challenge. Our approach is an example of
how to integrate three different modeling techniques to bridge multiple scales in the
context of tumor angiogenesis. The approach applied here to describe angiogenesis
can also be used to model other complex biological systems, such as the immune
system response and host-pathogen interactions.
This research is also relevant to experimentalists and clinicians. This model pro-
vides a great deal of biological flexibility and has been used to facilitate a deeper
understanding of the cellular and molecular interactions associated with angiogenesis.
We tested hypotheses formulated from conflicting experimental data to aid in the in-
terpretation of such data and predicted under what conditions critical various sprout
morphologies and cell behaviors emerge which can be tested experimentally. Most
importantly, our model can be easily modified to mimic other experimental assays
and to test new pro- and anti-angiogenic therapies for the treatment of angiogenesis-
dependent diseases. Such applications, if they result in therapeutic advances, could
have immediate and far-reaching impact.
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9.2 Future Outlook
Beyond the research proposed under this dissertation, there is still much to do
towards understanding all the mechanisms responsible for angiogenesis to occur. Ad-
ditional extensions and improvements to the cell-based multi-scale model developed
in this thesis research may include incorporating the effects of angiogenic inhibitors,
other intracellular signaling pathways and cell cycle controls, explicit protease pro-
duction and protein expression, variations in oxygen concentrations in the stroma,
vessel maturation, and blood flow through the capillaries. Below, we present and
partially develop two additional ideas for future model extensions.
9.2.1 Modeling matrix fiber reorganization
It is well-known that endothelial cells actively restructure the extracellular matrix
as they migrate. Matrix degradation, which facilitates cell migration through the
ECM, is already a feature of this model. ECM remodeling also occurs as a result
of endothelial cell matrix production. Endothelial cells synthesize matrix proteins
as they move through the ECM, recreating a matrix support structure along which
sprouting capillaries can continue to grow and a means by which endothelial cells
can self-regulate angiogenic events [147][57]. In Chapters V and VI, we predict
optimal densities conducive to angiogenic progress and branching. Endothelial cell
matrix secretion may be more likely when matrix density falls below these predicted
thresholds. The degree of protein synthesis should affect cell migration and capillary
formation and these proteins eventually form the mature vessels’ basement membrane
structure [147]. Endothelial cell matrix synthesis is easily incorporated into the model
by allowing matrix molecules to be secreted by the individual endothelial cells in a





The direction of the frictional force exerted by an endothelial cell is quantified by taking
the angle of inclination, φ, created by the ray joining a cell’s center of mass, C, and the
point, A, on the cell’s boundary along its major axis.
In its role as a support structure for the endothelial cells, the ECM provides
a type of scaffolding on which the endothelial cells can move. The cells try to
move chemotactically toward higher chemical concentrations, but are additionally
influenced by the matrix fibers. To gain traction to move, endothelial cells adhere
to fibers in the ECM via cell surface receptors called integrins [34]. Integrin ligation
gives rise to a frictional force that can restructure the ECM. These frictional forces
act to align the collagen fibers of the ECM forming linear tracks, which in turn
strongly influence the direction of endothelial cell migration [165][85]. Consequently,
branching and anastomosis have also been associated with the mechanical forces
exerted on the ECM by endothelial cells. An endothelial cell will exert a force in
the direction it is moving. As a cell moves, it elongates. Therefore, in the model a
cell’s direction, or orientation, can be considered to be the direction described by the
longest distance across the cell and can be quantified relative to the x-axis. Define
the angle of inclination, φ, as the ray created by joining a cell’s center of mass, C, and
the point, A, on the cell’s boundary (see Figure 9.1) along its major axis. Endothelial
cell migration is up a chemical gradient as the cell tries to move to a lower potential
energy state. Thus, chemotactic migration produces the force that is exerted on the
matrix fibers by the endothelial cells. The difference between the chemical potential
at two positions is the amount of energy liberated by moving to lower potential and
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is equal to
µV (~x)− µV (~x ′) .
This is the amount of energy now available to do work on matrix fibers. The work
will be distributed to (1) overcome friction as the cell moves along the fiber, (2)
deform the fiber, and (3) displace the fiber. The work done as the endothelial cell
moves along the fiber is equal to the frictional force multiplied by distance. The
frictional force is a result of the binding between an endothelial cell and a matrix
fiber. The deformation of the fiber is more complicated, and simplifying assumptions
will have to be made. Estimates of elasticity and stiffness, which are given by Young’s
modulus, exist for matrix-like substrates used for in vitro experiments that studied
how endothelial cells differentially remodel ECM proteins depending on the stiffness
of the substrate [55]. Another rich source of parameter values for matrix stiffness is
available in Holmes and Sleeman [61].
To implement ECM restructuring into the model, as was done with individual
endothelial cells, each matrix fiber possesses its own identifying number or fiber ID.
As an endothelial cell comes in contact with a matrix fiber, the cell exerts a force on
the fiber which deforms and displaces the fiber. The connectivity of the matrix fibers
also needs to be considered, that is, if the force exerted on a fiber by an endothelial
cell is large enough, connecting fibers may also be affected. The precise formulation
of the total force (friction+deformation+displacement) exerted on a matrix fiber by
an endothelial cell has not been developed in the context of the cellular Potts model,
but should be based on experimentally measured elasticity parameters, as was done
in [99], [61] and similar studies.
The ECM fibrils are thought to strongly influence the direction of EC migration.
In addition, we already know ECM topography is a critical regulator of morphogene-
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sis. Endothelial cell matrix fiber reorganization, however, has not been characterized
in mathematical models. Extending the model developed in this dissertation to ex-
plicitly incorporate fibril interactions is likely to provide additional insights into the
mechanisms controlling vascular morphology, including sprout branching and anas-
tomosis.
9.2.2 Influence of various VEGF isoforms
Including different VEGF isoforms and VEGF receptors in the model not only
improves the physiological accuracy of the system, but also provides a mechanism
allowing endothelial cells to respond to their microenvironment based on the actual
intracellular signal transduction induced by different VEGF isoform-receptor combi-
nations. Thus, endothelial cells can make informed decisions to migrate or proliferate
depending on the type of VEGF form bound, the amount internalized, and whether
binding has occurred via integrin receptors or VEGF receptors. In Chapter V, we
show that steep versus shallow VEGF gradients markedly influence capillary sprout
morphology, but do not explicitly model different VEGF isoforms. Incorporating
multiple VEGF isoforms into the multi-scale model of angiogenesis will allow a true
analysis of vessel morphology as a function of VEGF profiles to be conducted. The
model can then be used to further elucidate how the delicate balance between migra-
tion of the tip cell and proliferation of the stalk cells during angiogenesis is achieved
and maintained.
Hypotheses, including:
• The release of matrix bound growth factors (VEGF189 and VEGF165) as a result
of matrix degradation by tip cell secreted proteases distinguishes a proliferating
region of cells in the vicinity of the tip cell, and
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• Different VEGF isoforms play a significant role in the guidance and formation
of capillary sprouts
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